<?xml version="1.0" encoding="UTF-8"?>
<!-- Prepared by Business Wire using Fujitsu Interstage XWand for Instance Creation -->
<xbrli:xbrl xmlns:pfe="http://www.pfizer.com/2010-10-03" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://xbrl.us/us-gaap/2009-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-types="http://xbrl.us/us-types/2009-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.us/dei/2009-01-31" xmlns:NonMonetary="http://www.fujitsu.com/xbrl/taxeditor/NonMonetary" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-roles="http://xbrl.us/us-roles/2009-01-31" xmlns:xlink="http://www.w3.org/1999/xlink">
  <link:schemaRef xlink:type="simple" xlink:href="pfe-20101003.xsd"/>
  <xbrli:context id="Cur_20101003">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_9mos_20090927">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20081231">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2008-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20090927">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-09-27</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="DEI_2010-11-08">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-11-08</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="DEI_2009-06-26">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-06-26</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090927">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_AdditionalDepreciationAssetRestructuringMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringAndRelatedCostByTypeOfRestructuringAxis">pfe:AdditionalDepreciationAssetRestructuringMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_AdditionalDepreciationAssetRestructuringMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringAndRelatedCostByTypeOfRestructuringAxis">pfe:AdditionalDepreciationAssetRestructuringMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_69mos_20101003">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2005-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_69mos_20101003_EmployeeSeveranceMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringAndRelatedCostByTypeOfRestructuringAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2005-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_69mos_20101003_AssetImpairmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringAndRelatedCostByTypeOfRestructuringAxis">pfe:AssetImpairmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2005-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_69mos_20101003_OtherRestructuringChargesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringAndRelatedCostByTypeOfRestructuringAxis">pfe:OtherRestructuringChargesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2005-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_EmployeeSeveranceMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringAndRelatedCostByTypeOfRestructuringAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_AssetImpairmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringAndRelatedCostByTypeOfRestructuringAxis">pfe:AssetImpairmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_OtherRestructuringChargesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringAndRelatedCostByTypeOfRestructuringAxis">pfe:OtherRestructuringChargesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_TradingAccountAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisDisclosureItemsAxis">us-gaap:TradingAccountAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_AvailableForSaleDebtSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisDisclosureItemsAxis">pfe:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_AvailableForSaleMoneyMarketFundsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisDisclosureItemsAxis">pfe:AvailableForSaleMoneyMarketFundsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_AvailableForSaleEquitySecuritiesExcludingMoneyMarketFundsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisDisclosureItemsAxis">pfe:AvailableForSaleEquitySecuritiesExcludingMoneyMarketFundsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_ForeignExchangeContractMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisDisclosureItemsAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_InterestRateSwapMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisDisclosureItemsAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_ForeignExchangeForwardMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisDisclosureItemsAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_TradingAccountAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisDisclosureItemsAxis">us-gaap:TradingAccountAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_AvailableForSaleDebtSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisDisclosureItemsAxis">pfe:AvailableForSaleDebtSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_AvailableForSaleMoneyMarketFundsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisDisclosureItemsAxis">pfe:AvailableForSaleMoneyMarketFundsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_AvailableForSaleEquitySecuritiesExcludingMoneyMarketFundsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisDisclosureItemsAxis">pfe:AvailableForSaleEquitySecuritiesExcludingMoneyMarketFundsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_ForeignExchangeContractMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisDisclosureItemsAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_InterestRateSwapMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisDisclosureItemsAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_ForeignExchangeForwardMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisDisclosureItemsAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_ForeignExchangeContractMember_2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDisclosureItemsAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_InterestRateSwapMember_2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDisclosureItemsAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_ForeignExchangeForwardMember_2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDisclosureItemsAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_ForeignExchangeContractMember_2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDisclosureItemsAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_InterestRateSwapMember_2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDisclosureItemsAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_ForeignExchangeForwardMember_2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDisclosureItemsAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_ForeignExchangeContractMember_3">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_InterestRateSwapMember_3">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_ForeignExchangeForwardMember_3">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_ForeignExchangeContractMember_3">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_InterestRateSwapMember_3">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_ForeignExchangeForwardMember_3">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_CertificatesOfDepositAndOtherMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfHeldToMaturitySecuritiesMajorTypesOfDebtAndEquitySecuritiesAxis">pfe:CertificatesOfDepositAndOtherMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_WesternEuropeanAndOtherGovernmentDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfAvailableForSaleSecuritiesMajorTypesOfDebtAndEquitySecuritiesAxis">pfe:WesternEuropeanAndOtherGovernmentDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_WesternEuropeanAndOtherGovernmentAgencyDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfAvailableForSaleSecuritiesMajorTypesOfDebtAndEquitySecuritiesAxis">pfe:WesternEuropeanAndOtherGovernmentAgencyDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_CorporateDebtSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfAvailableForSaleSecuritiesMajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_FederalHomeLoanMortgageCorporationAndFederalNationalMortgageAssociationAssetBackedSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfAvailableForSaleSecuritiesMajorTypesOfDebtAndEquitySecuritiesAxis">pfe:FederalHomeLoanMortgageCorporationAndFederalNationalMortgageAssociationAssetBackedSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_ReverseRepurchaseAgreementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfAvailableForSaleSecuritiesMajorTypesOfDebtAndEquitySecuritiesAxis">pfe:ReverseRepurchaseAgreementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_SupranationalDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfAvailableForSaleSecuritiesMajorTypesOfDebtAndEquitySecuritiesAxis">pfe:SupranationalDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_CertificatesOfDepositMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfAvailableForSaleSecuritiesMajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_CommercialPaperMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_CommercialPaperMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByBalanceSheetGroupingDisclosureItemAmountsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20090324">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-03-24</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20090603">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-06-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_BiopharmaceuticalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:GoodwillBySegmentAxis">pfe:BiopharmaceuticalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_DiversifiedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:GoodwillBySegmentAxis">pfe:DiversifiedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_BiopharmaceuticalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:GoodwillBySegmentAxis">pfe:BiopharmaceuticalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_DiversifiedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:GoodwillBySegmentAxis">pfe:DiversifiedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_BiopharmaceuticalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:GoodwillBySegmentAxis">pfe:BiopharmaceuticalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_DiversifiedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:GoodwillBySegmentAxis">pfe:DiversifiedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_DevelopedTechnologyRightsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_BrandsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pfe:BrandsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_LicensingAgreementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_TrademarksMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_DevelopedTechnologyRightsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_BrandsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pfe:BrandsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_LicensingAgreementsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_TrademarksMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_OtherIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pfe:OtherIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_OtherIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">pfe:OtherIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_ForeignExchangeForwardMember_CashFlowHedgingMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_ForeignExchangeContractMember_CashFlowHedgingMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_9mos_20090927_ForeignExchangeForwardMember_CashFlowHedgingMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_9mos_20090927_ForeignExchangeContractMember_CashFlowHedgingMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">pfe:UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_ForeignPensionPlansDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:ForeignPensionPlansDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">pfe:UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_ForeignPensionPlansDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:ForeignPensionPlansDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">pfe:UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_ForeignPensionPlansDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:ForeignPensionPlansDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_BiopharmaceuticalMember_2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:BiopharmaceuticalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_DiversifiedMember_2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:DiversifiedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_CorporateOtherMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:CorporateOtherMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_BiopharmaceuticalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:BiopharmaceuticalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_DiversifiedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:DiversifiedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_CorporateOtherMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:CorporateOtherMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_LipitorMember_2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:LipitorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_EnbrelMember_2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:EnbrelMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_LyricaMember_2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:LyricaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_EffexorMember_2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:EffexorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_CelebrexMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:CelebrexMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_PrevnarPrevenar7Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:PrevnarPrevenar7Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_ViagraMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ViagraMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_XalatanXalacomMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:XalatanXalacomMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_NorvascMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:NorvascMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_ZyvoxMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ZyvoxMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_PrevnarPrevenar13Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:PrevnarPrevenar13Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_ZosynTazocinMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ZosynTazocinMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_DetrolDetrolLAMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:DetrolDetrolLAMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_SutentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:SutentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_PremarinFamilyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:PremarinFamilyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_GeodonZeldoxMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:GeodonZeldoxMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_GenotropinMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:GenotropinMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_ChantixChampixMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ChantixChampixMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_VfendMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:VfendMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_BeneFIXMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:BeneFIXMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_CaduetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:CaduetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_AromasinMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:AromasinMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_ZoloftMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ZoloftMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_RevatioMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:RevatioMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_MedrolMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:MedrolMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_CarduraMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:CarduraMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_AriceptMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:AriceptMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_ZithromaxZmaxMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ZithromaxZmaxMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_ReFactoAFXynthaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ReFactoAFXynthaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_AllOtherMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:AllOtherMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_AllianceRevenuesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:AllianceRevenuesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_AnimalHealthMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:AnimalHealthMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_ConsumerHealthcareMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ConsumerHealthcareMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_NutritionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:NutritionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_CapsugelMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:CapsugelMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_LipitorMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:LipitorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_LyricaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:LyricaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_CelebrexMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:CelebrexMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_ViagraMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ViagraMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_XalatanXalacomMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:XalatanXalacomMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_NorvascMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:NorvascMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_ZyvoxMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ZyvoxMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_DetrolDetrolLAMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:DetrolDetrolLAMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_SutentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:SutentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_GeodonZeldoxMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:GeodonZeldoxMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_GenotropinMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:GenotropinMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_ChantixChampixMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ChantixChampixMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_VfendMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:VfendMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_CaduetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:CaduetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_AromasinMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:AromasinMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_ZoloftMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ZoloftMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_RevatioMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:RevatioMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_MedrolMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:MedrolMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_CarduraMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:CarduraMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_AriceptMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:AriceptMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_ZithromaxZmaxMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ZithromaxZmaxMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_AllOtherMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:AllOtherMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_AllianceRevenuesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:AllianceRevenuesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_AnimalHealthMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:AnimalHealthMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_CapsugelMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:CapsugelMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_ImplementationCostsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringAndRelatedCostByTypeOfRestructuringAxis">pfe:ImplementationCostsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_RestructuringAccrualMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringAndRelatedCostByTypeOfRestructuringAxis">pfe:RestructuringAccrualMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_ScenarioPreviouslyReportedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_ScenarioAdjustmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioAdjustmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091015_WyethMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pfe:WyethMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-10-15</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_AssetBackedSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfAvailableForSaleSecuritiesMajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_9mos_20090927_InterestRateContractMember_CashFlowHedgingMember_OtherIncomeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">pfe:OtherIncomeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_9mos_20090927_InterestRateContractMember_CashFlowHedgingMember_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_9mos_20090927_InterestRateSwapMember_FairValueHedgingMember_OtherIncomeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">pfe:OtherIncomeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_9mos_20090927_ForeignExchangeContractMember_CashFlowHedgingMember_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_9mos_20090927_ForeignExchangeForwardMember_CashFlowHedgingMember_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_ForeignExchangeContractMember_CashFlowHedgingMember_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_ForeignExchangeContractMember_NetInvestmentHedgingMember_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6Mos_2009-09-27_ForeignExchangeContractMember_NetInvestmentHedgingMember_OtherIncomeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">pfe:OtherIncomeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6Mos_2009-09-27_ForeignExchangeContractMember_NetInvestmentHedgingMember_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_9mos_20090927_ForeignExchangeForwardMember_NondesignatedMember_OtherIncomeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">pfe:OtherIncomeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_9mos_20090927_ForeignExchangeContractMember_NondesignatedMember_OtherIncomeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">pfe:OtherIncomeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_ForeignExchangeForwardMember_NondesignatedMember_OtherIncomeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">pfe:OtherIncomeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_9mos_20090927_ForeignCurrencyShortTermBorrowingsMember_NetInvestmentHedgingMember_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">pfe:ForeignCurrencyShortTermBorrowingsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_2010-10-03_ForeignCurrencyShortTermBorrowingsMember_NetInvestmentHedgingMember_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">pfe:ForeignCurrencyShortTermBorrowingsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_2010-10-03_ForeignCurrencyLongTermDebtMember_NetInvestmentHedgingMember_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">pfe:ForeignCurrencyLongTermDebtMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">pfe:UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_ForeignPensionPlansDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:ForeignPensionPlansDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">pfe:UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_ForeignPensionPlansDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:ForeignPensionPlansDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis">us-gaap:UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">pfe:AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_AdditionalDepreciationAssetRestructuringMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringAndRelatedCostByTypeOfRestructuringAxis">pfe:AdditionalDepreciationAssetRestructuringMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_AdditionalDepreciationAssetRestructuringMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringAndRelatedCostByTypeOfRestructuringAxis">pfe:AdditionalDepreciationAssetRestructuringMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20090927_SeniorDebtObligationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorDebtObligationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-09-27</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_ImplementationCostsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringAndRelatedCostByTypeOfRestructuringAxis">pfe:ImplementationCostsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_BiopharmaceuticalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:BiopharmaceuticalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_DiversifiedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:DiversifiedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_CorporateOtherMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:CorporateOtherMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_LipitorMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:LipitorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_EnbrelMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:EnbrelMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_LyricaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:LyricaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_EffexorMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:EffexorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_CelebrexMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:CelebrexMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_ViagraMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ViagraMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_XalatanXalacomMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:XalatanXalacomMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_PrevnarPrevenar13Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:PrevnarPrevenar13Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_PrevnarPrevenar7Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:PrevnarPrevenar7Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_NorvascMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:NorvascMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_ZyvoxMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ZyvoxMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_DetrolDetrolLAMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:DetrolDetrolLAMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_PremarinFamilyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:PremarinFamilyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_SutentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:SutentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_GeodonZeldoxMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:GeodonZeldoxMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_ZosynTazocinMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ZosynTazocinMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_GenotropinMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:GenotropinMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_VfendMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:VfendMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_ChantixChampixMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ChantixChampixMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_BeneFIXMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:BeneFIXMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_ZoloftMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ZoloftMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_CaduetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:CaduetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_AromasinMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:AromasinMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_RevatioMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:RevatioMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_PristiqMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:PristiqMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_MedrolMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:MedrolMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_CarduraMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:CarduraMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_ZithromaxZmaxMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ZithromaxZmaxMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_AriceptMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:AriceptMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_ReFactoAFXynthaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ReFactoAFXynthaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_AllOtherMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:AllOtherMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_AllianceRevenuesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:AllianceRevenuesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_AnimalHealthMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:AnimalHealthMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_ConsumerHealthcareMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ConsumerHealthcareMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_NutritionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:NutritionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_CapsugelMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:CapsugelMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_BiopharmaceuticalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:BiopharmaceuticalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_DiversifiedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:DiversifiedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_CorporateOtherMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:CorporateOtherMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_LipitorMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:LipitorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_LyricaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:LyricaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_CelebrexMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:CelebrexMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_ViagraMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ViagraMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_XalatanXalacomMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:XalatanXalacomMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_NorvascMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:NorvascMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_ZyvoxMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ZyvoxMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_DetrolDetrolLAMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:DetrolDetrolLAMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_SutentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:SutentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_GeodonZeldoxMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:GeodonZeldoxMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_GenotropinMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:GenotropinMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_VfendMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:VfendMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_ChantixChampixMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ChantixChampixMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_ZoloftMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ZoloftMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_CaduetMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:CaduetMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_AromasinMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:AromasinMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_RevatioMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:RevatioMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_MedrolMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:MedrolMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_CarduraMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:CarduraMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_ZithromaxZmaxMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ZithromaxZmaxMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_AriceptMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:AriceptMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_AllOtherMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:AllOtherMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_AllianceRevenuesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:AllianceRevenuesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_AnimalHealthMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:AnimalHealthMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_CapsugelMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:CapsugelMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_PristiqMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:PristiqMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_DevelopedEuropeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToIndividualForeignCountriesAxis">pfe:DevelopedEuropeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_DevelopedRestOfWorldMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToIndividualForeignCountriesAxis">pfe:DevelopedRestOfWorldMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_6mos_20090628_EmergingMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToIndividualForeignCountriesAxis">pfe:EmergingMarketsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_DevelopedEuropeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToIndividualForeignCountriesAxis">pfe:DevelopedEuropeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_DevelopedRestOfWorldMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToIndividualForeignCountriesAxis">pfe:DevelopedRestOfWorldMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20090628_EmergingMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToIndividualForeignCountriesAxis">pfe:EmergingMarketsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_DevelopedEuropeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToIndividualForeignCountriesAxis">pfe:DevelopedEuropeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_DevelopedRestOfWorldMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToIndividualForeignCountriesAxis">pfe:DevelopedRestOfWorldMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_EmergingMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToIndividualForeignCountriesAxis">pfe:EmergingMarketsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_DevelopedEuropeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToIndividualForeignCountriesAxis">pfe:DevelopedEuropeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_DevelopedRestOfWorldMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToIndividualForeignCountriesAxis">pfe:DevelopedRestOfWorldMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_EmergingMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToIndividualForeignCountriesAxis">pfe:EmergingMarketsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_Q2_2009_InterestRateSwapMember_FairValueHedgingMember_OtherIncomeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">pfe:OtherIncomeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_Q2_2009_ForeignExchangeContractMember_FairValueHedgingMember_OtherIncomeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">pfe:OtherIncomeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_Q3_2010_ForeignExchangeContractMember_FairValueHedgingMember_OtherIncomeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">pfe:OtherIncomeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_Q2_2009_ForeignExchangeForwardMember_CashFlowHedgingMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_Q2_2009_ForeignExchangeForwardMember_CashFlowHedgingMember_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_Q2_2009_ForeignExchangeContractMember_CashFlowHedgingMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_Q2_2009_ForeignExchangeContractMember_CashFlowHedgingMember_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_Q3_2010_ForeignExchangeForwardMember_CashFlowHedgingMember_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_Q3_2010_ForeignExchangeContractMember_CashFlowHedgingMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_Q3_2010_ForeignExchangeContractMember_CashFlowHedgingMember_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_Q2_2009_ForeignExchangeContractMember_NetInvestmentHedgingMember_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_Q3_2010_ForeignExchangeContractMember_NetInvestmentHedgingMember_OtherIncomeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">pfe:OtherIncomeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_Q3_2010_ForeignExchangeContractMember_NetInvestmentHedgingMember_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_Q2_2009_ForeignExchangeForwardMember_NondesignatedMember_OtherIncomeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">pfe:OtherIncomeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_Q2_2009_ForeignExchangeContractMember_NondesignatedMember_OtherIncomeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">pfe:OtherIncomeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_Q3_2010_ForeignExchangeForwardMember_NondesignatedMember_OtherIncomeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">pfe:OtherIncomeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_Q3_2010_ForeignExchangeContractMember_NondesignatedMember_OtherIncomeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">pfe:OtherIncomeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_Q3_2009_ForeignCurrencyShortTermBorrowingsMember_NetInvestmentHedgingMember_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">pfe:ForeignCurrencyShortTermBorrowingsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_Q3_2009_ForeignCurrencyLongTermDebtMember_NetInvestmentHedgingMember_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">pfe:ForeignCurrencyLongTermDebtMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_Q3_2010_ForeignCurrencyShortTermBorrowingsMember_NetInvestmentHedgingMember_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">pfe:ForeignCurrencyShortTermBorrowingsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_Q3_2010_ForeignCurrencyLongTermDebtMember_NetInvestmentHedgingMember_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">pfe:ForeignCurrencyLongTermDebtMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_USCorporateDebtGuaranteedByFederalDepositInsuranceCorporationMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ScheduleOfAvailableForSaleSecuritiesMajorTypesOfDebtAndEquitySecuritiesAxis">pfe:USCorporateDebtGuaranteedByFederalDepositInsuranceCorporationMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_GoodwillNotAllocatedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:GoodwillBySegmentAxis">us-gaap:GoodwillNotAllocatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_6Mos_2010-10-03_GoodwillNotAllocatedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:GoodwillBySegmentAxis">us-gaap:GoodwillNotAllocatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_BiopharmaceuticalMember_AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:BiopharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">pfe:AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_DiversifiedMember_AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:DiversifiedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">pfe:AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_ForeignExchangeForwardMember_CashFlowHedgingMember_OtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_2009-03-12">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-03-12</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_MaturingIn2038Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">pfe:MaturingIn2038Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_FairValueInputsLevel1Member_2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisDisclosureItemsAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_FairValueInputsLevel1Member_2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueAssetsMeasuredOnRecurringBasisDisclosureItemsAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_ProtonixMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ProtonixMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_ProtonixMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:ProtonixMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_ForeignExchangeContractMember_FairValueHedgingMember_OtherIncomeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">pfe:OtherIncomeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_9mos_20101003_ForeignExchangeContractMember_FairValueHedgingMember_OtherIncomeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">pfe:OtherIncomeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101012_KingMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">pfe:KingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-12</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_BMP2Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:BMP2Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_RapamuneMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:RapamuneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_FragminMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:FragminMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_TygacilMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:TygacilMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_BMP2Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:BMP2Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_RapamuneMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:RapamuneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_FragminMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:FragminMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_TygacilMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:TygacilMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_3mos_20101003_FragminMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:FragminMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-06-29</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_9mos_20101003_FragminMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:FragminMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2009-01-01</xbrli:startDate>
      <xbrli:endDate>2009-09-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_3mos_20101003_QuigleyCompanyIncMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pfe:QuigleyCompanyIncMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-05</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_QuigleyCompanyIncMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">pfe:QuigleyCompanyIncMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_CorporateOtherMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:SegmentReportingInformationBySegmentAxis">pfe:CorporateOtherMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_9mos_20101003_ForeignExchangeContractMember_NondesignatedMember_OtherIncomeExpenseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByDerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">pfe:OtherIncomeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-01-01</xbrli:startDate>
      <xbrli:endDate>2010-10-03</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_GoodwillNotAllocatedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:GoodwillBySegmentAxis">us-gaap:GoodwillNotAllocatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_1mos_20100731">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-07-01</xbrli:startDate>
      <xbrli:endDate>2010-07-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_ForeignCurrencyDebtDesignatedAsHedgingInstrumentsLongTermLiabilityAtFairValueMember_2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDisclosureItemsAxis">pfe:ForeignCurrencyDebtDesignatedAsHedgingInstrumentsLongTermLiabilityAtFairValueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Cur_20101003_ForeignCurrencyBorrowingsDesignatedAsHedgingInstrumentsShortTermLiabilityAtFairValueMember_2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDisclosureItemsAxis">pfe:ForeignCurrencyBorrowingsDesignatedAsHedgingInstrumentsShortTermLiabilityAtFairValueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-10-03</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_ForeignCurrencyDebtDesignatedAsHedgingInstrumentsLongTermLiabilityAtFairValueMember_2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDisclosureItemsAxis">pfe:ForeignCurrencyDebtDesignatedAsHedgingInstrumentsLongTermLiabilityAtFairValueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Pri_20091231_ForeignCurrencyBorrowingsDesignatedAsHedgingInstrumentsShortTermLiabilityAtFairValueMember_2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0000078003</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDisclosureItemsAxis">pfe:ForeignCurrencyBorrowingsDesignatedAsHedgingInstrumentsShortTermLiabilityAtFairValueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2009-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:unit id="USD">
    <xbrli:measure>iso4217:USD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="Shares">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="USDperShare">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <xbrli:unit id="Percent">
    <xbrli:measure>xbrli:pure</xbrli:measure>
  </xbrli:unit>
  <us-gaap:PreferredStockValue id="id_footnote_elem_16156904" decimals="-6" contextRef="Pri_20091231" unitRef="USD">61000000</us-gaap:PreferredStockValue>
  <us-gaap:CommonStockValue id="id_footnote_elem_3196621" decimals="-6" contextRef="Pri_20091231" unitRef="USD">443000000</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapital id="id_footnote_elem_18486598" decimals="-6" contextRef="Pri_20091231" unitRef="USD">70497000000</us-gaap:AdditionalPaidInCapital>
  <us-gaap:CompensationAndBenefitsTrust id="id_footnote_elem_16207287" decimals="-6" contextRef="Pri_20091231" unitRef="USD">-333000000</us-gaap:CompensationAndBenefitsTrust>
  <us-gaap:TreasuryStockValue id="id_footnote_elem_4523795" decimals="-6" contextRef="Pri_20091231" unitRef="USD">21632000000</us-gaap:TreasuryStockValue>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="id_footnote_elem_26550426" decimals="-6" contextRef="Pri_20091231" unitRef="USD">40426000000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="id_footnote_elem_32699613" decimals="-6" contextRef="Pri_20091231" unitRef="USD">552000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:StockholdersEquity id="id_footnote_elem_1596607" decimals="-6" contextRef="Pri_20091231" unitRef="USD">90014000000</us-gaap:StockholdersEquity>
  <us-gaap:MinorityInterest id="id_footnote_elem_5843970" decimals="-6" contextRef="Pri_20091231" unitRef="USD">432000000</us-gaap:MinorityInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="id_footnote_elem_28695186" decimals="-6" contextRef="Pri_20091231" unitRef="USD">90446000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:LiabilitiesAndStockholdersEquity id="id_footnote_elem_23996372" decimals="-6" contextRef="Pri_20091231" unitRef="USD">212949000000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:AccountsPayableCurrent id="id_footnote_elem_20478500" decimals="-6" contextRef="Pri_20091231" unitRef="USD">4370000000</us-gaap:AccountsPayableCurrent>
  <us-gaap:DividendsPayableCurrentAndNoncurrent id="id_footnote_elem_2201126" decimals="-6" contextRef="Pri_20091231" unitRef="USD">1454000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
  <us-gaap:TaxesPayableCurrent id="id_footnote_elem_4432809" decimals="-6" contextRef="Pri_20091231" unitRef="USD">10107000000</us-gaap:TaxesPayableCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent id="id_footnote_elem_7027354" decimals="-6" contextRef="Pri_20091231" unitRef="USD">2242000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent id="id_footnote_elem_32692480" decimals="-6" contextRef="Pri_20091231" unitRef="USD">37225000000</us-gaap:LiabilitiesCurrent>
  <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent id="id_footnote_elem_4265072" decimals="-6" contextRef="Pri_20091231" unitRef="USD">6392000000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
  <us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent id="id_footnote_elem_13373123" decimals="-6" contextRef="Pri_20091231" unitRef="USD">3243000000</us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent>
  <us-gaap:DeferredTaxLiabilitiesNoncurrent id="id_footnote_elem_10419173" decimals="-6" contextRef="Pri_20091231" unitRef="USD">17839000000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <us-gaap:AccruedIncomeTaxesNoncurrent id="id_footnote_elem_32408649" decimals="-6" contextRef="Pri_20091231" unitRef="USD">9000000000</us-gaap:AccruedIncomeTaxesNoncurrent>
  <us-gaap:OtherLiabilitiesNoncurrent id="id_footnote_elem_4789029" decimals="-6" contextRef="Pri_20091231" unitRef="USD">5611000000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:Liabilities id="id_footnote_elem_31808566" decimals="-6" contextRef="Pri_20091231" unitRef="USD">122503000000</us-gaap:Liabilities>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="id_footnote_elem_5108018" decimals="-6" contextRef="Pri_20091231" unitRef="USD">1978000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:ShortTermInvestments id="id_footnote_elem_20678161" decimals="-6" contextRef="Pri_20091231" unitRef="USD">23991000000</us-gaap:ShortTermInvestments>
  <us-gaap:AccountsReceivableNetCurrent id="id_footnote_elem_8138457" decimals="-6" contextRef="Pri_20091231" unitRef="USD">14645000000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:InventoryNet id="id_footnote_elem_33550170" decimals="-6" contextRef="Pri_20091231" unitRef="USD">12403000000</us-gaap:InventoryNet>
  <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation id="id_footnote_elem_25426399" decimals="-6" contextRef="Pri_20091231" unitRef="USD">496000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
  <us-gaap:AssetsCurrent id="id_footnote_elem_20887422" decimals="-6" contextRef="Pri_20091231" unitRef="USD">61670000000</us-gaap:AssetsCurrent>
  <us-gaap:LongTermInvestmentsAndReceivablesNet id="id_footnote_elem_8797433" decimals="-6" contextRef="Pri_20091231" unitRef="USD">13122000000</us-gaap:LongTermInvestmentsAndReceivablesNet>
  <us-gaap:PropertyPlantAndEquipmentNet id="id_footnote_elem_18551847" decimals="-6" contextRef="Pri_20091231" unitRef="USD">22780000000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:Goodwill id="id_footnote_elem_11760951" decimals="-6" contextRef="Pri_20091231" unitRef="USD">42376000000</us-gaap:Goodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill id="id_footnote_elem_12428914" decimals="-6" contextRef="Pri_20091231" unitRef="USD">68015000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:Assets id="id_footnote_elem_31672210" decimals="-6" contextRef="Pri_20091231" unitRef="USD">212949000000</us-gaap:Assets>
  <dei:DocumentType contextRef="Cur_9mos_20101003">10-Q</dei:DocumentType>
  <dei:AmendmentFlag contextRef="Cur_9mos_20101003">false</dei:AmendmentFlag>
  <dei:DocumentPeriodEndDate contextRef="Cur_9mos_20101003">2010-10-03</dei:DocumentPeriodEndDate>
  <dei:EntityRegistrantName contextRef="Cur_9mos_20101003">PFIZER INC</dei:EntityRegistrantName>
  <dei:EntityCentralIndexKey contextRef="Cur_9mos_20101003">0000078003</dei:EntityCentralIndexKey>
  <dei:CurrentFiscalYearEndDate contextRef="Cur_9mos_20101003">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:EntityWellKnownSeasonedIssuer contextRef="Cur_9mos_20101003">Yes</dei:EntityWellKnownSeasonedIssuer>
  <dei:EntityVoluntaryFilers contextRef="Cur_9mos_20101003">No</dei:EntityVoluntaryFilers>
  <dei:EntityCurrentReportingStatus contextRef="Cur_9mos_20101003">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityFilerCategory contextRef="Cur_9mos_20101003">Large Accelerated Filer</dei:EntityFilerCategory>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue decimals="-6" contextRef="Pri_20081231" unitRef="USD">2122000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue decimals="-6" contextRef="Pri_20090927" unitRef="USD">4234000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <dei:EntityCommonStockSharesOutstanding decimals="INF" contextRef="DEI_2010-11-08" unitRef="Shares">8009951287</dei:EntityCommonStockSharesOutstanding>
  <us-gaap:CostOfGoodsAndServicesSold id="id_footnote_elem_30541845" decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">11997000000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:SellingGeneralAndAdministrativeExpense id="id_footnote_elem_25475491" decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">13876000000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost id="id_footnote_elem_6467458" decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">6607000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
  <us-gaap:AmortizationOfIntangibleAssets decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">3972000000</us-gaap:AmortizationOfIntangibleAssets>
  <pfe:RestructuringChargesAndAcquisitionRelatedCosts decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">2091000000</pfe:RestructuringChargesAndAcquisitionRelatedCosts>
  <pfe:OtherIncomeExpenseNet decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">3038000000</pfe:OtherIncomeExpenseNet>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="id_footnote_elem_9378859" decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">8593000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeTaxExpenseBenefit decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">3198000000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">5395000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ProfitLoss decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">5391000000</us-gaap:ProfitLoss>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">24000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare decimals="2" contextRef="Cur_9mos_20101003" unitRef="USDperShare">0.67</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:CostOfGoodsAndServicesSold id="id_footnote_elem_10718124" decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">4953000000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:SellingGeneralAndAdministrativeExpense id="id_footnote_elem_7255235" decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">9508000000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost id="id_footnote_elem_7898494" decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">5032000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
  <us-gaap:AmortizationOfIntangibleAssets decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">1755000000</us-gaap:AmortizationOfIntangibleAssets>
  <pfe:RestructuringChargesAndAcquisitionRelatedCosts decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">1206000000</pfe:RestructuringChargesAndAcquisitionRelatedCosts>
  <pfe:OtherIncomeExpenseNet decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">175000000</pfe:OtherIncomeExpenseNet>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="id_footnote_elem_8068372" decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">10823000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeTaxExpenseBenefit decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">2952000000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">7871000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ProfitLoss decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">7877000000</us-gaap:ProfitLoss>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">9000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare decimals="2" contextRef="Pri_9mos_20090927" unitRef="USDperShare">1.17</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:EarningsPerShareBasic decimals="2" contextRef="Cur_9mos_20101003" unitRef="USDperShare">0.67</us-gaap:EarningsPerShareBasic>
  <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare decimals="2" contextRef="Cur_9mos_20101003" unitRef="USDperShare">0.66</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
  <us-gaap:EarningsPerShareDiluted decimals="2" contextRef="Cur_9mos_20101003" unitRef="USDperShare">0.66</us-gaap:EarningsPerShareDiluted>
  <us-gaap:CommonStockDividendsPerShareCashPaid decimals="2" contextRef="Cur_9mos_20101003" unitRef="USDperShare">0.54</us-gaap:CommonStockDividendsPerShareCashPaid>
  <us-gaap:EarningsPerShareBasic decimals="2" contextRef="Pri_9mos_20090927" unitRef="USDperShare">1.17</us-gaap:EarningsPerShareBasic>
  <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare decimals="2" contextRef="Pri_9mos_20090927" unitRef="USDperShare">1.16</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
  <us-gaap:EarningsPerShareDiluted decimals="2" contextRef="Pri_9mos_20090927" unitRef="USDperShare">1.16</us-gaap:EarningsPerShareDiluted>
  <us-gaap:CommonStockDividendsPerShareCashPaid decimals="2" contextRef="Pri_9mos_20090927" unitRef="USDperShare">0.64</us-gaap:CommonStockDividendsPerShareCashPaid>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="id_footnote_elem_30977177" decimals="-6" contextRef="Cur_20101003" unitRef="USD">2176000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:ShortTermInvestments id="id_footnote_elem_13217999" decimals="-6" contextRef="Cur_20101003" unitRef="USD">20288000000</us-gaap:ShortTermInvestments>
  <us-gaap:AccountsReceivableNetCurrent id="id_footnote_elem_11622793" decimals="-6" contextRef="Cur_20101003" unitRef="USD">14302000000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:InventoryNet id="id_footnote_elem_31027218" decimals="-6" contextRef="Cur_20101003" unitRef="USD">8771000000</us-gaap:InventoryNet>
  <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation id="id_footnote_elem_6224878" decimals="-6" contextRef="Cur_20101003" unitRef="USD">494000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
  <us-gaap:AssetsCurrent id="id_footnote_elem_2301666" decimals="-6" contextRef="Cur_20101003" unitRef="USD">54089000000</us-gaap:AssetsCurrent>
  <us-gaap:LongTermInvestmentsAndReceivablesNet id="id_footnote_elem_28039522" decimals="-6" contextRef="Cur_20101003" unitRef="USD">10344000000</us-gaap:LongTermInvestmentsAndReceivablesNet>
  <us-gaap:PropertyPlantAndEquipmentNet id="id_footnote_elem_28036059" decimals="-6" contextRef="Cur_20101003" unitRef="USD">19450000000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill id="id_footnote_elem_31497660" decimals="-6" contextRef="Cur_20101003" unitRef="USD">58627000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:Assets id="id_footnote_elem_30927892" decimals="-6" contextRef="Cur_20101003" unitRef="USD">191415000000</us-gaap:Assets>
  <us-gaap:AccountsPayableCurrent id="id_footnote_elem_16894001" decimals="-6" contextRef="Cur_20101003" unitRef="USD">3206000000</us-gaap:AccountsPayableCurrent>
  <us-gaap:TaxesPayableCurrent id="id_footnote_elem_10206822" decimals="-6" contextRef="Cur_20101003" unitRef="USD">1620000000</us-gaap:TaxesPayableCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent id="id_footnote_elem_32785392" decimals="-6" contextRef="Cur_20101003" unitRef="USD">1853000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent id="id_footnote_elem_8499208" decimals="-6" contextRef="Cur_20101003" unitRef="USD">24172000000</us-gaap:LiabilitiesCurrent>
  <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent id="id_footnote_elem_10302187" decimals="-6" contextRef="Cur_20101003" unitRef="USD">5196000000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
  <us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent id="id_footnote_elem_26238751" decimals="-6" contextRef="Cur_20101003" unitRef="USD">3258000000</us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent>
  <us-gaap:DeferredTaxLiabilitiesNoncurrent id="id_footnote_elem_10659671" decimals="-6" contextRef="Cur_20101003" unitRef="USD">16940000000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <us-gaap:AccruedIncomeTaxesNoncurrent id="id_footnote_elem_7425806" decimals="-6" contextRef="Cur_20101003" unitRef="USD">8578000000</us-gaap:AccruedIncomeTaxesNoncurrent>
  <us-gaap:OtherLiabilitiesNoncurrent id="id_footnote_elem_19538094" decimals="-6" contextRef="Cur_20101003" unitRef="USD">6193000000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:Liabilities id="id_footnote_elem_23737063" decimals="-6" contextRef="Cur_20101003" unitRef="USD">103347000000</us-gaap:Liabilities>
  <us-gaap:CommonStockValue id="id_footnote_elem_28530245" decimals="-6" contextRef="Cur_20101003" unitRef="USD">443000000</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapital id="id_footnote_elem_7896109" decimals="-6" contextRef="Cur_20101003" unitRef="USD">70678000000</us-gaap:AdditionalPaidInCapital>
  <us-gaap:CompensationAndBenefitsTrust id="id_footnote_elem_10156666" decimals="-6" contextRef="Cur_20101003" unitRef="USD">-8000000</us-gaap:CompensationAndBenefitsTrust>
  <us-gaap:TreasuryStockValue id="id_footnote_elem_20934113" decimals="-6" contextRef="Cur_20101003" unitRef="USD">22707000000</us-gaap:TreasuryStockValue>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="id_footnote_elem_32747251" decimals="-6" contextRef="Cur_20101003" unitRef="USD">42873000000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="id_footnote_elem_22788901" decimals="-6" contextRef="Cur_20101003" unitRef="USD">-3698000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:StockholdersEquity id="id_footnote_elem_23838900" decimals="-6" contextRef="Cur_20101003" unitRef="USD">87635000000</us-gaap:StockholdersEquity>
  <us-gaap:MinorityInterest id="id_footnote_elem_32865100" decimals="-6" contextRef="Cur_20101003" unitRef="USD">433000000</us-gaap:MinorityInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest id="id_footnote_elem_11916577" decimals="-6" contextRef="Cur_20101003" unitRef="USD">88068000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:LiabilitiesAndStockholdersEquity id="id_footnote_elem_118755" decimals="-6" contextRef="Cur_20101003" unitRef="USD">191415000000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:DepreciationDepletionAndAmortization decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">6493000000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:ShareBasedCompensation decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">351000000</us-gaap:ShareBasedCompensation>
  <us-gaap:DeferredIncomeTaxExpenseBenefit decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">1277000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">-61000000</us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther>
  <us-gaap:IncreaseDecreaseInOperatingCapital decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">10505000000</us-gaap:IncreaseDecreaseInOperatingCapital>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">5196000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">966000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquireShortTermInvestments decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">5018000000</us-gaap:PaymentsToAcquireShortTermInvestments>
  <us-gaap:PaymentsToAcquireMarketableSecurities decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">2674000000</us-gaap:PaymentsToAcquireMarketableSecurities>
  <pfe:ProceedsFromSaleAndMaturityOfLongTermMarketableSecurities decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">3822000000</pfe:ProceedsFromSaleAndMaturityOfLongTermMarketableSecurities>
  <us-gaap:PaymentsForProceedsFromOtherInvestingActivities decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">-496000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">5153000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:DepreciationDepletionAndAmortization decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">2983000000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:ShareBasedCompensation decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">258000000</us-gaap:ShareBasedCompensation>
  <us-gaap:DeferredIncomeTaxExpenseBenefit decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">1121000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">-248000000</us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther>
  <us-gaap:IncreaseDecreaseInOperatingCapital decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">840000000</us-gaap:IncreaseDecreaseInOperatingCapital>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">11762000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">783000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquireShortTermInvestments decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">57148000000</us-gaap:PaymentsToAcquireShortTermInvestments>
  <us-gaap:PaymentsToAcquireMarketableSecurities decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">6053000000</us-gaap:PaymentsToAcquireMarketableSecurities>
  <pfe:ProceedsFromSaleAndMaturityOfLongTermMarketableSecurities decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">4824000000</pfe:ProceedsFromSaleAndMaturityOfLongTermMarketableSecurities>
  <us-gaap:PaymentsForProceedsFromOtherInvestingActivities decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">-508000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">-26905000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <pfe:ProceedsFromIssuancesOfShortTermDebtNetOfProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">4686000000</pfe:ProceedsFromIssuancesOfShortTermDebtNetOfProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
  <pfe:RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonthsNetOfRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">9265000000</pfe:RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonthsNetOfRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
  <us-gaap:RepaymentsOfLongTermDebt decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">4000000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:PaymentsOfOrdinaryDividends decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">4544000000</us-gaap:PaymentsOfOrdinaryDividends>
  <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">32000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">-10095000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">-56000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <pfe:ProceedsFromIssuancesOfShortTermDebtNetOfProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">28473000000</pfe:ProceedsFromIssuancesOfShortTermDebtNetOfProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
  <pfe:RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonthsNetOfRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">29976000000</pfe:RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonthsNetOfRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess>
  <us-gaap:ProceedsFromIssuanceOfLongTermDebt decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">23997000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
  <us-gaap:RepaymentsOfLongTermDebt decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">910000000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:PaymentsOfOrdinaryDividends decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">4268000000</us-gaap:PaymentsOfOrdinaryDividends>
  <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">-101000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">17215000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">40000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">2112000000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">198000000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:IncomeTaxesPaidNet decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">11519000000</us-gaap:IncomeTaxesPaidNet>
  <us-gaap:InterestPaid decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">2039000000</us-gaap:InterestPaid>
  <us-gaap:IncomeTaxesPaidNet decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">1748000000</us-gaap:IncomeTaxesPaidNet>
  <us-gaap:InterestPaid decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">723000000</us-gaap:InterestPaid>
  <dei:EntityPublicFloat decimals="-9" contextRef="DEI_2009-06-26" unitRef="USD">102000000000</dei:EntityPublicFloat>
  <dei:DocumentFiscalYearFocus contextRef="Cur_9mos_20101003">2010</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus contextRef="Cur_9mos_20101003">Q3</dei:DocumentFiscalPeriodFocus>
  <pfe:CurrentDeferredTaxAssetsAndOtherAssetsCurrent id="id_footnote_elem_24849391" decimals="-6" contextRef="Cur_20101003" unitRef="USD">7284000000</pfe:CurrentDeferredTaxAssetsAndOtherAssetsCurrent>
  <pfe:NonCurrentDeferredTaxAssetsAndOtherAssetsNoncurrent id="id_footnote_elem_11901456" decimals="-6" contextRef="Cur_20101003" unitRef="USD">5118000000</pfe:NonCurrentDeferredTaxAssetsAndOtherAssetsNoncurrent>
  <pfe:CurrentDeferredTaxLiabilitiesAndOtherCurrentLiabilities id="id_footnote_elem_33245904" decimals="-6" contextRef="Cur_20101003" unitRef="USD">12334000000</pfe:CurrentDeferredTaxLiabilitiesAndOtherCurrentLiabilities>
  <us-gaap:PreferredStockValue id="id_footnote_elem_25432974" decimals="-6" contextRef="Cur_20101003" unitRef="USD">54000000</us-gaap:PreferredStockValue>
  <pfe:CurrentDeferredTaxAssetsAndOtherAssetsCurrent id="id_footnote_elem_17097778" decimals="-6" contextRef="Pri_20091231" unitRef="USD">6962000000</pfe:CurrentDeferredTaxAssetsAndOtherAssetsCurrent>
  <pfe:NonCurrentDeferredTaxAssetsAndOtherAssetsNoncurrent id="id_footnote_elem_24151436" decimals="-6" contextRef="Pri_20091231" unitRef="USD">4986000000</pfe:NonCurrentDeferredTaxAssetsAndOtherAssetsNoncurrent>
  <pfe:CurrentDeferredTaxLiabilitiesAndOtherCurrentLiabilities id="id_footnote_elem_19915218" decimals="-6" contextRef="Pri_20091231" unitRef="USD">13583000000</pfe:CurrentDeferredTaxLiabilitiesAndOtherCurrentLiabilities>
  <pfe:ProceedsFromSaleAndMaturityOfShortTermMarketableSecurities decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">31747000000</pfe:ProceedsFromSaleAndMaturityOfShortTermMarketableSecurities>
  <pfe:ProceedsFromSaleAndMaturityOfShortTermMarketableSecurities decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">9493000000</pfe:ProceedsFromSaleAndMaturityOfShortTermMarketableSecurities>
  <us-gaap:DividendsPayableCurrentAndNoncurrent id="id_footnote_elem_5057129" decimals="-6" contextRef="Cur_20101003" unitRef="USD">1000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
  <pfe:BusinessCombinationAcquisitionRelatedCostsIntegrationCosts id="id_footnote_elem_23951645" decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">650000000</pfe:BusinessCombinationAcquisitionRelatedCostsIntegrationCosts>
  <pfe:BusinessCombinationAcquisitionRelatedCostsIntegrationCosts id="id_footnote_elem_31282145" decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">242000000</pfe:BusinessCombinationAcquisitionRelatedCostsIntegrationCosts>
  <pfe:ImplementationCosts id="id_footnote_elem_15103362" decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">249000000</pfe:ImplementationCosts>
  <us-gaap:RestructuringAndRelatedCostCostIncurredToDate decimals="-6" contextRef="Cur_69mos_20101003_EmployeeSeveranceMember" unitRef="USD">8324000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate>
  <us-gaap:RestructuringAndRelatedCostCostIncurredToDate decimals="-6" contextRef="Cur_69mos_20101003_AssetImpairmentsMember" unitRef="USD">2129000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate>
  <us-gaap:RestructuringAndRelatedCostCostIncurredToDate decimals="-6" contextRef="Cur_69mos_20101003_OtherRestructuringChargesMember" unitRef="USD">858000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate>
  <us-gaap:RestructuringAndRelatedCostCostIncurredToDate decimals="-6" contextRef="Cur_69mos_20101003" unitRef="USD">11311000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate>
  <us-gaap:CostOfGoodsAndServicesSold id="id_footnote_elem_23100079" decimals="-6" contextRef="Cur_9mos_20101003_AdditionalDepreciationAssetRestructuringMember" unitRef="USD">367000000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:CostOfGoodsAndServicesSold id="id_footnote_elem_5115534" decimals="-6" contextRef="Pri_6mos_20090628_AdditionalDepreciationAssetRestructuringMember" unitRef="USD">102000000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:SellingGeneralAndAdministrativeExpense id="id_footnote_elem_5640064" decimals="-6" contextRef="Cur_9mos_20101003_AdditionalDepreciationAssetRestructuringMember" unitRef="USD">190000000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense id="id_footnote_elem_18600551" decimals="-6" contextRef="Pri_6mos_20090628_AdditionalDepreciationAssetRestructuringMember" unitRef="USD">17000000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost id="id_footnote_elem_24723095" decimals="-6" contextRef="Pri_6mos_20090628_AdditionalDepreciationAssetRestructuringMember" unitRef="USD">42000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
  <pfe:AdditionalDepreciationAssetRestructuring id="id_footnote_elem_24623104" decimals="-6" contextRef="Pri_6mos_20090628_AdditionalDepreciationAssetRestructuringMember" unitRef="USD">161000000</pfe:AdditionalDepreciationAssetRestructuring>
  <us-gaap:NotesAndLoansReceivableGrossCurrent id="id_footnote_elem_30871688" decimals="-6" contextRef="Cur_20101003" unitRef="USD">774000000</us-gaap:NotesAndLoansReceivableGrossCurrent>
  <us-gaap:LongTermDebtNoncurrent id="id_footnote_elem_21780713" decimals="-6" contextRef="Cur_20101003" unitRef="USD">39010000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:NotesAndLoansReceivableGrossCurrent id="id_footnote_elem_5940981" decimals="-6" contextRef="Pri_20091231" unitRef="USD">1195000000</us-gaap:NotesAndLoansReceivableGrossCurrent>
  <us-gaap:LongTermDebtNoncurrent id="id_footnote_elem_24032731" decimals="-6" contextRef="Pri_20091231" unitRef="USD">43193000000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:DebtCurrent id="id_footnote_elem_5398582" decimals="-6" contextRef="Cur_20101003" unitRef="USD">5158000000</us-gaap:DebtCurrent>
  <us-gaap:DebtCurrent id="id_footnote_elem_913426" decimals="-6" contextRef="Pri_20091231" unitRef="USD">5469000000</us-gaap:DebtCurrent>
  <us-gaap:FairValueMeasuredOnRecurringBasisInvestments id="id_footnote_elem_21122959" decimals="-6" contextRef="Pri_20091231_TradingAccountAssetsMember" unitRef="USD">184000000</us-gaap:FairValueMeasuredOnRecurringBasisInvestments>
  <us-gaap:FairValueMeasuredOnRecurringBasisInvestments id="id_footnote_elem_25494603" decimals="-6" contextRef="Pri_20091231_AvailableForSaleDebtSecuritiesMember" unitRef="USD">32338000000</us-gaap:FairValueMeasuredOnRecurringBasisInvestments>
  <us-gaap:FairValueMeasuredOnRecurringBasisInvestments id="id_footnote_elem_6785621" decimals="-6" contextRef="Pri_20091231_AvailableForSaleMoneyMarketFundsMember" unitRef="USD">2569000000</us-gaap:FairValueMeasuredOnRecurringBasisInvestments>
  <us-gaap:FairValueMeasuredOnRecurringBasisInvestments id="id_footnote_elem_29591820" decimals="-6" contextRef="Pri_20091231_AvailableForSaleEquitySecuritiesExcludingMoneyMarketFundsMember" unitRef="USD">281000000</us-gaap:FairValueMeasuredOnRecurringBasisInvestments>
  <us-gaap:FairValueMeasuredOnRecurringBasisInvestments id="id_footnote_elem_2947176" decimals="-6" contextRef="Pri_20091231_ForeignExchangeContractMember" unitRef="USD">798000000</us-gaap:FairValueMeasuredOnRecurringBasisInvestments>
  <us-gaap:FairValueMeasuredOnRecurringBasisInvestments id="id_footnote_elem_30793763" decimals="-6" contextRef="Pri_20091231_InterestRateSwapMember" unitRef="USD">276000000</us-gaap:FairValueMeasuredOnRecurringBasisInvestments>
  <us-gaap:FairValueMeasuredOnRecurringBasisInvestments id="id_footnote_elem_6853796" decimals="-6" contextRef="Pri_20091231_ForeignExchangeForwardMember" unitRef="USD">502000000</us-gaap:FairValueMeasuredOnRecurringBasisInvestments>
  <us-gaap:FairValueMeasuredOnRecurringBasisInvestments id="id_footnote_elem_3712849" decimals="-6" contextRef="Pri_20091231" unitRef="USD">36948000000</us-gaap:FairValueMeasuredOnRecurringBasisInvestments>
  <us-gaap:FairValueMeasuredOnRecurringBasisInvestments id="id_footnote_elem_24393892" decimals="-6" contextRef="Cur_20101003_TradingAccountAssetsMember" unitRef="USD">169000000</us-gaap:FairValueMeasuredOnRecurringBasisInvestments>
  <us-gaap:FairValueMeasuredOnRecurringBasisInvestments id="id_footnote_elem_32384369" decimals="-6" contextRef="Cur_20101003_AvailableForSaleDebtSecuritiesMember" unitRef="USD">27558000000</us-gaap:FairValueMeasuredOnRecurringBasisInvestments>
  <us-gaap:FairValueMeasuredOnRecurringBasisInvestments id="id_footnote_elem_7342407" decimals="-6" contextRef="Cur_20101003_AvailableForSaleMoneyMarketFundsMember" unitRef="USD">862000000</us-gaap:FairValueMeasuredOnRecurringBasisInvestments>
  <us-gaap:FairValueMeasuredOnRecurringBasisInvestments id="id_footnote_elem_31592917" decimals="-6" contextRef="Cur_20101003_AvailableForSaleEquitySecuritiesExcludingMoneyMarketFundsMember" unitRef="USD">211000000</us-gaap:FairValueMeasuredOnRecurringBasisInvestments>
  <us-gaap:FairValueMeasuredOnRecurringBasisInvestments id="id_footnote_elem_28308201" decimals="-6" contextRef="Cur_20101003_ForeignExchangeContractMember" unitRef="USD">226000000</us-gaap:FairValueMeasuredOnRecurringBasisInvestments>
  <us-gaap:FairValueMeasuredOnRecurringBasisInvestments id="id_footnote_elem_8514072" decimals="-6" contextRef="Cur_20101003_InterestRateSwapMember" unitRef="USD">740000000</us-gaap:FairValueMeasuredOnRecurringBasisInvestments>
  <us-gaap:FairValueMeasuredOnRecurringBasisInvestments id="id_footnote_elem_17510351" decimals="-6" contextRef="Cur_20101003_ForeignExchangeForwardMember" unitRef="USD">263000000</us-gaap:FairValueMeasuredOnRecurringBasisInvestments>
  <us-gaap:FairValueMeasuredOnRecurringBasisInvestments id="id_footnote_elem_31036961" decimals="-6" contextRef="Cur_20101003" unitRef="USD">30029000000</us-gaap:FairValueMeasuredOnRecurringBasisInvestments>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDerivativeFinancialInstrumentsLiabilities id="id_footnote_elem_29428064" decimals="-6" contextRef="Cur_20101003_ForeignExchangeContractMember_2" unitRef="USD">684000000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDerivativeFinancialInstrumentsLiabilities>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDerivativeFinancialInstrumentsLiabilities id="id_footnote_elem_10785712" decimals="-6" contextRef="Cur_20101003_InterestRateSwapMember_2" unitRef="USD">5000000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDerivativeFinancialInstrumentsLiabilities>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDerivativeFinancialInstrumentsLiabilities id="id_footnote_elem_20685133" decimals="-6" contextRef="Cur_20101003_ForeignExchangeForwardMember_2" unitRef="USD">737000000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDerivativeFinancialInstrumentsLiabilities>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDerivativeFinancialInstrumentsLiabilities id="id_footnote_elem_4325399" decimals="-6" contextRef="Cur_20101003" unitRef="USD">1426000000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDerivativeFinancialInstrumentsLiabilities>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDerivativeFinancialInstrumentsLiabilities id="id_footnote_elem_21915073" decimals="-6" contextRef="Pri_20091231_ForeignExchangeContractMember_2" unitRef="USD">528000000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDerivativeFinancialInstrumentsLiabilities>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDerivativeFinancialInstrumentsLiabilities id="id_footnote_elem_12270302" decimals="-6" contextRef="Pri_20091231_InterestRateSwapMember_2" unitRef="USD">25000000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDerivativeFinancialInstrumentsLiabilities>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDerivativeFinancialInstrumentsLiabilities id="id_footnote_elem_23024147" decimals="-6" contextRef="Pri_20091231_ForeignExchangeForwardMember_2" unitRef="USD">237000000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDerivativeFinancialInstrumentsLiabilities>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDerivativeFinancialInstrumentsLiabilities id="id_footnote_elem_16257194" decimals="-6" contextRef="Pri_20091231" unitRef="USD">790000000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDerivativeFinancialInstrumentsLiabilities>
  <us-gaap:NotesAndLoansReceivableGrossNoncurrent id="id_footnote_elem_22768068" decimals="-6" contextRef="Cur_20101003" unitRef="USD">680000000</us-gaap:NotesAndLoansReceivableGrossNoncurrent>
  <pfe:OtherSelectedFinancialAssets id="id_footnote_elem_15160407" decimals="-6" contextRef="Cur_20101003" unitRef="USD">4132000000</pfe:OtherSelectedFinancialAssets>
  <pfe:SelectedFinancialAssets id="id_footnote_elem_30815794" decimals="-6" contextRef="Cur_20101003" unitRef="USD">34161000000</pfe:SelectedFinancialAssets>
  <us-gaap:NotesAndLoansReceivableGrossNoncurrent id="id_footnote_elem_27155255" decimals="-6" contextRef="Pri_20091231" unitRef="USD">784000000</us-gaap:NotesAndLoansReceivableGrossNoncurrent>
  <pfe:OtherSelectedFinancialAssets id="id_footnote_elem_17463607" decimals="-6" contextRef="Pri_20091231" unitRef="USD">3602000000</pfe:OtherSelectedFinancialAssets>
  <pfe:SelectedFinancialAssets id="id_footnote_elem_4910958" decimals="-6" contextRef="Pri_20091231" unitRef="USD">40550000000</pfe:SelectedFinancialAssets>
  <pfe:OtherFinancialLiabilities id="id_footnote_elem_1065958" decimals="-6" contextRef="Cur_20101003" unitRef="USD">44168000000</pfe:OtherFinancialLiabilities>
  <pfe:SelectedFinancialLiabilities decimals="-6" contextRef="Cur_20101003" unitRef="USD">45594000000</pfe:SelectedFinancialLiabilities>
  <pfe:OtherFinancialLiabilities id="id_footnote_elem_15360268" decimals="-6" contextRef="Pri_20091231" unitRef="USD">48662000000</pfe:OtherFinancialLiabilities>
  <pfe:SelectedFinancialLiabilities decimals="-6" contextRef="Pri_20091231" unitRef="USD">49452000000</pfe:SelectedFinancialLiabilities>
  <pfe:SelectedFinancialLiabilitiesCurrentDeferredTaxLiabilitiesAndOtherCurrentLiabilities id="id_footnote_elem_14908347" decimals="-6" contextRef="Cur_20101003" unitRef="USD">795000000</pfe:SelectedFinancialLiabilitiesCurrentDeferredTaxLiabilitiesAndOtherCurrentLiabilities>
  <pfe:SelectedFinancialLiabilitiesOtherNoncurrentLiabilities id="id_footnote_elem_11806855" decimals="-6" contextRef="Cur_20101003" unitRef="USD">631000000</pfe:SelectedFinancialLiabilitiesOtherNoncurrentLiabilities>
  <pfe:SelectedFinancialLiabilitiesCurrentDeferredTaxLiabilitiesAndOtherCurrentLiabilities id="id_footnote_elem_13076938" decimals="-6" contextRef="Pri_20091231" unitRef="USD">369000000</pfe:SelectedFinancialLiabilitiesCurrentDeferredTaxLiabilitiesAndOtherCurrentLiabilities>
  <pfe:SelectedFinancialLiabilitiesOtherNoncurrentLiabilities id="id_footnote_elem_23625618" decimals="-6" contextRef="Pri_20091231" unitRef="USD">421000000</pfe:SelectedFinancialLiabilitiesOtherNoncurrentLiabilities>
  <us-gaap:EscrowDeposit decimals="-6" contextRef="Cur_20101003" unitRef="USD">625000000</us-gaap:EscrowDeposit>
  <pfe:SelectedFinancialLiabilitiesCurrentDeferredTaxLiabilitiesAndOtherCurrentLiabilities decimals="-6" contextRef="Cur_20101003_ForeignExchangeForwardMember_3" unitRef="USD">737000000</pfe:SelectedFinancialLiabilitiesCurrentDeferredTaxLiabilitiesAndOtherCurrentLiabilities>
  <pfe:SelectedFinancialLiabilitiesCurrentDeferredTaxLiabilitiesAndOtherCurrentLiabilities decimals="-6" contextRef="Pri_20091231_ForeignExchangeForwardMember_3" unitRef="USD">237000000</pfe:SelectedFinancialLiabilitiesCurrentDeferredTaxLiabilitiesAndOtherCurrentLiabilities>
  <pfe:SelectedFinancialLiabilitiesCurrentDeferredTaxLiabilitiesAndOtherCurrentLiabilities decimals="-6" contextRef="Cur_20101003_ForeignExchangeContractMember_3" unitRef="USD">53000000</pfe:SelectedFinancialLiabilitiesCurrentDeferredTaxLiabilitiesAndOtherCurrentLiabilities>
  <pfe:SelectedFinancialLiabilitiesCurrentDeferredTaxLiabilitiesAndOtherCurrentLiabilities decimals="-6" contextRef="Pri_20091231_ForeignExchangeContractMember_3" unitRef="USD">132000000</pfe:SelectedFinancialLiabilitiesCurrentDeferredTaxLiabilitiesAndOtherCurrentLiabilities>
  <pfe:SelectedFinancialLiabilitiesOtherNoncurrentLiabilities decimals="-6" contextRef="Cur_20101003_ForeignExchangeContractMember_3" unitRef="USD">631000000</pfe:SelectedFinancialLiabilitiesOtherNoncurrentLiabilities>
  <pfe:SelectedFinancialLiabilitiesOtherNoncurrentLiabilities decimals="-6" contextRef="Pri_20091231_ForeignExchangeContractMember_3" unitRef="USD">396000000</pfe:SelectedFinancialLiabilitiesOtherNoncurrentLiabilities>
  <pfe:SelectedFinancialLiabilitiesOtherNoncurrentLiabilities decimals="-6" contextRef="Pri_20091231_InterestRateSwapMember_3" unitRef="USD">25000000</pfe:SelectedFinancialLiabilitiesOtherNoncurrentLiabilities>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue decimals="-6" contextRef="Cur_20101003_WesternEuropeanAndOtherGovernmentDebtMember" unitRef="USD">15799000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue decimals="-6" contextRef="Cur_20101003_WesternEuropeanAndOtherGovernmentDebtMember" unitRef="USD">2938000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesFairValue decimals="-6" contextRef="Cur_20101003_WesternEuropeanAndOtherGovernmentDebtMember" unitRef="USD">18737000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue decimals="-6" contextRef="Cur_20101003_WesternEuropeanAndOtherGovernmentAgencyDebtMember" unitRef="USD">1099000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue decimals="-6" contextRef="Cur_20101003_WesternEuropeanAndOtherGovernmentAgencyDebtMember" unitRef="USD">88000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesFairValue decimals="-6" contextRef="Cur_20101003_WesternEuropeanAndOtherGovernmentAgencyDebtMember" unitRef="USD">1187000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue id="id_footnote_elem_19371197" decimals="-6" contextRef="Cur_20101003_CorporateDebtSecuritiesMember" unitRef="USD">1225000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue id="id_footnote_elem_28620016" decimals="-6" contextRef="Cur_20101003_CorporateDebtSecuritiesMember" unitRef="USD">1759000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesFairValue id="id_footnote_elem_31104656" decimals="-6" contextRef="Cur_20101003_CorporateDebtSecuritiesMember" unitRef="USD">2984000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue decimals="-6" contextRef="Cur_20101003_FederalHomeLoanMortgageCorporationAndFederalNationalMortgageAssociationAssetBackedSecuritiesMember" unitRef="USD">2241000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesFairValue decimals="-6" contextRef="Cur_20101003_FederalHomeLoanMortgageCorporationAndFederalNationalMortgageAssociationAssetBackedSecuritiesMember" unitRef="USD">2342000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue decimals="-6" contextRef="Cur_20101003_SupranationalDebtMember" unitRef="USD">153000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesFairValue decimals="-6" contextRef="Cur_20101003_SupranationalDebtMember" unitRef="USD">845000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue decimals="-6" contextRef="Cur_20101003_CertificatesOfDepositMember" unitRef="USD">58000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesFairValue decimals="-6" contextRef="Cur_20101003_CertificatesOfDepositMember" unitRef="USD">58000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesFairValue id="id_footnote_elem_10063126" decimals="-6" contextRef="Cur_20101003_ReverseRepurchaseAgreementsMember" unitRef="USD">796000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue id="id_footnote_elem_21118344" decimals="-6" contextRef="Cur_20101003_ReverseRepurchaseAgreementsMember" unitRef="USD">796000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue decimals="-6" contextRef="Cur_20101003_SupranationalDebtMember" unitRef="USD">692000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
  <pfe:AvailableForSaleSecuritiesEquitySecuritiesMoneyMarketFunds id="id_footnote_elem_22383156" decimals="-6" contextRef="Cur_20101003" unitRef="USD">862000000</pfe:AvailableForSaleSecuritiesEquitySecuritiesMoneyMarketFunds>
  <pfe:AvailableForSaleSecuritiesEquitySecuritiesExcludingMoneyMarketFunds decimals="-6" contextRef="Cur_20101003" unitRef="USD">211000000</pfe:AvailableForSaleSecuritiesEquitySecuritiesExcludingMoneyMarketFunds>
  <pfe:DebtSecurities decimals="-6" contextRef="Cur_20101003" unitRef="USD">29355000000</pfe:DebtSecurities>
  <pfe:DebtSecuritiesMaturitiesWithin1Year decimals="-6" contextRef="Cur_20101003" unitRef="USD">21573000000</pfe:DebtSecuritiesMaturitiesWithin1Year>
  <pfe:DebtSecuritiesMaturitiesOver1To5Years decimals="-6" contextRef="Cur_20101003" unitRef="USD">7782000000</pfe:DebtSecuritiesMaturitiesOver1To5Years>
  <us-gaap:DebtCurrent decimals="-6" contextRef="Cur_20101003_CommercialPaperMember" unitRef="USD">1200000000</us-gaap:DebtCurrent>
  <us-gaap:DebtCurrent decimals="-6" contextRef="Pri_20091231_CommercialPaperMember" unitRef="USD">3900000000</us-gaap:DebtCurrent>
  <us-gaap:UnsecuredDebt decimals="-8" contextRef="Pri_20090324" unitRef="USD">13500000000</us-gaap:UnsecuredDebt>
  <us-gaap:UnsecuredDebt decimals="-8" contextRef="Pri_20090603" unitRef="USD">10500000000</us-gaap:UnsecuredDebt>
  <us-gaap:GuaranteeObligationsMaximumExposure decimals="-6" contextRef="Cur_20101003" unitRef="USD">1500000000</us-gaap:GuaranteeObligationsMaximumExposure>
  <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">-300000000</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">-86000000</us-gaap:OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">239000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">1139000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">23000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTax decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">1116000000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">-210000000</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">312000000</us-gaap:OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">-282000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">10550000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">11000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTax decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">10539000000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:InventoryFinishedGoodsNetOfReserves decimals="-6" contextRef="Cur_20101003" unitRef="USD">4117000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
  <us-gaap:InventoryWorkInProcessNetOfReserves decimals="-6" contextRef="Cur_20101003" unitRef="USD">3799000000</us-gaap:InventoryWorkInProcessNetOfReserves>
  <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves decimals="-6" contextRef="Cur_20101003" unitRef="USD">855000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
  <us-gaap:InventoryFinishedGoodsNetOfReserves decimals="-6" contextRef="Pri_20091231" unitRef="USD">5249000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
  <us-gaap:InventoryWorkInProcessNetOfReserves decimals="-6" contextRef="Pri_20091231" unitRef="USD">5776000000</us-gaap:InventoryWorkInProcessNetOfReserves>
  <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves decimals="-6" contextRef="Pri_20091231" unitRef="USD">1378000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
  <us-gaap:Goodwill decimals="-6" contextRef="Pri_20091231_BiopharmaceuticalMember" unitRef="USD">22165000000</us-gaap:Goodwill>
  <us-gaap:Goodwill decimals="-6" contextRef="Pri_20091231_DiversifiedMember" unitRef="USD">173000000</us-gaap:Goodwill>
  <pfe:AdditionalDepreciationAssetRestructuring id="id_footnote_elem_9728083" decimals="-6" contextRef="Cur_9mos_20101003_AdditionalDepreciationAssetRestructuringMember" unitRef="USD">603000000</pfe:AdditionalDepreciationAssetRestructuring>
  <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost id="id_footnote_elem_19562454" decimals="-6" contextRef="Cur_9mos_20101003_AdditionalDepreciationAssetRestructuringMember" unitRef="USD">46000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
  <us-gaap:RestructuringReserve id="id_footnote_elem_18306193" decimals="-6" contextRef="Cur_20101003_EmployeeSeveranceMember" unitRef="USD">1937000000</us-gaap:RestructuringReserve>
  <us-gaap:RestructuringReserve id="id_footnote_elem_17713691" decimals="-6" contextRef="Cur_20101003_OtherRestructuringChargesMember" unitRef="USD">104000000</us-gaap:RestructuringReserve>
  <us-gaap:RestructuringReserve id="id_footnote_elem_5292631" decimals="-6" contextRef="Cur_20101003" unitRef="USD">2041000000</us-gaap:RestructuringReserve>
  <us-gaap:FiniteLivedIntangibleAssetsGross decimals="-6" contextRef="Cur_20101003_DevelopedTechnologyRightsMember" unitRef="USD">68436000000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization decimals="-6" contextRef="Cur_20101003_DevelopedTechnologyRightsMember" unitRef="USD">24782000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsNet decimals="-6" contextRef="Cur_20101003_DevelopedTechnologyRightsMember" unitRef="USD">43654000000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsGross decimals="-6" contextRef="Cur_20101003_BrandsMember" unitRef="USD">1622000000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization decimals="-6" contextRef="Cur_20101003_BrandsMember" unitRef="USD">587000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsNet decimals="-6" contextRef="Cur_20101003_BrandsMember" unitRef="USD">1035000000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsGross decimals="-6" contextRef="Cur_20101003_LicensingAgreementsMember" unitRef="USD">633000000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization decimals="-6" contextRef="Cur_20101003_LicensingAgreementsMember" unitRef="USD">219000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsNet decimals="-6" contextRef="Cur_20101003_LicensingAgreementsMember" unitRef="USD">414000000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsGross decimals="-6" contextRef="Cur_20101003_TrademarksMember" unitRef="USD">107000000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization decimals="-6" contextRef="Cur_20101003_TrademarksMember" unitRef="USD">72000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsNet decimals="-6" contextRef="Cur_20101003_TrademarksMember" unitRef="USD">35000000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsGross decimals="-6" contextRef="Cur_20101003" unitRef="USD">71233000000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="id_footnote_elem_7119001" decimals="-6" contextRef="Cur_20101003" unitRef="USD">25905000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsNet decimals="-6" contextRef="Cur_20101003" unitRef="USD">45328000000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsGross decimals="-6" contextRef="Pri_20091231_DevelopedTechnologyRightsMember" unitRef="USD">68870000000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization decimals="-6" contextRef="Pri_20091231_DevelopedTechnologyRightsMember" unitRef="USD">21223000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsNet decimals="-6" contextRef="Pri_20091231_DevelopedTechnologyRightsMember" unitRef="USD">47647000000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsGross decimals="-6" contextRef="Pri_20091231_BrandsMember" unitRef="USD">1637000000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization decimals="-6" contextRef="Pri_20091231_BrandsMember" unitRef="USD">535000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsNet decimals="-6" contextRef="Pri_20091231_BrandsMember" unitRef="USD">1102000000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsGross decimals="-6" contextRef="Pri_20091231_LicensingAgreementsMember" unitRef="USD">622000000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization decimals="-6" contextRef="Pri_20091231_LicensingAgreementsMember" unitRef="USD">119000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsNet decimals="-6" contextRef="Pri_20091231_LicensingAgreementsMember" unitRef="USD">503000000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsGross decimals="-6" contextRef="Pri_20091231_TrademarksMember" unitRef="USD">113000000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization decimals="-6" contextRef="Pri_20091231_TrademarksMember" unitRef="USD">73000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsNet decimals="-6" contextRef="Pri_20091231_TrademarksMember" unitRef="USD">40000000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsGross decimals="-6" contextRef="Pri_20091231" unitRef="USD">71730000000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="id_footnote_elem_5455295" decimals="-6" contextRef="Pri_20091231" unitRef="USD">22181000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsNet decimals="-6" contextRef="Pri_20091231" unitRef="USD">49549000000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsGross decimals="-6" contextRef="Cur_20101003_OtherIntangibleAssetsMember" unitRef="USD">435000000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization decimals="-6" contextRef="Cur_20101003_OtherIntangibleAssetsMember" unitRef="USD">245000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsNet decimals="-6" contextRef="Cur_20101003_OtherIntangibleAssetsMember" unitRef="USD">190000000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsGross decimals="-6" contextRef="Pri_20091231_OtherIntangibleAssetsMember" unitRef="USD">488000000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization decimals="-6" contextRef="Pri_20091231_OtherIntangibleAssetsMember" unitRef="USD">231000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsNet decimals="-6" contextRef="Pri_20091231_OtherIntangibleAssetsMember" unitRef="USD">257000000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <pfe:IndefiniteLivedBrands id="id_footnote_elem_21915029" decimals="-6" contextRef="Cur_20101003" unitRef="USD">10264000000</pfe:IndefiniteLivedBrands>
  <us-gaap:IndefiniteLivedTrademarks decimals="-6" contextRef="Cur_20101003" unitRef="USD">70000000</us-gaap:IndefiniteLivedTrademarks>
  <pfe:IndefiniteLivedInprocessResearchAndDevelopment id="id_footnote_elem_31037672" decimals="-6" contextRef="Cur_20101003" unitRef="USD">2965000000</pfe:IndefiniteLivedInprocessResearchAndDevelopment>
  <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill decimals="-6" contextRef="Cur_20101003" unitRef="USD">13299000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
  <pfe:IndefiniteLivedBrands id="id_footnote_elem_31149885" decimals="-6" contextRef="Pri_20091231" unitRef="USD">12562000000</pfe:IndefiniteLivedBrands>
  <us-gaap:IndefiniteLivedTrademarks decimals="-6" contextRef="Pri_20091231" unitRef="USD">70000000</us-gaap:IndefiniteLivedTrademarks>
  <pfe:IndefiniteLivedInprocessResearchAndDevelopment id="id_footnote_elem_15620629" decimals="-6" contextRef="Pri_20091231" unitRef="USD">5834000000</pfe:IndefiniteLivedInprocessResearchAndDevelopment>
  <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill decimals="-6" contextRef="Pri_20091231" unitRef="USD">18466000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpense decimals="-8" contextRef="Pri_9mos_20090927" unitRef="USD">1900000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpense>
  <us-gaap:CollateralAlreadyPostedAggregateFairValue decimals="-6" contextRef="Cur_20101003" unitRef="USD">1200000000</us-gaap:CollateralAlreadyPostedAggregateFairValue>
  <us-gaap:AdditionalCollateralAggregateFairValue decimals="-6" contextRef="Cur_20101003" unitRef="USD">29000000</us-gaap:AdditionalCollateralAggregateFairValue>
  <us-gaap:NotionalAmountOfInterestRateDerivatives decimals="-8" contextRef="Cur_20101003" unitRef="USD">11300000000</us-gaap:NotionalAmountOfInterestRateDerivatives>
  <us-gaap:DefinedBenefitPlanServiceCost decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">266000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DefinedBenefitPlanInterestCost decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">562000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">595000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
  <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-72000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments>
  <us-gaap:DefinedBenefitPlanSpecialTerminationBenefits decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-57000000</us-gaap:DefinedBenefitPlanSpecialTerminationBenefits>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">333000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:DefinedBenefitPlanServiceCost decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">22000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DefinedBenefitPlanInterestCost decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">59000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-2000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
  <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-1000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments>
  <us-gaap:DefinedBenefitPlanSpecialTerminationBenefits decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-155000000</us-gaap:DefinedBenefitPlanSpecialTerminationBenefits>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">255000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:DefinedBenefitPlanServiceCost decimals="-6" contextRef="Cur_9mos_20101003_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">172000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DefinedBenefitPlanInterestCost decimals="-6" contextRef="Cur_9mos_20101003_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">319000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets decimals="-6" contextRef="Cur_9mos_20101003_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">324000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
  <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit decimals="-6" contextRef="Cur_9mos_20101003_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">-3000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
  <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments decimals="-6" contextRef="Cur_9mos_20101003_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">-5000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments>
  <us-gaap:DefinedBenefitPlanSpecialTerminationBenefits decimals="-6" contextRef="Cur_9mos_20101003_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">-4000000</us-gaap:DefinedBenefitPlanSpecialTerminationBenefits>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost decimals="-6" contextRef="Cur_9mos_20101003_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">213000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:DefinedBenefitPlanServiceCost decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">61000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DefinedBenefitPlanInterestCost decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">160000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">23000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
  <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-24000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
  <us-gaap:DefinedBenefitPlanSpecialTerminationBenefits decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-13000000</us-gaap:DefinedBenefitPlanSpecialTerminationBenefits>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">188000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:DefinedBenefitPlanContributionsByEmployer decimals="-6" contextRef="Cur_9mos_20101003_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">286000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
  <us-gaap:DefinedBenefitPlanContributionsByEmployer decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">326000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
  <us-gaap:DefinedBenefitPlanContributionsByEmployer decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">182000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
  <us-gaap:DefinedBenefitPlanEstimatedFutureEmployerContributionsInNextFiscalYear decimals="-6" contextRef="Cur_20101003_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">456000000</us-gaap:DefinedBenefitPlanEstimatedFutureEmployerContributionsInNextFiscalYear>
  <us-gaap:DefinedBenefitPlanEstimatedFutureEmployerContributionsInNextFiscalYear decimals="-6" contextRef="Cur_20101003_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">243000000</us-gaap:DefinedBenefitPlanEstimatedFutureEmployerContributionsInNextFiscalYear>
  <us-gaap:DefinedBenefitPlanEstimatedFutureEmployerContributionsInNextFiscalYear decimals="-6" contextRef="Cur_20101003_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">420000000</us-gaap:DefinedBenefitPlanEstimatedFutureEmployerContributionsInNextFiscalYear>
  <us-gaap:DefinedBenefitPlanEstimatedFutureEmployerContributionsInNextFiscalYear decimals="-6" contextRef="Cur_20101003_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">901000000</us-gaap:DefinedBenefitPlanEstimatedFutureEmployerContributionsInNextFiscalYear>
  <us-gaap:DefinedBenefitPlanServiceCost decimals="-6" contextRef="Pri_6mos_20090628_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">162000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DefinedBenefitPlanInterestCost decimals="-6" contextRef="Pri_6mos_20090628_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">351000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets decimals="-6" contextRef="Pri_6mos_20090628_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">349000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
  <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit decimals="-6" contextRef="Pri_6mos_20090628_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">2000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
  <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments decimals="-6" contextRef="Pri_6mos_20090628_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">101000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments>
  <us-gaap:DefinedBenefitPlanSpecialTerminationBenefits decimals="-6" contextRef="Pri_6mos_20090628_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-24000000</us-gaap:DefinedBenefitPlanSpecialTerminationBenefits>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost decimals="-6" contextRef="Pri_6mos_20090628_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">452000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:DefinedBenefitPlanServiceCost decimals="-6" contextRef="Pri_6mos_20090628_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">15000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DefinedBenefitPlanInterestCost decimals="-6" contextRef="Pri_6mos_20090628_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">37000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit decimals="-6" contextRef="Pri_6mos_20090628_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-2000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
  <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments decimals="-6" contextRef="Pri_6mos_20090628_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">15000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost decimals="-6" contextRef="Pri_6mos_20090628_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">88000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:DefinedBenefitPlanServiceCost decimals="-6" contextRef="Pri_6mos_20090628_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">133000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DefinedBenefitPlanInterestCost decimals="-6" contextRef="Pri_6mos_20090628_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">240000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets decimals="-6" contextRef="Pri_6mos_20090628_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">268000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
  <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit decimals="-6" contextRef="Pri_6mos_20090628_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">-2000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
  <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments decimals="-6" contextRef="Pri_6mos_20090628_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">2000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments>
  <us-gaap:DefinedBenefitPlanSpecialTerminationBenefits decimals="-6" contextRef="Pri_6mos_20090628_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">-5000000</us-gaap:DefinedBenefitPlanSpecialTerminationBenefits>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost decimals="-6" contextRef="Pri_6mos_20090628_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">128000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:DefinedBenefitPlanServiceCost decimals="-6" contextRef="Pri_6mos_20090628_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">22000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DefinedBenefitPlanInterestCost decimals="-6" contextRef="Pri_6mos_20090628_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">91000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets decimals="-6" contextRef="Pri_6mos_20090628_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">19000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
  <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit decimals="-6" contextRef="Pri_6mos_20090628_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-3000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
  <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments decimals="-6" contextRef="Pri_6mos_20090628_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">7000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments>
  <us-gaap:DefinedBenefitPlanSpecialTerminationBenefits decimals="-6" contextRef="Pri_6mos_20090628_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-17000000</us-gaap:DefinedBenefitPlanSpecialTerminationBenefits>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost decimals="-6" contextRef="Pri_6mos_20090628_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">128000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations decimals="3" contextRef="Cur_9mos_20101003" unitRef="Percent">0.372</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations decimals="3" contextRef="Pri_9mos_20090927" unitRef="Percent">0.273</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">-460000000</us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions>
  <us-gaap:SegmentReportingInformationRevenue id="id_footnote_elem_5063810" decimals="-6" contextRef="Cur_9mos_20101003_BiopharmaceuticalMember_2" unitRef="USD">43472000000</us-gaap:SegmentReportingInformationRevenue>
  <us-gaap:SegmentReportingInformationRevenue id="id_footnote_elem_32820211" decimals="-6" contextRef="Cur_9mos_20101003_DiversifiedMember_2" unitRef="USD">6533000000</us-gaap:SegmentReportingInformationRevenue>
  <us-gaap:SegmentReportingInformationRevenue id="id_footnote_elem_20183131" decimals="-6" contextRef="Cur_9mos_20101003_CorporateOtherMember" unitRef="USD">243000000</us-gaap:SegmentReportingInformationRevenue>
  <us-gaap:SegmentReportingInformationProfitLoss id="id_footnote_elem_9838300" decimals="-6" contextRef="Cur_9mos_20101003_BiopharmaceuticalMember_2" unitRef="USD">22844000000</us-gaap:SegmentReportingInformationProfitLoss>
  <us-gaap:SegmentReportingInformationProfitLoss id="id_footnote_elem_8867762" decimals="-6" contextRef="Cur_9mos_20101003_DiversifiedMember_2" unitRef="USD">1647000000</us-gaap:SegmentReportingInformationProfitLoss>
  <us-gaap:SegmentReportingInformationProfitLoss id="id_footnote_elem_4896334" decimals="-6" contextRef="Cur_9mos_20101003_CorporateOtherMember" unitRef="USD">-15898000000</us-gaap:SegmentReportingInformationProfitLoss>
  <us-gaap:SegmentReportingInformationRevenue id="id_footnote_elem_25909524" decimals="-6" contextRef="Pri_6mos_20090628_BiopharmaceuticalMember" unitRef="USD">30842000000</us-gaap:SegmentReportingInformationRevenue>
  <us-gaap:SegmentReportingInformationRevenue id="id_footnote_elem_2610379" decimals="-6" contextRef="Pri_6mos_20090628_DiversifiedMember" unitRef="USD">2379000000</us-gaap:SegmentReportingInformationRevenue>
  <us-gaap:SegmentReportingInformationRevenue id="id_footnote_elem_14566130" decimals="-6" contextRef="Pri_6mos_20090628_CorporateOtherMember" unitRef="USD">251000000</us-gaap:SegmentReportingInformationRevenue>
  <us-gaap:SegmentReportingInformationProfitLoss id="id_footnote_elem_29214554" decimals="-6" contextRef="Pri_6mos_20090628_BiopharmaceuticalMember" unitRef="USD">15868000000</us-gaap:SegmentReportingInformationProfitLoss>
  <us-gaap:SegmentReportingInformationProfitLoss id="id_footnote_elem_16007468" decimals="-6" contextRef="Pri_6mos_20090628_DiversifiedMember" unitRef="USD">598000000</us-gaap:SegmentReportingInformationProfitLoss>
  <us-gaap:SegmentReportingInformationProfitLoss id="id_footnote_elem_26915528" decimals="-6" contextRef="Pri_6mos_20090628_CorporateOtherMember" unitRef="USD">-5643000000</us-gaap:SegmentReportingInformationProfitLoss>
  <pfe:DeferredTaxAssetWriteoff decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">270000000</pfe:DeferredTaxAssetWriteoff>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_9mos_20101003_LipitorMember_2" unitRef="USD">8104000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_25561773" decimals="-6" contextRef="Cur_9mos_20101003_EnbrelMember_2" unitRef="USD">2409000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_9mos_20101003_LyricaMember_2" unitRef="USD">2242000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_23016041" decimals="-6" contextRef="Cur_9mos_20101003_EffexorMember_2" unitRef="USD">1512000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_9mos_20101003_CelebrexMember" unitRef="USD">1752000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_17524110" decimals="-6" contextRef="Cur_9mos_20101003_PrevnarPrevenar7Member" unitRef="USD">1030000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_9mos_20101003_ViagraMember" unitRef="USD">1429000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_9mos_20101003_XalatanXalacomMember" unitRef="USD">1287000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_9mos_20101003_NorvascMember" unitRef="USD">1120000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_9mos_20101003_ZyvoxMember" unitRef="USD">876000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_28358141" decimals="-6" contextRef="Cur_9mos_20101003_PrevnarPrevenar13Member" unitRef="USD">1590000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_29757771" decimals="-6" contextRef="Cur_9mos_20101003_ZosynTazocinMember" unitRef="USD">749000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_9mos_20101003_DetrolDetrolLAMember" unitRef="USD">758000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_9mos_20101003_SutentMember" unitRef="USD">771000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_17959986" decimals="-6" contextRef="Cur_9mos_20101003_PremarinFamilyMember" unitRef="USD">779000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_9mos_20101003_GeodonZeldoxMember" unitRef="USD">763000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_9mos_20101003_GenotropinMember" unitRef="USD">650000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_9mos_20101003_ChantixChampixMember" unitRef="USD">522000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_9mos_20101003_VfendMember" unitRef="USD">595000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_3590817" decimals="-6" contextRef="Cur_9mos_20101003_BeneFIXMember" unitRef="USD">474000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_9mos_20101003_CaduetMember" unitRef="USD">388000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_9mos_20101003_AromasinMember" unitRef="USD">361000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_9mos_20101003_ZoloftMember" unitRef="USD">390000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_9mos_20101003_RevatioMember" unitRef="USD">352000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_9mos_20101003_MedrolMember" unitRef="USD">341000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_9mos_20101003_CarduraMember" unitRef="USD">312000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_16044887" decimals="-6" contextRef="Cur_9mos_20101003_AriceptMember" unitRef="USD">310000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_9mos_20101003_ZithromaxZmaxMember" unitRef="USD">303000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_31302908" decimals="-6" contextRef="Cur_9mos_20101003_ReFactoAFXynthaMember" unitRef="USD">290000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_27151659" decimals="-6" contextRef="Cur_9mos_20101003_AllOtherMember" unitRef="USD">5932000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_13831573" decimals="-6" contextRef="Cur_9mos_20101003_AllianceRevenuesMember" unitRef="USD">3107000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_59310" decimals="-6" contextRef="Cur_9mos_20101003_AnimalHealthMember" unitRef="USD">2599000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_10634937" decimals="-6" contextRef="Cur_9mos_20101003_ConsumerHealthcareMember" unitRef="USD">2014000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_5235036" decimals="-6" contextRef="Cur_9mos_20101003_NutritionMember" unitRef="USD">1375000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_29896831" decimals="-6" contextRef="Cur_9mos_20101003_CapsugelMember" unitRef="USD">545000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_9mos_20101003_DiversifiedMember_2" unitRef="USD">6533000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_9mos_20101003_CorporateOtherMember" unitRef="USD">243000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_6mos_20090628_LipitorMember" unitRef="USD">8259000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_6mos_20090628_LyricaMember" unitRef="USD">2020000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_6mos_20090628_CelebrexMember" unitRef="USD">1714000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_6mos_20090628_ViagraMember" unitRef="USD">1343000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_6mos_20090628_XalatanXalacomMember" unitRef="USD">1238000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_6mos_20090628_NorvascMember" unitRef="USD">1487000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_6mos_20090628_ZyvoxMember" unitRef="USD">811000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_6mos_20090628_DetrolDetrolLAMember" unitRef="USD">845000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_6mos_20090628_SutentMember" unitRef="USD">671000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_6mos_20090628_GeodonZeldoxMember" unitRef="USD">713000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_6mos_20090628_GenotropinMember" unitRef="USD">636000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_6mos_20090628_ChantixChampixMember" unitRef="USD">524000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_6mos_20090628_VfendMember" unitRef="USD">555000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_6mos_20090628_CaduetMember" unitRef="USD">392000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_6mos_20090628_AromasinMember" unitRef="USD">347000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_6mos_20090628_ZoloftMember" unitRef="USD">368000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_6mos_20090628_RevatioMember" unitRef="USD">319000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_6mos_20090628_MedrolMember" unitRef="USD">334000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_6mos_20090628_CarduraMember" unitRef="USD">330000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_17063767" decimals="-6" contextRef="Pri_6mos_20090628_AriceptMember" unitRef="USD">311000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_6mos_20090628_ZithromaxZmaxMember" unitRef="USD">299000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_25216326" decimals="-6" contextRef="Pri_6mos_20090628_AllOtherMember" unitRef="USD">5210000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_6189085" decimals="-6" contextRef="Pri_6mos_20090628_AllianceRevenuesMember" unitRef="USD">1872000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_7464954" decimals="-6" contextRef="Pri_6mos_20090628_AnimalHealthMember" unitRef="USD">1863000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_29806925" decimals="-6" contextRef="Pri_6mos_20090628_CapsugelMember" unitRef="USD">516000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_6mos_20090628_DiversifiedMember" unitRef="USD">2379000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_6mos_20090628_CorporateOtherMember" unitRef="USD">251000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:CostOfGoodsAndServicesSold decimals="-6" contextRef="Pri_6mos_20090628_ImplementationCostsMember" unitRef="USD">42000000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:SellingGeneralAndAdministrativeExpense decimals="-6" contextRef="Pri_6mos_20090628_ImplementationCostsMember" unitRef="USD">165000000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost decimals="-6" contextRef="Pri_6mos_20090628_ImplementationCostsMember" unitRef="USD">36000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
  <pfe:OtherIncomeExpenseNet decimals="-6" contextRef="Pri_6mos_20090628_ImplementationCostsMember" unitRef="USD">6000000</pfe:OtherIncomeExpenseNet>
  <pfe:CurrentDeferredTaxLiabilitiesAndOtherCurrentLiabilities decimals="-8" contextRef="Cur_20101003_RestructuringAccrualMember" unitRef="USD">1600000000</pfe:CurrentDeferredTaxLiabilitiesAndOtherCurrentLiabilities>
  <us-gaap:OtherLiabilitiesNoncurrent decimals="-6" contextRef="Cur_20101003_RestructuringAccrualMember" unitRef="USD">482000000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:RestructuringReserve xsi:nil="true" contextRef="Cur_20101003_AssetImpairmentsMember" unitRef="USD"/>
  <pfe:IntangibleAssetsGrossCarryingAmount id="id_footnote_elem_9054811" decimals="-6" contextRef="Cur_20101003" unitRef="USD">84532000000</pfe:IntangibleAssetsGrossCarryingAmount>
  <pfe:IntangibleAssetsGrossCarryingAmount id="id_footnote_elem_21441372" decimals="-6" contextRef="Pri_20091231" unitRef="USD">90196000000</pfe:IntangibleAssetsGrossCarryingAmount>
  <pfe:ActualEmployeesTerminated decimals="INF" contextRef="Cur_20101003" unitRef="Percent">33400</pfe:ActualEmployeesTerminated>
  <pfe:EstimatedEmployeeTerminations decimals="INF" contextRef="Cur_69mos_20101003" unitRef="Percent">46600</pfe:EstimatedEmployeeTerminations>
  <pfe:GoodwillOtherAdjustments id="id_footnote_elem_32792751" decimals="-6" contextRef="Cur_9mos_20101003_BiopharmaceuticalMember" unitRef="USD">-551000000</pfe:GoodwillOtherAdjustments>
  <pfe:GoodwillOtherAdjustments id="id_footnote_elem_29689911" decimals="-6" contextRef="Cur_9mos_20101003_DiversifiedMember" unitRef="USD">-6000000</pfe:GoodwillOtherAdjustments>
  <pfe:GoodwillOtherAdjustments id="id_footnote_elem_14437372" decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">-735000000</pfe:GoodwillOtherAdjustments>
  <us-gaap:Goodwill decimals="-6" contextRef="Cur_20101003_BiopharmaceuticalMember" unitRef="USD">40705000000</us-gaap:Goodwill>
  <us-gaap:Goodwill decimals="-6" contextRef="Cur_20101003_DiversifiedMember" unitRef="USD">3082000000</us-gaap:Goodwill>
  <us-gaap:Goodwill id="id_footnote_elem_19921939" decimals="-6" contextRef="Cur_20101003" unitRef="USD">43787000000</us-gaap:Goodwill>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">-4252000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">2673000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease>
  <pfe:BusinessCombinationAcquisitionRelatedCostsTransactionCosts id="id_footnote_elem_27872276" decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">13000000</pfe:BusinessCombinationAcquisitionRelatedCostsTransactionCosts>
  <pfe:BusinessCombinationAcquisitionRelatedCostsTransactionCosts id="id_footnote_elem_25997733" decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">572000000</pfe:BusinessCombinationAcquisitionRelatedCostsTransactionCosts>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-114000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-22000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses decimals="-6" contextRef="Cur_9mos_20101003_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">-50000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses decimals="-6" contextRef="Pri_6mos_20090628_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-161000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses decimals="-6" contextRef="Pri_6mos_20090628_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-23000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses decimals="-6" contextRef="Pri_6mos_20090628_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">-18000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses decimals="-6" contextRef="Pri_6mos_20090628_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-13000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">-4000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">6000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:NetIncomeLoss decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">5367000000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">7868000000</us-gaap:NetIncomeLoss>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic decimals="-6" contextRef="Cur_9mos_20101003" unitRef="Shares">8045000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding decimals="-6" contextRef="Cur_9mos_20101003" unitRef="Shares">8079000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic decimals="-6" contextRef="Pri_9mos_20090927" unitRef="Shares">6727000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding decimals="-6" contextRef="Pri_9mos_20090927" unitRef="Shares">6758000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:IncomeLossFromContinuingOperations decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">5371000000</us-gaap:IncomeLossFromContinuingOperations>
  <us-gaap:IncomeLossFromContinuingOperations decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">7862000000</us-gaap:IncomeLossFromContinuingOperations>
  <us-gaap:PreferredStockDividends decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">2000000</us-gaap:PreferredStockDividends>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">5365000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">7866000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">5367000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">7868000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment decimals="-6" contextRef="Cur_9mos_20101003" unitRef="Shares">34000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment decimals="-6" contextRef="Pri_9mos_20090927" unitRef="Shares">31000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="id_footnote_elem_15966392" decimals="-6" contextRef="Cur_9mos_20101003" unitRef="Shares">419000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="id_footnote_elem_17941209" decimals="-6" contextRef="Pri_9mos_20090927" unitRef="Shares">406000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <pfe:UnusedBridgeLoan decimals="-8" contextRef="Pri_2009-03-12" unitRef="USD">22500000000</pfe:UnusedBridgeLoan>
  <us-gaap:GoodwillAcquiredDuringPeriod xsi:nil="true" contextRef="Cur_9mos_20101003_BiopharmaceuticalMember" unitRef="USD"/>
  <us-gaap:GoodwillAcquiredDuringPeriod decimals="-6" contextRef="Cur_9mos_20101003_DiversifiedMember" unitRef="USD">19000000</us-gaap:GoodwillAcquiredDuringPeriod>
  <us-gaap:GoodwillAcquiredDuringPeriod decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">2146000000</us-gaap:GoodwillAcquiredDuringPeriod>
  <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmount id="id_footnote_elem_26820159" decimals="-6" contextRef="Cur_20101003" unitRef="USD">1797000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmount>
  <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmount id="id_footnote_elem_30710731" decimals="-6" contextRef="Pri_20091231" unitRef="USD">812000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmount>
  <us-gaap:DerivativeLiabilityNotDesignatedAsHedgingInstrumentFairValue decimals="-6" contextRef="Cur_20101003_ForeignExchangeContractMember_2" unitRef="USD">59000000</us-gaap:DerivativeLiabilityNotDesignatedAsHedgingInstrumentFairValue>
  <us-gaap:DerivativeLiabilityNotDesignatedAsHedgingInstrumentFairValue decimals="-6" contextRef="Pri_20091231_ForeignExchangeForwardMember_2" unitRef="USD">122000000</us-gaap:DerivativeLiabilityNotDesignatedAsHedgingInstrumentFairValue>
  <pfe:SelectedFinancialAssetsCashAndCashEquivalents decimals="-6" contextRef="Cur_20101003" unitRef="USD">1526000000</pfe:SelectedFinancialAssetsCashAndCashEquivalents>
  <pfe:SelectedFinancialAssetsLongTermInvestmentsAndLoans decimals="-6" contextRef="Cur_20101003" unitRef="USD">10344000000</pfe:SelectedFinancialAssetsLongTermInvestmentsAndLoans>
  <pfe:SelectedFinancialAssetsCurrentDeferredTaxAssetsAndOtherCurrentAssets decimals="-6" contextRef="Cur_20101003_ForeignExchangeContractMember_3" unitRef="USD">16000000</pfe:SelectedFinancialAssetsCurrentDeferredTaxAssetsAndOtherCurrentAssets>
  <pfe:SelectedFinancialAssetsCurrentDeferredTaxAssetsAndOtherCurrentAssets decimals="-6" contextRef="Cur_20101003_ForeignExchangeForwardMember_3" unitRef="USD">262000000</pfe:SelectedFinancialAssetsCurrentDeferredTaxAssetsAndOtherCurrentAssets>
  <pfe:SelectedFinancialAssetsCurrentDeferredTaxAssetsAndOtherCurrentAssets id="id_footnote_elem_33312085" decimals="-6" contextRef="Cur_20101003" unitRef="USD">278000000</pfe:SelectedFinancialAssetsCurrentDeferredTaxAssetsAndOtherCurrentAssets>
  <pfe:SelectedFinancialAssetsCurrentDeferredTaxAssetsAndOtherCurrentAssets decimals="-6" contextRef="Pri_20091231_ForeignExchangeContractMember_3" unitRef="USD">23000000</pfe:SelectedFinancialAssetsCurrentDeferredTaxAssetsAndOtherCurrentAssets>
  <pfe:SelectedFinancialAssetsCurrentDeferredTaxAssetsAndOtherCurrentAssets decimals="-6" contextRef="Pri_20091231_ForeignExchangeForwardMember_3" unitRef="USD">503000000</pfe:SelectedFinancialAssetsCurrentDeferredTaxAssetsAndOtherCurrentAssets>
  <pfe:SelectedFinancialAssetsCashAndCashEquivalents decimals="-6" contextRef="Pri_20091231" unitRef="USD">666000000</pfe:SelectedFinancialAssetsCashAndCashEquivalents>
  <pfe:SelectedFinancialAssetsLongTermInvestmentsAndLoans decimals="-6" contextRef="Pri_20091231" unitRef="USD">13122000000</pfe:SelectedFinancialAssetsLongTermInvestmentsAndLoans>
  <pfe:SelectedFinancialAssetsCurrentDeferredTaxAssetsAndOtherCurrentAssets id="id_footnote_elem_535153" decimals="-6" contextRef="Pri_20091231" unitRef="USD">526000000</pfe:SelectedFinancialAssetsCurrentDeferredTaxAssetsAndOtherCurrentAssets>
  <pfe:SelectedFinancialAssetsNoncurrentDeferredTaxAssetsAndOtherNoncurrentAssets decimals="-6" contextRef="Cur_20101003_ForeignExchangeContractMember_3" unitRef="USD">211000000</pfe:SelectedFinancialAssetsNoncurrentDeferredTaxAssetsAndOtherNoncurrentAssets>
  <pfe:SelectedFinancialAssetsNoncurrentDeferredTaxAssetsAndOtherNoncurrentAssets decimals="-6" contextRef="Cur_20101003_InterestRateSwapMember_3" unitRef="USD">740000000</pfe:SelectedFinancialAssetsNoncurrentDeferredTaxAssetsAndOtherNoncurrentAssets>
  <pfe:SelectedFinancialAssetsNoncurrentDeferredTaxAssetsAndOtherNoncurrentAssets id="id_footnote_elem_22533548" decimals="-6" contextRef="Cur_20101003" unitRef="USD">951000000</pfe:SelectedFinancialAssetsNoncurrentDeferredTaxAssetsAndOtherNoncurrentAssets>
  <pfe:SelectedFinancialAssetsNoncurrentDeferredTaxAssetsAndOtherNoncurrentAssets decimals="-6" contextRef="Pri_20091231_ForeignExchangeContractMember_3" unitRef="USD">774000000</pfe:SelectedFinancialAssetsNoncurrentDeferredTaxAssetsAndOtherNoncurrentAssets>
  <pfe:SelectedFinancialAssetsNoncurrentDeferredTaxAssetsAndOtherNoncurrentAssets decimals="-6" contextRef="Pri_20091231_InterestRateSwapMember_3" unitRef="USD">276000000</pfe:SelectedFinancialAssetsNoncurrentDeferredTaxAssetsAndOtherNoncurrentAssets>
  <pfe:SelectedFinancialAssetsNoncurrentDeferredTaxAssetsAndOtherNoncurrentAssets id="id_footnote_elem_19733667" decimals="-6" contextRef="Pri_20091231" unitRef="USD">1050000000</pfe:SelectedFinancialAssetsNoncurrentDeferredTaxAssetsAndOtherNoncurrentAssets>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue decimals="-6" contextRef="Cur_20101003_AssetBackedSecuritiesMember" unitRef="USD">12000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue decimals="-6" contextRef="Cur_20101003_AssetBackedSecuritiesMember" unitRef="USD">36000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesFairValue decimals="-6" contextRef="Cur_20101003_AssetBackedSecuritiesMember" unitRef="USD">48000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesFairValue>
  <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount decimals="-6" contextRef="Cur_20101003_CertificatesOfDepositAndOtherMember" unitRef="USD">1791000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount>
  <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount decimals="-6" contextRef="Cur_20101003_CertificatesOfDepositAndOtherMember" unitRef="USD">6000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount>
  <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmount decimals="-6" contextRef="Cur_20101003_CertificatesOfDepositAndOtherMember" unitRef="USD">1797000000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmount>
  <us-gaap:MarketableSecurities decimals="-6" contextRef="Cur_20101003" unitRef="USD">30597000000</us-gaap:MarketableSecurities>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet id="id_footnote_elem_18341231" decimals="-6" contextRef="Pri_9mos_20090927_InterestRateSwapMember_FairValueHedgingMember_OtherIncomeExpenseMember" unitRef="USD">-2000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet id="id_footnote_elem_29159164" decimals="-6" contextRef="Pri_9mos_20090927_InterestRateContractMember_CashFlowHedgingMember_OtherIncomeExpenseMember" unitRef="USD">-11000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet id="id_footnote_elem_3700134" decimals="-6" contextRef="Pri_9mos_20090927_InterestRateContractMember_CashFlowHedgingMember_OtherComprehensiveIncomeMember" unitRef="USD">-16000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet id="id_footnote_elem_24740077" decimals="-6" contextRef="Pri_9mos_20090927_ForeignExchangeContractMember_CashFlowHedgingMember_OtherComprehensiveIncomeMember" unitRef="USD">100000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet id="id_footnote_elem_26443018" decimals="-6" contextRef="Pri_9mos_20090927_ForeignExchangeForwardMember_CashFlowHedgingMember_OtherComprehensiveIncomeMember" unitRef="USD">5000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet id="id_footnote_elem_27701184" decimals="-6" contextRef="Pri_9mos_20090927_ForeignExchangeForwardMember_CashFlowHedgingMember" unitRef="USD">17000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet id="id_footnote_elem_3229069" decimals="-6" contextRef="Cur_9mos_20101003_ForeignExchangeContractMember_CashFlowHedgingMember_OtherComprehensiveIncomeMember" unitRef="USD">-1000000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet id="id_footnote_elem_12850754" decimals="-6" contextRef="Cur_9mos_20101003_ForeignExchangeContractMember_CashFlowHedgingMember" unitRef="USD">-440000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet id="id_footnote_elem_32970440" decimals="-6" contextRef="Cur_9mos_20101003_ForeignExchangeForwardMember_CashFlowHedgingMember" unitRef="USD">2000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet id="id_footnote_elem_18238100" decimals="-6" contextRef="Cur_9mos_20101003_ForeignExchangeContractMember_NetInvestmentHedgingMember_OtherComprehensiveIncomeMember" unitRef="USD">-78000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet id="id_footnote_elem_26063808" decimals="-6" contextRef="Pri_6Mos_2009-09-27_ForeignExchangeContractMember_NetInvestmentHedgingMember_OtherIncomeExpenseMember" unitRef="USD">-1000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet id="id_footnote_elem_30076697" decimals="-6" contextRef="Pri_6Mos_2009-09-27_ForeignExchangeContractMember_NetInvestmentHedgingMember_OtherComprehensiveIncomeMember" unitRef="USD">-1000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet id="id_footnote_elem_26454222" decimals="-6" contextRef="Pri_9mos_20090927_ForeignExchangeContractMember_NondesignatedMember_OtherIncomeExpenseMember" unitRef="USD">17000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet id="id_footnote_elem_3110333" decimals="-6" contextRef="Pri_9mos_20090927_ForeignExchangeForwardMember_NondesignatedMember_OtherIncomeExpenseMember" unitRef="USD">-795000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet id="id_footnote_elem_30095808" decimals="-6" contextRef="Cur_9mos_20101003_ForeignExchangeForwardMember_NondesignatedMember_OtherIncomeExpenseMember" unitRef="USD">-943000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:NotionalAmountOfForeignCurrencyDerivatives decimals="-8" contextRef="Cur_20101003" unitRef="USD">58200000000</us-gaap:NotionalAmountOfForeignCurrencyDerivatives>
  <pfe:NonDerivativeFinancialInstrumentsInNetInvestmentHedgeRelationshipsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet id="id_footnote_elem_8137426" decimals="-6" contextRef="Pri_9mos_20090927_ForeignCurrencyShortTermBorrowingsMember_NetInvestmentHedgingMember_OtherComprehensiveIncomeMember" unitRef="USD">26000000</pfe:NonDerivativeFinancialInstrumentsInNetInvestmentHedgeRelationshipsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <pfe:NonDerivativeFinancialInstrumentsInNetInvestmentHedgeRelationshipsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet id="id_footnote_elem_22931680" decimals="-6" contextRef="Cur_9mos_2010-10-03_ForeignCurrencyLongTermDebtMember_NetInvestmentHedgingMember_OtherComprehensiveIncomeMember" unitRef="USD">-72000000</pfe:NonDerivativeFinancialInstrumentsInNetInvestmentHedgeRelationshipsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <pfe:NonDerivativeFinancialInstrumentsInNetInvestmentHedgeRelationshipsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet id="id_footnote_elem_25900910" decimals="-6" contextRef="Cur_9mos_2010-10-03_ForeignCurrencyShortTermBorrowingsMember_NetInvestmentHedgingMember_OtherComprehensiveIncomeMember" unitRef="USD">-195000000</pfe:NonDerivativeFinancialInstrumentsInNetInvestmentHedgeRelationshipsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeNetLiabilityPositionAggregateFairValue decimals="-6" contextRef="Cur_20101003" unitRef="USD">1200000000</us-gaap:DerivativeNetLiabilityPositionAggregateFairValue>
  <us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure decimals="-8" contextRef="Cur_9mos_20101003" unitRef="USD">1800000000</us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure>
  <us-gaap:SecuritiesReceivedAsCollateral decimals="-6" contextRef="Cur_20101003" unitRef="USD">391000000</us-gaap:SecuritiesReceivedAsCollateral>
  <us-gaap:AssetImpairmentCharges decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">2956000000</us-gaap:AssetImpairmentCharges>
  <us-gaap:AssetImpairmentCharges decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">293000000</us-gaap:AssetImpairmentCharges>
  <us-gaap:PaymentsForRepurchaseOfCommonStock decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">1000000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
  <us-gaap:CostOfGoodsAndServicesSold id="id_footnote_elem_14016316" decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">3896000000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:CostOfGoodsAndServicesSold id="id_footnote_elem_5678564" decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">1789000000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:SellingGeneralAndAdministrativeExpense id="id_footnote_elem_31919607" decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">4633000000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:SellingGeneralAndAdministrativeExpense id="id_footnote_elem_12788712" decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">3282000000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost id="id_footnote_elem_15123188" decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">2194000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
  <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost id="id_footnote_elem_4702277" decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">1632000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
  <us-gaap:AmortizationOfIntangibleAssets decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">1156000000</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">594000000</us-gaap:AmortizationOfIntangibleAssets>
  <pfe:RestructuringChargesAndAcquisitionRelatedCosts decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">499000000</pfe:RestructuringChargesAndAcquisitionRelatedCosts>
  <pfe:RestructuringChargesAndAcquisitionRelatedCosts decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">193000000</pfe:RestructuringChargesAndAcquisitionRelatedCosts>
  <pfe:OtherIncomeExpenseNet decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">2353000000</pfe:OtherIncomeExpenseNet>
  <pfe:OtherIncomeExpenseNet decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">160000000</pfe:OtherIncomeExpenseNet>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="id_footnote_elem_399447" decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">1440000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="id_footnote_elem_10000045" decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">3971000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeTaxExpenseBenefit decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">564000000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefit decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">1092000000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">876000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">2879000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">-5000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">2000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:ProfitLoss decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">871000000</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">2881000000</us-gaap:ProfitLoss>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">5000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:NetIncomeLoss decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">866000000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">2878000000</us-gaap:NetIncomeLoss>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare decimals="2" contextRef="Cur_3mos_20101003" unitRef="USDperShare">0.11</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare decimals="2" contextRef="Pri_3mos_20090927" unitRef="USDperShare">0.43</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:EarningsPerShareBasic decimals="2" contextRef="Cur_3mos_20101003" unitRef="USDperShare">0.11</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic decimals="2" contextRef="Pri_3mos_20090927" unitRef="USDperShare">0.43</us-gaap:EarningsPerShareBasic>
  <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare decimals="2" contextRef="Cur_3mos_20101003" unitRef="USDperShare">0.11</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
  <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare decimals="2" contextRef="Pri_3mos_20090927" unitRef="USDperShare">0.43</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
  <us-gaap:EarningsPerShareDiluted decimals="2" contextRef="Cur_3mos_20101003" unitRef="USDperShare">0.11</us-gaap:EarningsPerShareDiluted>
  <us-gaap:EarningsPerShareDiluted decimals="2" contextRef="Pri_3mos_20090927" unitRef="USDperShare">0.43</us-gaap:EarningsPerShareDiluted>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic decimals="-6" contextRef="Cur_3mos_20101003" unitRef="Shares">8027000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic decimals="-6" contextRef="Pri_3mos_20090927" unitRef="Shares">6730000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding decimals="-6" contextRef="Cur_3mos_20101003" unitRef="Shares">8057000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding decimals="-6" contextRef="Pri_3mos_20090927" unitRef="Shares">6762000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:CommonStockDividendsPerShareCashPaid decimals="2" contextRef="Cur_3mos_20101003" unitRef="USDperShare">0.18</us-gaap:CommonStockDividendsPerShareCashPaid>
  <us-gaap:CommonStockDividendsPerShareCashPaid decimals="2" contextRef="Pri_3mos_20090927" unitRef="USDperShare">0.16</us-gaap:CommonStockDividendsPerShareCashPaid>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare decimals="2" contextRef="Cur_3mos_20101003" unitRef="USDperShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare decimals="2" contextRef="Pri_3mos_20090927" unitRef="USDperShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare decimals="2" contextRef="Cur_9mos_20101003" unitRef="USDperShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare decimals="2" contextRef="Pri_9mos_20090927" unitRef="USDperShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare decimals="2" contextRef="Cur_3mos_20101003" unitRef="USDperShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare decimals="2" contextRef="Pri_3mos_20090927" unitRef="USDperShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare decimals="2" contextRef="Cur_9mos_20101003" unitRef="USDperShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare decimals="2" contextRef="Pri_9mos_20090927" unitRef="USDperShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
  <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">-59000000</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">-43000000</us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">26000000</us-gaap:OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">86000000</us-gaap:OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">-45000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">-459000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">708000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">183000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">1579000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">3064000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">5000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">-3000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTax decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">1574000000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">3067000000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:DefinedBenefitPlanServiceCost decimals="-6" contextRef="Pri_3mos_20090628_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">51000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DefinedBenefitPlanInterestCost decimals="-6" contextRef="Pri_3mos_20090628_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">116000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets decimals="-6" contextRef="Pri_3mos_20090628_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">115000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses decimals="-6" contextRef="Pri_3mos_20090628_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-51000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments decimals="-6" contextRef="Pri_3mos_20090628_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">47000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments>
  <us-gaap:DefinedBenefitPlanSpecialTerminationBenefits decimals="-6" contextRef="Pri_3mos_20090628_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-5000000</us-gaap:DefinedBenefitPlanSpecialTerminationBenefits>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost decimals="-6" contextRef="Pri_3mos_20090628_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">156000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:DefinedBenefitPlanServiceCost decimals="-6" contextRef="Pri_3mos_20090628_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">5000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DefinedBenefitPlanInterestCost decimals="-6" contextRef="Pri_3mos_20090628_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">12000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses decimals="-6" contextRef="Pri_3mos_20090628_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-7000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments decimals="-6" contextRef="Pri_3mos_20090628_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">2000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost decimals="-6" contextRef="Pri_3mos_20090628_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">25000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:DefinedBenefitPlanServiceCost decimals="-6" contextRef="Pri_3mos_20090628_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">46000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DefinedBenefitPlanInterestCost decimals="-6" contextRef="Pri_3mos_20090628_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">85000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets decimals="-6" contextRef="Pri_3mos_20090628_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">96000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses decimals="-6" contextRef="Pri_3mos_20090628_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">-6000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments decimals="-6" contextRef="Pri_3mos_20090628_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">1000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments>
  <us-gaap:DefinedBenefitPlanSpecialTerminationBenefits decimals="-6" contextRef="Pri_3mos_20090628_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">-3000000</us-gaap:DefinedBenefitPlanSpecialTerminationBenefits>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost decimals="-6" contextRef="Pri_3mos_20090628_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">45000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:DefinedBenefitPlanServiceCost decimals="-6" contextRef="Pri_3mos_20090628_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">7000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DefinedBenefitPlanInterestCost decimals="-6" contextRef="Pri_3mos_20090628_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">30000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets decimals="-6" contextRef="Pri_3mos_20090628_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">6000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses decimals="-6" contextRef="Pri_3mos_20090628_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-4000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit decimals="-6" contextRef="Pri_3mos_20090628_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
  <us-gaap:DefinedBenefitPlanSpecialTerminationBenefits decimals="-6" contextRef="Pri_3mos_20090628_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-2000000</us-gaap:DefinedBenefitPlanSpecialTerminationBenefits>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost decimals="-6" contextRef="Pri_3mos_20090628_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">38000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:DefinedBenefitPlanServiceCost decimals="-6" contextRef="Cur_3mos_20101003_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">83000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DefinedBenefitPlanInterestCost decimals="-6" contextRef="Cur_3mos_20101003_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">183000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets decimals="-6" contextRef="Cur_3mos_20101003_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">193000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses decimals="-6" contextRef="Cur_3mos_20101003_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-38000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments decimals="-6" contextRef="Cur_3mos_20101003_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-3000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments>
  <us-gaap:DefinedBenefitPlanSpecialTerminationBenefits decimals="-6" contextRef="Cur_3mos_20101003_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-7000000</us-gaap:DefinedBenefitPlanSpecialTerminationBenefits>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost decimals="-6" contextRef="Cur_3mos_20101003_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">115000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:DefinedBenefitPlanServiceCost decimals="-6" contextRef="Cur_3mos_20101003_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">7000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DefinedBenefitPlanInterestCost decimals="-6" contextRef="Cur_3mos_20101003_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">19000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses decimals="-6" contextRef="Cur_3mos_20101003_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-7000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments decimals="-6" contextRef="Cur_3mos_20101003_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">8000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments>
  <us-gaap:DefinedBenefitPlanSpecialTerminationBenefits decimals="-6" contextRef="Cur_3mos_20101003_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-3000000</us-gaap:DefinedBenefitPlanSpecialTerminationBenefits>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost decimals="-6" contextRef="Cur_3mos_20101003_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">43000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:DefinedBenefitPlanServiceCost decimals="-6" contextRef="Cur_3mos_20101003_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">55000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DefinedBenefitPlanInterestCost decimals="-6" contextRef="Cur_3mos_20101003_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">103000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets decimals="-6" contextRef="Cur_3mos_20101003_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">105000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
  <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses decimals="-6" contextRef="Cur_3mos_20101003_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">-17000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
  <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit decimals="-6" contextRef="Cur_3mos_20101003_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">-1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
  <us-gaap:DefinedBenefitPlanSpecialTerminationBenefits decimals="-6" contextRef="Cur_3mos_20101003_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">-1000000</us-gaap:DefinedBenefitPlanSpecialTerminationBenefits>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost decimals="-6" contextRef="Cur_3mos_20101003_ForeignPensionPlansDefinedBenefitMember" unitRef="USD">70000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
  <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments decimals="-6" contextRef="Cur_9mos_20101003_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-6000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets xsi:nil="true" contextRef="Cur_3mos_20101003_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD"/>
  <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit decimals="-6" contextRef="Cur_3mos_20101003_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets xsi:nil="true" contextRef="Pri_3mos_20090628_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD"/>
  <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit decimals="-6" contextRef="Pri_3mos_20090628_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets xsi:nil="true" contextRef="Pri_6mos_20090628_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD"/>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets xsi:nil="true" contextRef="Cur_9mos_20101003_UnitedStatesSupplementalNonQualifiedPensionPlansOfUSEntityDefinedBenefitMember" unitRef="USD"/>
  <us-gaap:DefinedBenefitPlanServiceCost decimals="-6" contextRef="Cur_3mos_20101003_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">18000000</us-gaap:DefinedBenefitPlanServiceCost>
  <us-gaap:DefinedBenefitPlanInterestCost decimals="-6" contextRef="Cur_3mos_20101003_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">52000000</us-gaap:DefinedBenefitPlanInterestCost>
  <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets decimals="-6" contextRef="Cur_3mos_20101003_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">7000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
  <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit decimals="-6" contextRef="Cur_3mos_20101003_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-15000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
  <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments decimals="-6" contextRef="Cur_3mos_20101003_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-4000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments>
  <us-gaap:DefinedBenefitPlanSpecialTerminationBenefits decimals="-6" contextRef="Cur_3mos_20101003_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">-1000000</us-gaap:DefinedBenefitPlanSpecialTerminationBenefits>
  <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost decimals="-6" contextRef="Cur_3mos_20101003_UnitedStatesPostretirementBenefitPlansOfUSEntityDefinedBenefitMember" unitRef="USD">52000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
  <us-gaap:IncomeLossFromContinuingOperations decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">871000000</us-gaap:IncomeLossFromContinuingOperations>
  <us-gaap:IncomeLossFromContinuingOperations decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">2876000000</us-gaap:IncomeLossFromContinuingOperations>
  <us-gaap:PreferredStockDividends decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">1000000</us-gaap:PreferredStockDividends>
  <us-gaap:PreferredStockDividends decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">2000000</us-gaap:PreferredStockDividends>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">865000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">2878000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">866000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">2878000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment decimals="-6" contextRef="Cur_3mos_20101003" unitRef="Shares">30000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment decimals="-6" contextRef="Pri_3mos_20090927" unitRef="Shares">32000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="id_footnote_elem_23968816" decimals="-6" contextRef="Cur_3mos_20101003" unitRef="Shares">419000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount id="id_footnote_elem_24503952" decimals="-6" contextRef="Pri_3mos_20090927" unitRef="Shares">406000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalExcludingInventories id="id_footnote_elem_3814439" decimals="-6" contextRef="Cur_20101003_ScenarioPreviouslyReportedMember" unitRef="USD">16342000000</pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalExcludingInventories>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory id="id_footnote_elem_22495042" decimals="-6" contextRef="Cur_20101003_ScenarioPreviouslyReportedMember" unitRef="USD">8388000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment id="id_footnote_elem_11572157" decimals="-6" contextRef="Cur_20101003_ScenarioPreviouslyReportedMember" unitRef="USD">10054000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
  <pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangiblesExcludingInProcessResearchAndDevelopment id="id_footnote_elem_2496098" decimals="-6" contextRef="Cur_20101003_ScenarioPreviouslyReportedMember" unitRef="USD">37595000000</pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangiblesExcludingInProcessResearchAndDevelopment>
  <pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInProcessResearchAndDevelopment id="id_footnote_elem_24985548" decimals="-6" contextRef="Cur_20101003_ScenarioPreviouslyReportedMember" unitRef="USD">14918000000</pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInProcessResearchAndDevelopment>
  <pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets id="id_footnote_elem_1908335" decimals="-6" contextRef="Cur_20101003_ScenarioPreviouslyReportedMember" unitRef="USD">2394000000</pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
  <pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt id="id_footnote_elem_27150915" decimals="-6" contextRef="Cur_20101003_ScenarioPreviouslyReportedMember" unitRef="USD">11187000000</pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt>
  <pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBenefitObligations id="id_footnote_elem_32263375" decimals="-6" contextRef="Cur_20101003_ScenarioPreviouslyReportedMember" unitRef="USD">3211000000</pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBenefitObligations>
  <pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetTaxAccounts id="id_footnote_elem_28168159" decimals="-6" contextRef="Cur_20101003_ScenarioPreviouslyReportedMember" unitRef="USD">24773000000</pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetTaxAccounts>
  <pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentLiabilities id="id_footnote_elem_7052448" decimals="-6" contextRef="Cur_20101003_ScenarioPreviouslyReportedMember" unitRef="USD">1908000000</pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentLiabilities>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet id="id_footnote_elem_33501463" decimals="-6" contextRef="Cur_20101003_ScenarioPreviouslyReportedMember" unitRef="USD">48612000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
  <pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInGoodwill id="id_footnote_elem_10982722" decimals="-6" contextRef="Cur_20101003_ScenarioPreviouslyReportedMember" unitRef="USD">19954000000</pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInGoodwill>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet id="id_footnote_elem_18800674" decimals="-6" contextRef="Cur_20101003_ScenarioPreviouslyReportedMember" unitRef="USD">68566000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
  <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue id="id_footnote_elem_16270280" decimals="-6" contextRef="Cur_20101003_ScenarioPreviouslyReportedMember" unitRef="USD">330000000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest id="id_footnote_elem_11728950" decimals="-6" contextRef="Cur_20101003_ScenarioPreviouslyReportedMember" unitRef="USD">68236000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest>
  <pfe:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalExcludingInventories decimals="-6" contextRef="Cur_9mos_20101003_ScenarioAdjustmentMember" unitRef="USD">37000000</pfe:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalExcludingInventories>
  <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory id="id_footnote_elem_18192423" decimals="-6" contextRef="Cur_9mos_20101003_ScenarioAdjustmentMember" unitRef="USD">-417000000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory>
  <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment decimals="-6" contextRef="Cur_9mos_20101003_ScenarioAdjustmentMember" unitRef="USD">-216000000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment>
  <pfe:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIdentifiableIntangibleAssetsExcludingInProcessResearchAndDevelopment id="id_footnote_elem_20108933" decimals="-6" contextRef="Cur_9mos_20101003_ScenarioAdjustmentMember" unitRef="USD">-1533000000</pfe:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIdentifiableIntangibleAssetsExcludingInProcessResearchAndDevelopment>
  <pfe:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInprocessResearchAndDevelopment id="id_footnote_elem_6420260" decimals="-6" contextRef="Cur_9mos_20101003_ScenarioAdjustmentMember" unitRef="USD">-1096000000</pfe:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInprocessResearchAndDevelopment>
  <pfe:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentBenefitObligations decimals="-6" contextRef="Cur_9mos_20101003_ScenarioAdjustmentMember" unitRef="USD">-36000000</pfe:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentBenefitObligations>
  <pfe:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetTaxAccounts id="id_footnote_elem_27720458" decimals="-6" contextRef="Cur_9mos_20101003_ScenarioAdjustmentMember" unitRef="USD">-1058000000</pfe:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetTaxAccounts>
  <pfe:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet decimals="-6" contextRef="Cur_9mos_20101003_ScenarioAdjustmentMember" unitRef="USD">-2131000000</pfe:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
  <pfe:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInGoodwill id="id_footnote_elem_27148632" decimals="-6" contextRef="Cur_9mos_20101003_ScenarioAdjustmentMember" unitRef="USD">2127000000</pfe:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInGoodwill>
  <pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalExcludingInventories decimals="-6" contextRef="Cur_20101003_AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember" unitRef="USD">16379000000</pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalExcludingInventories>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory id="id_footnote_elem_12868605" decimals="-6" contextRef="Cur_20101003_AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember" unitRef="USD">7971000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment decimals="-6" contextRef="Cur_20101003_AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember" unitRef="USD">9838000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
  <pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangiblesExcludingInProcessResearchAndDevelopment id="id_footnote_elem_2177848" decimals="-6" contextRef="Cur_20101003_AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember" unitRef="USD">36062000000</pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangiblesExcludingInProcessResearchAndDevelopment>
  <pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInProcessResearchAndDevelopment id="id_footnote_elem_5948935" decimals="-6" contextRef="Cur_20101003_AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember" unitRef="USD">13822000000</pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInProcessResearchAndDevelopment>
  <pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets decimals="-6" contextRef="Cur_20101003_AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember" unitRef="USD">2394000000</pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
  <pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt decimals="-6" contextRef="Cur_20101003_AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember" unitRef="USD">11187000000</pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt>
  <pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBenefitObligations decimals="-6" contextRef="Cur_20101003_AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember" unitRef="USD">3175000000</pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBenefitObligations>
  <pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetTaxAccounts id="id_footnote_elem_5109272" decimals="-6" contextRef="Cur_20101003_AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember" unitRef="USD">23715000000</pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetTaxAccounts>
  <pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentLiabilities decimals="-6" contextRef="Cur_20101003_AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember" unitRef="USD">1908000000</pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentLiabilities>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet decimals="-6" contextRef="Cur_20101003_AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember" unitRef="USD">46481000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
  <pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInGoodwill id="id_footnote_elem_4274493" decimals="-6" contextRef="Cur_20101003_AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember" unitRef="USD">22081000000</pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInGoodwill>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet decimals="-6" contextRef="Cur_20101003_AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember" unitRef="USD">68562000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
  <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue decimals="-6" contextRef="Cur_20101003_AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember" unitRef="USD">326000000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest decimals="-6" contextRef="Cur_20101003_AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember" unitRef="USD">68236000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest>
  <us-gaap:BusinessAcquisitionCostOfAcquiredEntityPurchasePrice decimals="-9" contextRef="Pri_20091015_WyethMember" unitRef="USD">68000000000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityPurchasePrice>
  <pfe:BusinessCombinationAcquisitionRelatedCostsTransactionCosts id="id_footnote_elem_29029840" decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">19000000</pfe:BusinessCombinationAcquisitionRelatedCostsTransactionCosts>
  <pfe:BusinessCombinationAcquisitionRelatedCostsIntegrationCosts id="id_footnote_elem_4164762" decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">231000000</pfe:BusinessCombinationAcquisitionRelatedCostsIntegrationCosts>
  <pfe:BusinessCombinationAcquisitionRelatedCostsIntegrationCosts id="id_footnote_elem_8579239" decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">113000000</pfe:BusinessCombinationAcquisitionRelatedCostsIntegrationCosts>
  <pfe:ImplementationCosts id="id_footnote_elem_29790199" decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">70000000</pfe:ImplementationCosts>
  <pfe:AdditionalDepreciationAssetRestructuring id="id_footnote_elem_186965" decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">295000000</pfe:AdditionalDepreciationAssetRestructuring>
  <pfe:AdditionalDepreciationAssetRestructuring id="id_footnote_elem_26463051" decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">10000000</pfe:AdditionalDepreciationAssetRestructuring>
  <pfe:AdditionalDepreciationAssetRestructuring id="id_footnote_elem_5088530" decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">603000000</pfe:AdditionalDepreciationAssetRestructuring>
  <pfe:AdditionalDepreciationAssetRestructuring id="id_footnote_elem_10622007" decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">161000000</pfe:AdditionalDepreciationAssetRestructuring>
  <us-gaap:CostOfGoodsAndServicesSold id="id_footnote_elem_20939654" decimals="-6" contextRef="Cur_3mos_20101003_AdditionalDepreciationAssetRestructuringMember" unitRef="USD">241000000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:SellingGeneralAndAdministrativeExpense id="id_footnote_elem_15821282" decimals="-6" contextRef="Cur_3mos_20101003_AdditionalDepreciationAssetRestructuringMember" unitRef="USD">28000000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <pfe:AdditionalDepreciationAssetRestructuring decimals="-6" contextRef="Cur_3mos_20101003_AdditionalDepreciationAssetRestructuringMember" unitRef="USD">295000000</pfe:AdditionalDepreciationAssetRestructuring>
  <us-gaap:CostOfGoodsAndServicesSold id="id_footnote_elem_7199108" decimals="-6" contextRef="Pri_3mos_20090628_AdditionalDepreciationAssetRestructuringMember" unitRef="USD">7000000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:SellingGeneralAndAdministrativeExpense id="id_footnote_elem_11961233" decimals="-6" contextRef="Pri_3mos_20090628_AdditionalDepreciationAssetRestructuringMember" unitRef="USD">3000000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <pfe:AdditionalDepreciationAssetRestructuring decimals="-6" contextRef="Pri_3mos_20090628_AdditionalDepreciationAssetRestructuringMember" unitRef="USD">10000000</pfe:AdditionalDepreciationAssetRestructuring>
  <us-gaap:UnsecuredDebt decimals="-8" contextRef="Pri_20090927_SeniorDebtObligationsMember" unitRef="USD">24000000000</us-gaap:UnsecuredDebt>
  <us-gaap:CostOfGoodsAndServicesSold decimals="-6" contextRef="Pri_3mos_20090628_ImplementationCostsMember" unitRef="USD">16000000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:SellingGeneralAndAdministrativeExpense decimals="-6" contextRef="Pri_3mos_20090628_ImplementationCostsMember" unitRef="USD">48000000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost decimals="-6" contextRef="Pri_3mos_20090628_ImplementationCostsMember" unitRef="USD">5000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
  <pfe:OtherIncomeExpenseNet decimals="-6" contextRef="Pri_3mos_20090628_ImplementationCostsMember" unitRef="USD">1000000</pfe:OtherIncomeExpenseNet>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations decimals="3" contextRef="Cur_3mos_20101003" unitRef="Percent">0.392</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations decimals="3" contextRef="Pri_3mos_20090927" unitRef="Percent">0.275</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:SegmentReportingInformationRevenue id="id_footnote_elem_13569756" decimals="-6" contextRef="Cur_3mos_20101003_BiopharmaceuticalMember" unitRef="USD">13945000000</us-gaap:SegmentReportingInformationRevenue>
  <us-gaap:SegmentReportingInformationRevenue id="id_footnote_elem_453168" decimals="-6" contextRef="Cur_3mos_20101003_DiversifiedMember" unitRef="USD">2150000000</us-gaap:SegmentReportingInformationRevenue>
  <us-gaap:SegmentReportingInformationRevenue id="id_footnote_elem_23002584" decimals="-6" contextRef="Cur_3mos_20101003_CorporateOtherMember" unitRef="USD">76000000</us-gaap:SegmentReportingInformationRevenue>
  <us-gaap:SegmentReportingInformationProfitLoss id="id_footnote_elem_11139174" decimals="-6" contextRef="Cur_3mos_20101003_BiopharmaceuticalMember" unitRef="USD">7005000000</us-gaap:SegmentReportingInformationProfitLoss>
  <us-gaap:SegmentReportingInformationProfitLoss id="id_footnote_elem_3873675" decimals="-6" contextRef="Cur_3mos_20101003_DiversifiedMember" unitRef="USD">530000000</us-gaap:SegmentReportingInformationProfitLoss>
  <us-gaap:SegmentReportingInformationProfitLoss id="id_footnote_elem_26139694" decimals="-6" contextRef="Cur_3mos_20101003_CorporateOtherMember" unitRef="USD">-6095000000</us-gaap:SegmentReportingInformationProfitLoss>
  <us-gaap:SegmentReportingInformationRevenue id="id_footnote_elem_8210209" decimals="-6" contextRef="Pri_3mos_20090628_BiopharmaceuticalMember" unitRef="USD">10677000000</us-gaap:SegmentReportingInformationRevenue>
  <us-gaap:SegmentReportingInformationRevenue id="id_footnote_elem_6543866" decimals="-6" contextRef="Pri_3mos_20090628_DiversifiedMember" unitRef="USD">855000000</us-gaap:SegmentReportingInformationRevenue>
  <us-gaap:SegmentReportingInformationRevenue id="id_footnote_elem_29819603" decimals="-6" contextRef="Pri_3mos_20090628_CorporateOtherMember" unitRef="USD">89000000</us-gaap:SegmentReportingInformationRevenue>
  <us-gaap:SegmentReportingInformationProfitLoss id="id_footnote_elem_19115050" decimals="-6" contextRef="Pri_3mos_20090628_BiopharmaceuticalMember" unitRef="USD">5501000000</us-gaap:SegmentReportingInformationProfitLoss>
  <us-gaap:SegmentReportingInformationProfitLoss id="id_footnote_elem_28945144" decimals="-6" contextRef="Pri_3mos_20090628_DiversifiedMember" unitRef="USD">230000000</us-gaap:SegmentReportingInformationProfitLoss>
  <us-gaap:SegmentReportingInformationProfitLoss id="id_footnote_elem_12946147" decimals="-6" contextRef="Pri_3mos_20090628_CorporateOtherMember" unitRef="USD">-1760000000</us-gaap:SegmentReportingInformationProfitLoss>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_21296393" decimals="-6" contextRef="Cur_9mos_20101003_PristiqMember" unitRef="USD">341000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_3mos_20101003_LipitorMember" unitRef="USD">2534000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_14010426" decimals="-6" contextRef="Cur_3mos_20101003_EnbrelMember" unitRef="USD">799000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_3mos_20101003_LyricaMember" unitRef="USD">757000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_31549375" decimals="-6" contextRef="Cur_3mos_20101003_EffexorMember" unitRef="USD">175000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_3mos_20101003_CelebrexMember" unitRef="USD">578000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_3mos_20101003_ViagraMember" unitRef="USD">459000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_3mos_20101003_XalatanXalacomMember" unitRef="USD">416000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_5065534" decimals="-6" contextRef="Cur_3mos_20101003_PrevnarPrevenar13Member" unitRef="USD">735000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_13986351" decimals="-6" contextRef="Cur_3mos_20101003_PrevnarPrevenar7Member" unitRef="USD">179000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_3mos_20101003_NorvascMember" unitRef="USD">330000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_3mos_20101003_ZyvoxMember" unitRef="USD">285000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_3mos_20101003_DetrolDetrolLAMember" unitRef="USD">237000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_19081692" decimals="-6" contextRef="Cur_3mos_20101003_PremarinFamilyMember" unitRef="USD">263000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_3mos_20101003_SutentMember" unitRef="USD">257000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_3mos_20101003_GeodonZeldoxMember" unitRef="USD">262000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_23787862" decimals="-6" contextRef="Cur_3mos_20101003_ZosynTazocinMember" unitRef="USD">255000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_3mos_20101003_GenotropinMember" unitRef="USD">211000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_3mos_20101003_VfendMember" unitRef="USD">200000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_3mos_20101003_ChantixChampixMember" unitRef="USD">163000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_16210949" decimals="-6" contextRef="Cur_3mos_20101003_BeneFIXMember" unitRef="USD">156000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_3mos_20101003_ZoloftMember" unitRef="USD">126000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_3mos_20101003_CaduetMember" unitRef="USD">127000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_3mos_20101003_AromasinMember" unitRef="USD">111000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_3mos_20101003_RevatioMember" unitRef="USD">116000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_22289713" decimals="-6" contextRef="Cur_3mos_20101003_PristiqMember" unitRef="USD">118000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_3mos_20101003_MedrolMember" unitRef="USD">119000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_3mos_20101003_CarduraMember" unitRef="USD">95000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_3mos_20101003_ZithromaxZmaxMember" unitRef="USD">90000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_3915642" decimals="-6" contextRef="Cur_3mos_20101003_AriceptMember" unitRef="USD">100000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_17224173" decimals="-6" contextRef="Cur_3mos_20101003_ReFactoAFXynthaMember" unitRef="USD">102000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_20768369" decimals="-6" contextRef="Cur_3mos_20101003_AllOtherMember" unitRef="USD">1978000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_26287139" decimals="-6" contextRef="Cur_3mos_20101003_AllianceRevenuesMember" unitRef="USD">1042000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_23112350" decimals="-6" contextRef="Cur_3mos_20101003_AnimalHealthMember" unitRef="USD">860000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_27313522" decimals="-6" contextRef="Cur_3mos_20101003_ConsumerHealthcareMember" unitRef="USD">673000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_16391572" decimals="-6" contextRef="Cur_3mos_20101003_NutritionMember" unitRef="USD">441000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_17981771" decimals="-6" contextRef="Cur_3mos_20101003_CapsugelMember" unitRef="USD">176000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_3mos_20101003_DiversifiedMember" unitRef="USD">2150000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_3mos_20101003_CorporateOtherMember" unitRef="USD">76000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_3mos_20090628_LipitorMember" unitRef="USD">2853000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_3mos_20090628_LyricaMember" unitRef="USD">708000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_3mos_20090628_CelebrexMember" unitRef="USD">602000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_3mos_20090628_ViagraMember" unitRef="USD">466000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_3mos_20090628_XalatanXalacomMember" unitRef="USD">436000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_3mos_20090628_NorvascMember" unitRef="USD">488000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_3mos_20090628_ZyvoxMember" unitRef="USD">271000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_3mos_20090628_DetrolDetrolLAMember" unitRef="USD">283000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_3mos_20090628_SutentMember" unitRef="USD">246000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_3mos_20090628_GeodonZeldoxMember" unitRef="USD">252000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_3mos_20090628_GenotropinMember" unitRef="USD">232000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_3mos_20090628_VfendMember" unitRef="USD">196000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_3mos_20090628_ChantixChampixMember" unitRef="USD">155000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_3mos_20090628_ZoloftMember" unitRef="USD">128000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_3mos_20090628_CaduetMember" unitRef="USD">130000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_3mos_20090628_AromasinMember" unitRef="USD">123000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_3mos_20090628_RevatioMember" unitRef="USD">111000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_3mos_20090628_MedrolMember" unitRef="USD">106000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_3mos_20090628_CarduraMember" unitRef="USD">109000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_3mos_20090628_ZithromaxZmaxMember" unitRef="USD">85000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_672302" decimals="-6" contextRef="Pri_3mos_20090628_AriceptMember" unitRef="USD">108000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_5258272" decimals="-6" contextRef="Pri_3mos_20090628_AllOtherMember" unitRef="USD">1815000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_22403165" decimals="-6" contextRef="Pri_3mos_20090628_AllianceRevenuesMember" unitRef="USD">692000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_32184417" decimals="-6" contextRef="Pri_3mos_20090628_AnimalHealthMember" unitRef="USD">678000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_17899191" decimals="-6" contextRef="Pri_3mos_20090628_CapsugelMember" unitRef="USD">177000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_3mos_20090628_DiversifiedMember" unitRef="USD">855000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_3mos_20090628_CorporateOtherMember" unitRef="USD">89000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <pfe:PurchaseAccountingSignificantImpacts decimals="-8" contextRef="Cur_3mos_20101003_CorporateOtherMember" unitRef="USD">1600000000</pfe:PurchaseAccountingSignificantImpacts>
  <pfe:NetInterestIncomeExpense decimals="-6" contextRef="Cur_3mos_20101003_CorporateOtherMember" unitRef="USD">328000000</pfe:NetInterestIncomeExpense>
  <pfe:PurchaseAccountingSignificantImpacts decimals="-6" contextRef="Pri_3mos_20090628_CorporateOtherMember" unitRef="USD">564000000</pfe:PurchaseAccountingSignificantImpacts>
  <pfe:CostReductionInitiatives decimals="-6" contextRef="Pri_3mos_20090628_CorporateOtherMember" unitRef="USD">141000000</pfe:CostReductionInitiatives>
  <pfe:AcquisitionRelatedCosts decimals="-6" contextRef="Pri_3mos_20090628_CorporateOtherMember" unitRef="USD">132000000</pfe:AcquisitionRelatedCosts>
  <pfe:NetInterestIncomeExpense decimals="-6" contextRef="Pri_3mos_20090628_CorporateOtherMember" unitRef="USD">198000000</pfe:NetInterestIncomeExpense>
  <pfe:PurchaseAccountingSignificantImpacts decimals="-8" contextRef="Cur_9mos_20101003_CorporateOtherMember" unitRef="USD">6600000000</pfe:PurchaseAccountingSignificantImpacts>
  <pfe:NetInterestIncomeExpense decimals="-6" contextRef="Cur_9mos_20101003_CorporateOtherMember" unitRef="USD">1000000000</pfe:NetInterestIncomeExpense>
  <pfe:PurchaseAccountingSignificantImpacts decimals="-8" contextRef="Pri_6mos_20090628_CorporateOtherMember" unitRef="USD">1700000000</pfe:PurchaseAccountingSignificantImpacts>
  <pfe:AcquisitionRelatedCosts decimals="-6" contextRef="Pri_6mos_20090628_CorporateOtherMember" unitRef="USD">814000000</pfe:AcquisitionRelatedCosts>
  <pfe:CostReductionInitiatives decimals="-6" contextRef="Pri_6mos_20090628_CorporateOtherMember" unitRef="USD">802000000</pfe:CostReductionInitiatives>
  <pfe:NetInterestIncomeExpense decimals="-6" contextRef="Pri_6mos_20090628_CorporateOtherMember" unitRef="USD">149000000</pfe:NetInterestIncomeExpense>
  <us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries id="id_footnote_elem_14711961" decimals="-6" contextRef="Cur_3mos_20101003_DevelopedEuropeMember" unitRef="USD">3840000000</us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries>
  <us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries id="id_footnote_elem_2778148" decimals="-6" contextRef="Cur_3mos_20101003_DevelopedRestOfWorldMember" unitRef="USD">2377000000</us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries>
  <us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries id="id_footnote_elem_21311330" decimals="-6" contextRef="Cur_3mos_20101003_EmergingMarketsMember" unitRef="USD">2842000000</us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries>
  <us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToEntitysCountryOfDomicile id="id_footnote_elem_7742112" decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">7112000000</us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToEntitysCountryOfDomicile>
  <us-gaap:SalesRevenueNet id="id_footnote_elem_32192580" decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">16171000000</us-gaap:SalesRevenueNet>
  <us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToEntitysCountryOfDomicile id="id_footnote_elem_4849304" decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">4816000000</us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToEntitysCountryOfDomicile>
  <us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries id="id_footnote_elem_32284948" decimals="-6" contextRef="Pri_3mos_20090628_DevelopedEuropeMember" unitRef="USD">3137000000</us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries>
  <us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries id="id_footnote_elem_6497155" decimals="-6" contextRef="Pri_3mos_20090628_DevelopedRestOfWorldMember" unitRef="USD">1958000000</us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries>
  <us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries id="id_footnote_elem_23544151" decimals="-6" contextRef="Pri_3mos_20090628_EmergingMarketsMember" unitRef="USD">1710000000</us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries>
  <us-gaap:SalesRevenueNet id="id_footnote_elem_16151445" decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">11621000000</us-gaap:SalesRevenueNet>
  <us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToEntitysCountryOfDomicile id="id_footnote_elem_4843173" decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">21807000000</us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToEntitysCountryOfDomicile>
  <us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries id="id_footnote_elem_26390610" decimals="-6" contextRef="Cur_9mos_20101003_DevelopedEuropeMember" unitRef="USD">12313000000</us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries>
  <us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries id="id_footnote_elem_5706768" decimals="-6" contextRef="Cur_9mos_20101003_DevelopedRestOfWorldMember" unitRef="USD">7401000000</us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries>
  <us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries id="id_footnote_elem_29270066" decimals="-6" contextRef="Cur_9mos_20101003_EmergingMarketsMember" unitRef="USD">8727000000</us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries>
  <us-gaap:SalesRevenueNet id="id_footnote_elem_7672248" decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">50248000000</us-gaap:SalesRevenueNet>
  <us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToEntitysCountryOfDomicile id="id_footnote_elem_15266665" decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">14309000000</us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToEntitysCountryOfDomicile>
  <us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries id="id_footnote_elem_30981529" decimals="-6" contextRef="Pri_6mos_20090628_DevelopedEuropeMember" unitRef="USD">8726000000</us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries>
  <us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries id="id_footnote_elem_21672959" decimals="-6" contextRef="Pri_6mos_20090628_DevelopedRestOfWorldMember" unitRef="USD">5648000000</us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries>
  <us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries id="id_footnote_elem_5606189" decimals="-6" contextRef="Pri_6mos_20090628_EmergingMarketsMember" unitRef="USD">4789000000</us-gaap:EntityWideDisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToForeignCountries>
  <us-gaap:SalesRevenueNet id="id_footnote_elem_2421900" decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">33472000000</us-gaap:SalesRevenueNet>
  <pfe:SelectedFinancialLiabilitiesCurrentDeferredTaxLiabilitiesAndOtherCurrentLiabilities decimals="-6" contextRef="Cur_20101003_InterestRateSwapMember_3" unitRef="USD">5000000</pfe:SelectedFinancialLiabilitiesCurrentDeferredTaxLiabilitiesAndOtherCurrentLiabilities>
  <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet id="id_footnote_elem_31850246" decimals="-6" contextRef="Pri_9mos_20090927_ForeignExchangeContractMember_CashFlowHedgingMember" unitRef="USD">400000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet id="id_footnote_elem_32743257" decimals="-6" contextRef="Pri_Q2_2009_InterestRateSwapMember_FairValueHedgingMember_OtherIncomeExpenseMember" unitRef="USD">5000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet id="id_footnote_elem_5659812" decimals="-6" contextRef="Pri_Q2_2009_ForeignExchangeContractMember_FairValueHedgingMember_OtherIncomeExpenseMember" unitRef="USD">-2000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet id="id_footnote_elem_6386921" decimals="-6" contextRef="Cur_Q3_2010_ForeignExchangeContractMember_FairValueHedgingMember_OtherIncomeExpenseMember" unitRef="USD">-1000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet id="id_footnote_elem_13737902" decimals="-6" contextRef="Cur_Q3_2010_ForeignExchangeContractMember_CashFlowHedgingMember_OtherComprehensiveIncomeMember" unitRef="USD">656000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet id="id_footnote_elem_27063451" decimals="-6" contextRef="Cur_Q3_2010_ForeignExchangeContractMember_CashFlowHedgingMember" unitRef="USD">815000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet id="id_footnote_elem_17152618" decimals="-6" contextRef="Pri_Q2_2009_ForeignExchangeContractMember_CashFlowHedgingMember_OtherComprehensiveIncomeMember" unitRef="USD">185000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet id="id_footnote_elem_5494255" decimals="-6" contextRef="Pri_Q2_2009_ForeignExchangeContractMember_CashFlowHedgingMember" unitRef="USD">245000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet id="id_footnote_elem_2264840" decimals="-6" contextRef="Pri_Q2_2009_ForeignExchangeForwardMember_CashFlowHedgingMember" unitRef="USD">2000000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet id="id_footnote_elem_14970233" decimals="-6" contextRef="Pri_Q2_2009_ForeignExchangeForwardMember_CashFlowHedgingMember_OtherComprehensiveIncomeMember" unitRef="USD">-2000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet id="id_footnote_elem_20348741" decimals="-6" contextRef="Cur_Q3_2010_ForeignExchangeForwardMember_CashFlowHedgingMember_OtherComprehensiveIncomeMember" unitRef="USD">-1000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet id="id_footnote_elem_29591371" decimals="-6" contextRef="Pri_Q2_2009_ForeignExchangeContractMember_NetInvestmentHedgingMember_OtherComprehensiveIncomeMember" unitRef="USD">-40000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet id="id_footnote_elem_19210833" decimals="-6" contextRef="Cur_Q3_2010_ForeignExchangeContractMember_NetInvestmentHedgingMember_OtherIncomeExpenseMember" unitRef="USD">1000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet id="id_footnote_elem_14385653" decimals="-6" contextRef="Cur_Q3_2010_ForeignExchangeContractMember_NetInvestmentHedgingMember_OtherComprehensiveIncomeMember" unitRef="USD">-39000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet id="id_footnote_elem_7720610" decimals="-6" contextRef="Cur_Q3_2010_ForeignExchangeContractMember_NondesignatedMember_OtherIncomeExpenseMember" unitRef="USD">6000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet id="id_footnote_elem_3846285" decimals="-6" contextRef="Cur_Q3_2010_ForeignExchangeForwardMember_NondesignatedMember_OtherIncomeExpenseMember" unitRef="USD">419000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet id="id_footnote_elem_20148112" decimals="-6" contextRef="Pri_Q2_2009_ForeignExchangeForwardMember_NondesignatedMember_OtherIncomeExpenseMember" unitRef="USD">-354000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet id="id_footnote_elem_5694670" decimals="-6" contextRef="Pri_Q2_2009_ForeignExchangeContractMember_NondesignatedMember_OtherIncomeExpenseMember" unitRef="USD">3000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <pfe:NonDerivativeFinancialInstrumentsInNetInvestmentHedgeRelationshipsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet id="id_footnote_elem_18194444" decimals="-6" contextRef="Pri_Q3_2009_ForeignCurrencyShortTermBorrowingsMember_NetInvestmentHedgingMember_OtherComprehensiveIncomeMember" unitRef="USD">-62000000</pfe:NonDerivativeFinancialInstrumentsInNetInvestmentHedgeRelationshipsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <pfe:NonDerivativeFinancialInstrumentsInNetInvestmentHedgeRelationshipsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet id="id_footnote_elem_30074868" decimals="-6" contextRef="Pri_Q3_2009_ForeignCurrencyLongTermDebtMember_NetInvestmentHedgingMember_OtherComprehensiveIncomeMember" unitRef="USD">-111000000</pfe:NonDerivativeFinancialInstrumentsInNetInvestmentHedgeRelationshipsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <pfe:NonDerivativeFinancialInstrumentsInNetInvestmentHedgeRelationshipsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet id="id_footnote_elem_534316" decimals="-6" contextRef="Cur_Q3_2010_ForeignCurrencyShortTermBorrowingsMember_NetInvestmentHedgingMember_OtherComprehensiveIncomeMember" unitRef="USD">-96000000</pfe:NonDerivativeFinancialInstrumentsInNetInvestmentHedgeRelationshipsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <pfe:NonDerivativeFinancialInstrumentsInNetInvestmentHedgeRelationshipsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet id="id_footnote_elem_28576576" decimals="-6" contextRef="Cur_Q3_2010_ForeignCurrencyLongTermDebtMember_NetInvestmentHedgingMember_OtherComprehensiveIncomeMember" unitRef="USD">-38000000</pfe:NonDerivativeFinancialInstrumentsInNetInvestmentHedgeRelationshipsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpense decimals="-8" contextRef="Cur_3mos_20101003" unitRef="USD">1200000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpense>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpense decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">626000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpense>
  <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpense decimals="-8" contextRef="Cur_9mos_20101003" unitRef="USD">4100000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpense>
  <pfe:PrivateEquitySecuritiesOwnedCarriedAtCostOrEquity id="id_footnote_elem_23830098" decimals="-6" contextRef="Pri_20091231" unitRef="USD">811000000</pfe:PrivateEquitySecuritiesOwnedCarriedAtCostOrEquity>
  <pfe:LongTermDebtFairValue decimals="-8" contextRef="Cur_20101003" unitRef="USD">44800000000</pfe:LongTermDebtFairValue>
  <pfe:LongTermDebtFairValue decimals="-8" contextRef="Pri_20091231" unitRef="USD">46200000000</pfe:LongTermDebtFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue decimals="-6" contextRef="Cur_20101003_USCorporateDebtGuaranteedByFederalDepositInsuranceCorporationMember" unitRef="USD">561000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesFairValue decimals="-6" contextRef="Cur_20101003_USCorporateDebtGuaranteedByFederalDepositInsuranceCorporationMember" unitRef="USD">561000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesFairValue>
  <pfe:TradingSecuritiesHeldInTrust decimals="-6" contextRef="Cur_20101003" unitRef="USD">169000000</pfe:TradingSecuritiesHeldInTrust>
  <us-gaap:RestructuringAndRelatedCostIncurredCost id="id_footnote_elem_11918385" decimals="-6" contextRef="Cur_69mos_20101003_EmployeeSeveranceMember" unitRef="USD">6387000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
  <us-gaap:RestructuringAndRelatedCostIncurredCost id="id_footnote_elem_27206936" decimals="-6" contextRef="Cur_69mos_20101003_AssetImpairmentsMember" unitRef="USD">2129000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
  <us-gaap:RestructuringAndRelatedCostIncurredCost id="id_footnote_elem_18635620" decimals="-6" contextRef="Cur_69mos_20101003_OtherRestructuringChargesMember" unitRef="USD">754000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
  <us-gaap:RestructuringAndRelatedCostIncurredCost id="id_footnote_elem_17545042" decimals="-6" contextRef="Cur_69mos_20101003" unitRef="USD">9270000000</us-gaap:RestructuringAndRelatedCostIncurredCost>
  <us-gaap:Goodwill id="id_footnote_elem_16465336" decimals="-6" contextRef="Pri_20091231_GoodwillNotAllocatedMember" unitRef="USD">20038000000</us-gaap:Goodwill>
  <pfe:GoodwillPurchasePriceAdjustments id="id_footnote_elem_17861195" decimals="-6" contextRef="Cur_6Mos_2010-10-03_GoodwillNotAllocatedMember" unitRef="USD">2127000000</pfe:GoodwillPurchasePriceAdjustments>
  <pfe:GoodwillOtherAdjustments id="id_footnote_elem_17228719" decimals="-6" contextRef="Cur_6Mos_2010-10-03_GoodwillNotAllocatedMember" unitRef="USD">-178000000</pfe:GoodwillOtherAdjustments>
  <pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInGoodwill decimals="-6" contextRef="Cur_20101003_BiopharmaceuticalMember_AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember" unitRef="USD">19172000000</pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInGoodwill>
  <pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInGoodwill decimals="-6" contextRef="Cur_20101003_DiversifiedMember_AmountsRecognizedAsOfAcquisitionDateAsAdjustedMember" unitRef="USD">2909000000</pfe:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInGoodwill>
  <us-gaap:GoodwillAllocationAdjustment id="id_footnote_elem_9013714" decimals="-6" contextRef="Cur_9mos_20101003_BiopharmaceuticalMember" unitRef="USD">19091000000</us-gaap:GoodwillAllocationAdjustment>
  <us-gaap:GoodwillAllocationAdjustment id="id_footnote_elem_8911066" decimals="-6" contextRef="Cur_9mos_20101003_DiversifiedMember" unitRef="USD">2896000000</us-gaap:GoodwillAllocationAdjustment>
  <us-gaap:GoodwillAllocationAdjustment id="id_footnote_elem_18397794" decimals="-6" contextRef="Cur_6Mos_2010-10-03_GoodwillNotAllocatedMember" unitRef="USD">-21987000000</us-gaap:GoodwillAllocationAdjustment>
  <pfe:CostReductionInitiativesAndAcquisitionCosts decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">794000000</pfe:CostReductionInitiativesAndAcquisitionCosts>
  <pfe:CostReductionInitiativesAndAcquisitionCosts decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">273000000</pfe:CostReductionInitiativesAndAcquisitionCosts>
  <pfe:CostReductionInitiativesAndAcquisitionCosts decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">2694000000</pfe:CostReductionInitiativesAndAcquisitionCosts>
  <pfe:CostReductionInitiativesAndAcquisitionCosts decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">1616000000</pfe:CostReductionInitiativesAndAcquisitionCosts>
  <pfe:PercentageChangeInRevenue id="id_footnote_elem_25356830" decimals="2" contextRef="Cur_3mos_20101003" unitRef="Percent">0.39</pfe:PercentageChangeInRevenue>
  <pfe:PercentageChangeInRevenue id="id_footnote_elem_26644349" decimals="2" contextRef="Cur_9mos_20101003" unitRef="Percent">0.50</pfe:PercentageChangeInRevenue>
  <us-gaap:DebtCurrent xsi:nil="true" contextRef="Pri_20090603" unitRef="USD"/>
  <pfe:SelectedFinancialLiabilitiesOtherNoncurrentLiabilities xsi:nil="true" contextRef="Pri_20090603" unitRef="USD"/>
  <pfe:SelectedFinancialLiabilitiesOtherNoncurrentLiabilities xsi:nil="true" contextRef="Pri_20090324" unitRef="USD"/>
  <us-gaap:DebtCurrent xsi:nil="true" contextRef="Pri_20090324" unitRef="USD"/>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet id="id_footnote_elem_13275272" decimals="-6" contextRef="Cur_9mos_20101003_ForeignExchangeForwardMember_CashFlowHedgingMember_OtherComprehensiveIncomeMember" unitRef="USD">-2000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">786000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">-4105000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">599000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">2853000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:UnsecuredDebt xsi:nil="true" contextRef="Pri_2009-03-12" unitRef="USD"/>
  <pfe:PercentageChangeInRevenueUnitedStates id="id_footnote_elem_29501653" decimals="2" contextRef="Cur_3mos_20101003" unitRef="Percent">0.48</pfe:PercentageChangeInRevenueUnitedStates>
  <pfe:PercentageChangeInRevenueForeignCountries id="id_footnote_elem_32012147" decimals="2" contextRef="Cur_3mos_20101003_DevelopedEuropeMember" unitRef="Percent">0.22</pfe:PercentageChangeInRevenueForeignCountries>
  <pfe:PercentageChangeInRevenueForeignCountries id="id_footnote_elem_18061564" decimals="2" contextRef="Cur_3mos_20101003_DevelopedRestOfWorldMember" unitRef="Percent">0.21</pfe:PercentageChangeInRevenueForeignCountries>
  <pfe:PercentageChangeInRevenueForeignCountries id="id_footnote_elem_32883021" decimals="2" contextRef="Cur_3mos_20101003_EmergingMarketsMember" unitRef="Percent">0.66</pfe:PercentageChangeInRevenueForeignCountries>
  <pfe:PercentageChangeInRevenueUnitedStates id="id_footnote_elem_6267844" decimals="2" contextRef="Cur_9mos_20101003" unitRef="Percent">0.52</pfe:PercentageChangeInRevenueUnitedStates>
  <pfe:PercentageChangeInRevenueForeignCountries id="id_footnote_elem_11664314" decimals="2" contextRef="Cur_9mos_20101003_DevelopedEuropeMember" unitRef="Percent">0.41</pfe:PercentageChangeInRevenueForeignCountries>
  <pfe:PercentageChangeInRevenueForeignCountries id="id_footnote_elem_32661174" decimals="2" contextRef="Cur_9mos_20101003_DevelopedRestOfWorldMember" unitRef="Percent">0.31</pfe:PercentageChangeInRevenueForeignCountries>
  <pfe:PercentageChangeInRevenueForeignCountries id="id_footnote_elem_14508474" decimals="2" contextRef="Cur_9mos_20101003_EmergingMarketsMember" unitRef="Percent">0.82</pfe:PercentageChangeInRevenueForeignCountries>
  <us-gaap:UnsecuredDebt decimals="-8" contextRef="Cur_20101003_MaturingIn2038Member" unitRef="USD">2400000000</us-gaap:UnsecuredDebt>
  <us-gaap:NotionalAmountOfForeignCurrencyDerivatives xsi:nil="true" contextRef="Cur_20101003_MaturingIn2038Member" unitRef="USD"/>
  <pfe:AvailableForSaleSecuritiesEquitySecuritiesExcludingMoneyMarketFunds decimals="-6" contextRef="Cur_20101003_FairValueInputsLevel1Member_2" unitRef="USD">100000000</pfe:AvailableForSaleSecuritiesEquitySecuritiesExcludingMoneyMarketFunds>
  <pfe:AvailableForSaleSecuritiesEquitySecuritiesExcludingMoneyMarketFunds decimals="-6" contextRef="Pri_20091231_FairValueInputsLevel1Member_2" unitRef="USD">77000000</pfe:AvailableForSaleSecuritiesEquitySecuritiesExcludingMoneyMarketFunds>
  <us-gaap:DerivativeAssetNotDesignatedAsHedgingInstrumentFairValue decimals="-6" contextRef="Pri_20091231_ForeignExchangeContractMember" unitRef="USD">106000000</us-gaap:DerivativeAssetNotDesignatedAsHedgingInstrumentFairValue>
  <us-gaap:DerivativeLiabilityNotDesignatedAsHedgingInstrumentFairValue decimals="-6" contextRef="Pri_20091231_ForeignExchangeContractMember_2" unitRef="USD">3000000</us-gaap:DerivativeLiabilityNotDesignatedAsHedgingInstrumentFairValue>
  <us-gaap:DerivativeLiabilityNotDesignatedAsHedgingInstrumentFairValue decimals="-6" contextRef="Cur_20101003_ForeignExchangeForwardMember_2" unitRef="USD">88000000</us-gaap:DerivativeLiabilityNotDesignatedAsHedgingInstrumentFairValue>
  <us-gaap:DerivativeAssetNotDesignatedAsHedgingInstrumentFairValue decimals="-6" contextRef="Cur_20101003_ForeignExchangeForwardMember" unitRef="USD">118000000</us-gaap:DerivativeAssetNotDesignatedAsHedgingInstrumentFairValue>
  <us-gaap:DerivativeAssetNotDesignatedAsHedgingInstrumentFairValue decimals="-6" contextRef="Pri_20091231_ForeignExchangeForwardMember" unitRef="USD">100000000</us-gaap:DerivativeAssetNotDesignatedAsHedgingInstrumentFairValue>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_13731308" decimals="-6" contextRef="Cur_3mos_20101003_ProtonixMember" unitRef="USD">203000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_9411749" decimals="-6" contextRef="Cur_9mos_20101003_ProtonixMember" unitRef="USD">535000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <pfe:EmployeeTerminationCosts id="id_footnote_elem_15342087" decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">27000000</pfe:EmployeeTerminationCosts>
  <pfe:EmployeeTerminationCosts id="id_footnote_elem_2117867" decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">36000000</pfe:EmployeeTerminationCosts>
  <pfe:EmployeeTerminationCosts id="id_footnote_elem_2690674" decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">603000000</pfe:EmployeeTerminationCosts>
  <pfe:EmployeeTerminationCosts id="id_footnote_elem_13745962" decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">200000000</pfe:EmployeeTerminationCosts>
  <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse id="id_footnote_elem_23775117" decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">174000000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
  <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse id="id_footnote_elem_11515704" decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">17000000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
  <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse id="id_footnote_elem_28577821" decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">677000000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
  <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse id="id_footnote_elem_7593047" decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">108000000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
  <us-gaap:OtherRestructuringCosts id="id_footnote_elem_27649050" decimals="-6" contextRef="Cur_3mos_20101003" unitRef="USD">67000000</us-gaap:OtherRestructuringCosts>
  <us-gaap:OtherRestructuringCosts id="id_footnote_elem_3622159" decimals="-6" contextRef="Pri_3mos_20090927" unitRef="USD">8000000</us-gaap:OtherRestructuringCosts>
  <us-gaap:OtherRestructuringCosts id="id_footnote_elem_16386589" decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">148000000</us-gaap:OtherRestructuringCosts>
  <us-gaap:OtherRestructuringCosts id="id_footnote_elem_10831841" decimals="-6" contextRef="Pri_9mos_20090927" unitRef="USD">84000000</us-gaap:OtherRestructuringCosts>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet id="id_footnote_elem_27641541" decimals="-6" contextRef="Cur_9mos_20101003_ForeignExchangeContractMember_FairValueHedgingMember_OtherIncomeExpenseMember" unitRef="USD">-1000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet id="id_footnote_elem_12782288" decimals="-6" contextRef="Pri_9mos_20101003_ForeignExchangeContractMember_FairValueHedgingMember_OtherIncomeExpenseMember" unitRef="USD">-2000000</us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeNet>
  <pfe:BusinessAcquisitionCostOfAcquiredEntityPurchasePricePerShare decimals="2" contextRef="Cur_20101012_KingMember" unitRef="USDperShare">14.25</pfe:BusinessAcquisitionCostOfAcquiredEntityPurchasePricePerShare>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_9mos_20101003_FragminMember" unitRef="USD">258000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_3mos_20101003_FragminMember" unitRef="USD">82000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Pri_9mos_20101003_FragminMember" unitRef="USD">244000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_3560270" decimals="-6" contextRef="Cur_3mos_20101003_TygacilMember" unitRef="USD">78000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_9383262" decimals="-6" contextRef="Cur_9mos_20101003_TygacilMember" unitRef="USD">250000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount decimals="-6" contextRef="Cur_3mos_20101003_FragminMember" unitRef="USD">84000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_1442064" decimals="-6" contextRef="Cur_3mos_20101003_BMP2Member" unitRef="USD">101000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_2173256" decimals="-6" contextRef="Cur_9mos_20101003_BMP2Member" unitRef="USD">298000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_3227753" decimals="-6" contextRef="Cur_3mos_20101003_RapamuneMember" unitRef="USD">104000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount id="id_footnote_elem_2072861" decimals="-6" contextRef="Cur_9mos_20101003_RapamuneMember" unitRef="USD">292000000</us-gaap:EntityWideInformationRevenueFromExternalCustomerAmount>
  <us-gaap:InvestmentIncomeNonoperating id="id_footnote_elem_12456700" decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">297000000</us-gaap:InvestmentIncomeNonoperating>
  <us-gaap:InterestExpense id="id_footnote_elem_20557672" decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">1339000000</us-gaap:InterestExpense>
  <us-gaap:GainLossOnDispositionOfAssets decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">243000000</us-gaap:GainLossOnDispositionOfAssets>
  <pfe:AssetImpairmentChargesAndOtherCharges id="id_footnote_elem_1151375" decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">1710000000</pfe:AssetImpairmentChargesAndOtherCharges>
  <us-gaap:OtherNonoperatingIncomeExpense decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">-38000000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:RoyaltyRevenue decimals="-6" contextRef="Cur_9mos_20101003" unitRef="USD">395000000</us-gaap:RoyaltyRevenue>
  <us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock contextRef="Cur_9mos_20101003">&lt;div class="BWxbrlnote5"&gt;&lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;div&gt;&lt;div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;a id="xbrlnote5" name="xbrlnote5"
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font
       style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline"&gt;Note
      5. Other (Income)/Deductions&lt;/font&gt;&lt;font
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; TEXT-DECORATION: underline"&gt;--&lt;/font&gt;&lt;font
       style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline"&gt;Net&lt;/font&gt;&lt;/a&gt;
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: justify"&gt;
      The following table sets forth details related to amounts
      recorded in &lt;font
      style="DISPLAY: inline; FONT-STYLE: italic"&gt;Other
      deductions&lt;/font&gt;&lt;font
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"&gt;--&lt;/font&gt;&lt;font
       style="DISPLAY: inline; FONT-STYLE: italic"&gt;net:&lt;/font&gt;
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table cellpadding="0" cellspacing="0" width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr&gt;
          &lt;td valign="bottom"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="6" valign="bottom"
          style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: center"&gt;
              Three Months Ended
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="6" valign="bottom"
          style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: center"&gt;
              Nine Months Ended
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom"
          style="BORDER-BOTTOM: black 2px solid"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-VARIANT: small-caps; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              (millions of dollars)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Oct. 3, 2010
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Sept. 27, 2009
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Oct. 3, 2010
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Sept. 27, 2009
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Interest income&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (100
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (171
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (297
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (620
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"
          style="PADDING-BOTTOM: 2px"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Interest expense&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            428
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            369
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,339
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            769
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Net interest expense
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            328
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            198
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,042
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            149
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Royalty-related income
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (158
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (35
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (395
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (142
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Net gain on asset disposals
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (13
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (40
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (243
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (81
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Legal matters, net&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(b)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            712
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            54
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            886
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            130
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Certain asset impairment charges&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(c)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,478
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            6
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,710
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            96
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"
          style="PADDING-BOTTOM: 2px"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Other, net
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            6
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (23
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            38
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            23
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"
          style="BORDER-BOTTOM: black 4px double"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Other deductions&lt;font
              style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic"&gt;--&lt;/font&gt;net
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2,353
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            160
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            3,038
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            175
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt; text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="right" width="2%" style="WIDTH: 18pt"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
              (a)&amp;nbsp;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" width="98%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
              Interest expense increased in 2010 due to our
              issuance of $13.5 billion of senior unsecured notes
              on March 24, 2009 and approximately $10.5 billion of
              senior unsecured notes on June 3, 2009, primarily
              related to the acquisition of Wyeth as well as the
              addition of legacy Wyeth debt. Interest income
              decreased in 2010 due to lower interest rates coupled
              with lower average investment balances.
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt; text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="right" width="2%" style="WIDTH: 18pt"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
              (b)&amp;nbsp;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" width="98%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
              Legal matters, net in the three-month and nine-month
              periods ended October 3, 2010 includes an additional
              $701 million charge for asbestos litigation related
              to our wholly owned subsidiary, Quigley Company, Inc.
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt; text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="right" width="2%" style="WIDTH: 18pt"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
              (c)&amp;nbsp;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" width="98%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
              The asset impairment charges in the three-month and
              nine-month periods ended October 3, 2010 are
              primarily related to intangible assets acquired as
              part of our acquisition of Wyeth, including IPR&amp;amp;D
              assets, Brands and, to a lesser extent, Developed
              Technology Rights. See also &lt;font
              style="DISPLAY: inline; FONT-STYLE: italic"&gt;Note 3.
              Acquisition of Wyeth&lt;/font&gt; and &lt;font
              style="DISPLAY: inline; FONT-STYLE: italic"&gt;Note 10B.
              Goodwill and Other Intangible Assets: Other
              Intangible Assets.&lt;/font&gt; The impairment charges
              result from our current estimate of the fair value of
              these assets, based upon updated forecasts, compared
              with their assigned fair values as of the Wyeth
              acquisition date, October 15, 2009. The fair value of
              acquired identifiable intangible assets generally is
              determined using an income approach that starts with
              a forecast of all of the expected future net cash
              flows associated with the asset which are then
              adjusted to present value by applying an appropriate
              discount rate that reflects the risk factors
              associated with the cash flow streams. Our updated
              forecasts of net cash flows for the impaired assets,
              reflect, among other things the following: for
              IPR&amp;amp;D assets, the impact of changes to the
              development programs, the projected development and
              regulatory timeframes and the risk associated with
              these assets; for Brand assets, the current
              competitive environment and planned investment
              support; and, for Developed Technology Rights, an
              increased competitive environment. Of these amounts,
              in the third quarter of 2010, about $900 million
              related to our Biopharmaceutical segment and $600
              million related to our Diversified segment. The
              nine-month period of 2010 also included another $200
              million in impairments related to our
              Biopharmaceutical segment.
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
  &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
  <us-gaap:LossContingencyLossInPeriod decimals="-6" contextRef="Cur_3mos_20101003_QuigleyCompanyIncMember" unitRef="USD">701000000</us-gaap:LossContingencyLossInPeriod>
  <us-gaap:LossContingencyLossInPeriod decimals="-6" contextRef="Cur_9mos_20101003_QuigleyCompanyIncMember" unitRef="USD">701000000</us-gaap:LossContingencyLossInPeriod>
  <us-gaap:SegmentReportingDisclosureTextBlock contextRef="Cur_9mos_20101003">&lt;div class="BWxbrlnote13"&gt;&lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;div&gt;&lt;div&gt;
    &lt;div
    style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
      &lt;a id="xbrlnote13" name="xbrlnote13"
      style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"&gt;Note
      13. Segment Information&lt;/a&gt;
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
      We operate in the following two distinct commercial
      organizations, which constitute our two business segments:
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div&gt;
      &lt;table cellpadding="0" cellspacing="0" width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="right" style="WIDTH: 9pt"&gt;
            &lt;div style="DISPLAY: inline; FONT-SIZE: 10pt;"&gt;
              &lt;font
              style="DISPLAY: inline; FONT-FAMILY: Times New Roman"&gt;&amp;#9679;&lt;/font&gt;&amp;nbsp;&amp;nbsp;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td style="TEXT-ALIGN: left"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
              &lt;font
              style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;Biopharmaceutical&lt;/font&gt;
              consists of the Primary Care, Specialty Care,
              Oncology, Established Products and Emerging Markets
              units and includes products that prevent and treat
              cardiovascular and metabolic diseases, central
              nervous system disorders, arthritis and pain,
              infectious and respiratory diseases, urogenital
              conditions, cancer, eye diseases and endocrine
              disorders, among others. Biopharmaceutical's segment
              profit includes costs related to research and
              development, manufacturing, and sales and marketing
              activities that are associated with the products in
              our Biopharmaceutical segment.
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div&gt;
      &lt;table cellpadding="0" cellspacing="0" width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="right" style="WIDTH: 9pt"&gt;
            &lt;div style="DISPLAY: inline; FONT-SIZE: 10pt;"&gt;
              &lt;font
              style="DISPLAY: inline; FONT-FAMILY: Times New Roman"&gt;&amp;#9679;&lt;/font&gt;&amp;nbsp;&amp;nbsp;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td style="TEXT-ALIGN: left"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
              &lt;font
              style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;Diversified&lt;/font&gt;
              includes Animal Health products and services that
              prevent and treat diseases in livestock and companion
              animals, including vaccines, parasiticides and
              anti-infectives; Consumer Healthcare products that
              include over-the-counter healthcare products such as
              pain management therapies (analgesics and heat
              wraps), cough/cold/allergy remedies, dietary
              supplements, hemorrhoidal care and personal care
              items; Nutrition products such as infant and toddler
              nutritional products; and Capsugel, which represents
              our capsule products and services business.
              Diversified's segment profit includes costs related
              to research and development, manufacturing, and sales
              and marketing activities that are associated with the
              products in our Diversified segment.
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
      Segment profit/(loss) is measured based on income from
      continuing operations before provision for taxes on income
      and income attributable to noncontrolling interests. Certain
      costs, such as significant impacts of purchase accounting for
      acquisitions, restructuring and acquisition-related costs,
      costs related to our cost-reduction initiatives and certain
      asset impairment charges are included in &lt;font
      style="DISPLAY: inline; FONT-STYLE: italic"&gt;Corporate/Other&lt;/font&gt;
      only. This methodology is utilized by management to evaluate
      our businesses. Each segment is managed separately and offers
      different products requiring different marketing and
      distribution strategies.
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
      &amp;nbsp;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
      Revenues and profit/(loss) by segment for the three months
      and nine months ended October 3, 2010 and September 27, 2009
      follow:
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table cellpadding="0" cellspacing="0" width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-VARIANT: small-caps; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="6" valign="bottom"
          style="BORDER-TOP: black 2px solid; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: center"&gt;
              Three Months Ended&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="6" valign="bottom"
          style="BORDER-TOP: black 2px solid; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: center"&gt;
              Nine Months Ended&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom"
          style="BORDER-BOTTOM: black 2px solid"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-VARIANT: small-caps; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              (millions of dollars)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Oct. 3,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2010
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Sept. 27,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2009
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Oct. 3,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2010
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Sept. 27,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2009
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Revenues
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Biopharmaceutical
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            13,945
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            10,677
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            43,472
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            30,842
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Diversified
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2,150
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            855
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            6,533
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2,379
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"
          style="PADDING-BOTTOM: 2px"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Corporate/Other&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(b)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            76
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            89
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            243
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            251
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"
          style="PADDING-BOTTOM: 4px"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Total revenues
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            16,171
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            11,621
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            50,248
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            33,472
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign="bottom" width="52%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Segment profit/(loss)&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(c)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Biopharmaceutical
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            7,005
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            5,501
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            22,844
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            15,868
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Diversified
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            530
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            230
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,647
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            598
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"
          style="PADDING-BOTTOM: 2px"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Corporate/Other&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(b),
              (d)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (6,095
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (1,760
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (15,898
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (5,643
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"
          style="BORDER-BOTTOM: black 4px double"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Total profit
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,440
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            3,971
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            8,593
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            10,823
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td width="2%" style="WIDTH: 36pt"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt;
              (a)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td width="98%"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: left"&gt;
              Includes revenues and profit/(loss) from legacy Wyeth
              products and operations for the three months and nine
              months ended October 3, 2010. Revenues and
              profit/(loss) from legacy Wyeth products and
              operations are not included in the three months and
              nine months ended September 27, 2009. Prior-period
              amounts for Capsugel, which were previously
              classified in &lt;font
              style="DISPLAY: inline; FONT-STYLE: italic"&gt;Corporate/Other&lt;/font&gt;,
              are now classified in &lt;font
              style="DISPLAY: inline; FONT-STYLE: italic"&gt;Diversified.&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td width="2%" style="WIDTH: 36pt"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt;
              (b)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td width="98%"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: left"&gt;
              &lt;font
              style="DISPLAY: inline; FONT-STYLE: italic"&gt;Corporate/Other&lt;/font&gt;
              includes, among other things, Pfizer CentreSource,
              which includes contract manufacturing and bulk
              pharmaceutical chemical sales. &lt;font
              style="DISPLAY: inline; FONT-STYLE: italic"&gt;Corporate/Other&lt;/font&gt;
              under &lt;font
              style="DISPLAY: inline; FONT-STYLE: italic"&gt;Segment
              profit/(loss)&lt;/font&gt; also includes, among other
              things, interest income/(expense), corporate
              administration expenses, certain performance-based
              and all share-based compensation expenses, most
              purchase accounting adjustments, all
              acquisition-related costs, substantially all
              restructurings and significant asset impairments and
              litigation charges.
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td width="2%" style="WIDTH: 36pt"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt;
              (c)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td width="98%"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: left"&gt;
              &lt;font
              style="DISPLAY: inline; FONT-STYLE: italic"&gt;Segment
              profit/(loss)&lt;/font&gt; equals &lt;font
              style="DISPLAY: inline; FONT-STYLE: italic"&gt;Income
              from continuing operations before provision for taxes
              on income.&lt;/font&gt; Certain costs are included in &lt;font
              style="DISPLAY: inline; FONT-STYLE: italic"&gt;Corporate/Other&lt;/font&gt;
              only (see note (b) above). This methodology is
              utilized by management to evaluate our businesses.
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td width="2%" style="WIDTH: 36pt"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt;
              (d)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td width="98%"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: left"&gt;
              For the three months ended October 3, 2010, &lt;font
              style="DISPLAY: inline; FONT-STYLE: italic"&gt;Corporate/Other&lt;/font&gt;
              includes: (i) significant impacts of purchase
              accounting for acquisitions of $1.6 billion,
              including intangible asset amortization related to
              our acquisitions of Wyeth in 2009 and Pharmacia in
              2003 and charges related to fair value adjustments of
              inventory acquired as part of our acquisition of
              Wyeth and sold during the period; (ii) restructuring
              and acquisition-related costs of $794 million,
              related to our acquisition of Wyeth; (iii) intangible
              asset impairments of $1.5 billion (pre-tax) related
              to certain intangible assets acquired as part of our
              acquisition of Wyeth; (iv) Wyeth-related inventory
              write-off of $212 million (pre-tax) (which includes a
              purchase accounting fair value adjustment of $104
              million), primarily related to Biopharmaceutical
              inventory; and (v) net interest expense of $328
              million.
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td width="2%" style="WIDTH: 14.4pt"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
              &amp;nbsp;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td width="98%" style="TEXT-ALIGN: left"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
              For the three months ended September 27, 2009, &lt;font
              style="DISPLAY: inline; FONT-STYLE: italic"&gt;Corporate/Other&lt;/font&gt;
              includes: (i) significant impacts of purchase
              accounting for acquisitions of $564 million,
              including intangible asset amortization and other
              charges, primarily related to our acquisition of
              Pharmacia in 2003; (ii) restructuring charges and
              implementation costs associated with our
              cost-reduction initiatives of $141 million; (iii)
              acquisition-related costs of $132 million, primarily
              related to our acquisition of Wyeth; and (iv) net
              interest expense of $198 million.
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td width="2%" style="WIDTH: 14.4pt"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
              &amp;nbsp;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td width="98%" style="TEXT-ALIGN: left"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
              For the nine months ended October 3, 2010, &lt;font
              style="DISPLAY: inline; FONT-STYLE: italic"&gt;Corporate/Other&lt;/font&gt;
              includes: (i) significant impacts of purchase
              accounting for acquisitions of $6.6 billion,
              including intangible asset amortization related to
              our acquisitions of Wyeth in 2009 and Pharmacia in
              2003 and charges related to fair value adjustments of
              inventory acquired as part of our acquisition of
              Wyeth and sold during the period; (ii) restructuring
              and acquisition-related costs of $2.7 billion,
              related to our acquisition of Wyeth; (iii) intangible
              asset impairments of $1.7 billion (pre-tax) related
              to certain intangible assets acquired as part of our
              acquisition of Wyeth; (iv) Wyeth-related inventory
              write-off of $212 million (pre-tax) (which includes a
              purchase accounting fair value adjustment of $104
              million), primarily related to Biopharmaceutical
              inventory; and (v) net interest expense of $1.0
              billion.
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td width="2%" style="WIDTH: 14.4pt"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
              &amp;nbsp;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td width="98%" style="TEXT-ALIGN: left"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
              For the nine months ended September 27, 2009, &lt;font
              style="DISPLAY: inline; FONT-STYLE: italic"&gt;Corporate/Other&lt;/font&gt;
              includes: (i) significant impacts of purchase
              accounting for acquisitions of $1.7 billion,
              including intangible asset amortization and other
              charges, primarily related to our acquisition of
              Pharmacia in 2003; (ii) acquisition-related costs of
              $814 million, primarily related to our acquisition of
              Wyeth; (iii) restructuring charges and implementation
              costs associated with our cost-reduction initiatives
              of $802 million; and (iv) net interest expense of
              $149 million.
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-INDENT: 0pt"&gt;
      Significant product revenues are as follows:
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table cellpadding="0" cellspacing="0" width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr&gt;
          &lt;td valign="bottom" width="52%"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="6" valign="bottom" width="22%"
          style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: center"&gt;
              Three Months Ended
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="6" valign="bottom" width="22%"
          style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: center"&gt;
              Nine Months Ended
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"
          style="BORDER-BOTTOM: black 2px solid"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-VARIANT: small-caps; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              (millions of dollars)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="10%"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Oct. 3,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2010
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="10%"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Sept. 27,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2009
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="10%"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Oct. 3,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2010
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="10%"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Sept. 27,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2009
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign="bottom" width="52%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="10%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="10%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="10%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="10%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Biopharmaceutical products:
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="10%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="10%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="10%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="10%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Lipitor
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2,534
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2,853
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            8,104
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            8,259
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Enbrel&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a),
              (b)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            799
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2,409
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Lyrica
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            757
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            708
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2,242
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2,020
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Celebrex
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            578
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            602
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,752
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,714
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Prevnar/Prevenar 13&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            735
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,590
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Effexor&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            175
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,512
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Viagra
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            459
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            466
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,429
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,343
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Xalatan/Xalacom
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            416
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            436
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,287
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,238
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Norvasc
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            330
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            488
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,120
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,487
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Prevnar/Prevenar (7-valent)&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            179
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,030
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Zyvox
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            285
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            271
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            876
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            811
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Premarin family&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            263
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            779
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Sutent
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            257
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            246
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            771
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            671
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Geodon/Zeldox
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            262
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            252
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            763
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            713
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Detrol/Detrol LA
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            237
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            283
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            758
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            845
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Zosyn/Tazocin&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            255
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            749
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Genotropin
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            211
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            232
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            650
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            636
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Vfend
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            200
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            196
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            595
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            555
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Protonix&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            203
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            535
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Chantix/Champix
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            163
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            155
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            522
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            524
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; BeneFIX&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            156
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            474
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Zoloft
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            126
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            128
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            390
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            368
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Caduet
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            127
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            130
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            388
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            392
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Aromasin
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            111
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            123
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            361
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            347
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Revatio
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            116
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            111
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            352
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            319
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Pristiq&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            118
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            341
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Medrol
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            119
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            106
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            341
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            334
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Cardura
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            95
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            109
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            312
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            330
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Aricept&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(c)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            100
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            108
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            310
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            311
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Zithromax/Zmax
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            90
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            85
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            303
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            299
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; BMP2&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            101
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            298
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Rapamune&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            104
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            292
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; ReFacto AF/Xyntha&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            102
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            290
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Fragmin
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            84
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            82
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            258
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            244
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Tygacil&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            78
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            250
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Alliance revenues&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(d)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,042
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            692
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            3,107
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,872
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"
          style="PADDING-BOTTOM: 2px"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; All other&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(e)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,978
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,815
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            5,932
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            5,210
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"
          style="PADDING-BOTTOM: 2px"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 18pt; text-align: left"&gt;
              Total Biopharmaceutical products
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            13,945
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            10,677
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            43,472
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            30,842
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Diversified:
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Animal Health&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(e)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            860
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            678
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2,599
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,863
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Consumer Healthcare&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            673
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2,014
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Nutrition&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            441
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,375
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"
          style="PADDING-BOTTOM: 2px"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Capsugel&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(f)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            176
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            177
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            545
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            516
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 18pt; text-align: left"&gt;
              Total Diversified
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2,150
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            855
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            6,533
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2,379
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"
          style="PADDING-BOTTOM: 2px"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Corporate/Other
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            76
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            89
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            243
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            251
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"
          style="BORDER-BOTTOM: black 4px double"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Total revenues
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            16,171
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            11,621
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            50,248
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            33,472
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td width="2%" style="WIDTH: 36pt"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt;
              (a)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td width="98%"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: left"&gt;
              Represents legacy Wyeth products for the three and
              nine months ended October 3, 2010. Legacy Wyeth
              products are not included in the three and nine
              months ended September 27, 2009.
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td width="2%" style="WIDTH: 36pt"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt;
              (b)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td width="98%"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: left"&gt;
              Outside the U.S. and Canada.
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td width="2%" style="WIDTH: 36pt"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt;
              (c)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td width="98%"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: left"&gt;
              Represents direct sales under license agreement with
              Eisai. Co. Ltd.
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="right" width="2%" style="WIDTH: 9pt"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              (d)&amp;nbsp;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" width="98%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              &lt;font
              style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Enbrel
              (in the U.S. and Canada)&lt;/font&gt;&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;,
              Aricept, Exforge, Rebif and Spiriva.
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td width="2%" style="WIDTH: 36pt"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt;
              (e)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td width="98%"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: left"&gt;
              Includes legacy Pfizer and legacy Wyeth products for
              the three and nine months ended October 3, 2010 and
              includes only legacy Pfizer products in the three and
              nine months ended September 27, 2009.
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td width="2%" style="WIDTH: 18pt"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt;
              (f)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td width="98%"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: left"&gt;
              Prior-period amounts for Capsugel, which were
              previously classified in &lt;font
              style="DISPLAY: inline; FONT-STYLE: italic"&gt;Corporate/Other,&lt;/font&gt;
              are now classified in &lt;font
              style="DISPLAY: inline; FONT-STYLE: italic"&gt;Diversified.&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-INDENT: 0pt"&gt;
      &amp;nbsp;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
      Revenues by geographic area follow:
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table cellpadding="0" cellspacing="0" width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr&gt;
          &lt;td valign="bottom" width="32%"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="10" valign="bottom" width="32%"
          style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: center"&gt;
              Three Months Ended&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="10" valign="bottom" width="32%"
          style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: center"&gt;
              Nine Months Ended&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="32%"
          style="BORDER-BOTTOM: black 2px solid"&gt;
            &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
              &amp;nbsp;
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-VARIANT: small-caps; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              (millions of dollars)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="10%"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Oct. 3,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2010
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="10%"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Sept. 27,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2009
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="8%"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              %
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Change
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="10%"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Oct. 3,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2010
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="10%"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Sept. 27,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2009
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="8%"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              %
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Change
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="32%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              United States
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            7,112
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            4,816
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="7%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            48
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            %
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            21,807
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            14,309
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="7%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            52
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            %
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="32%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Developed Europe&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(b)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            3,840
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            3,137
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="7%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            22
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            12,313
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            8,726
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="7%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            41
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="32%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Developed Rest of World&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(c)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2,377
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,958
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="7%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            21
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            7,401
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            5,648
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="7%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            31
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="32%"
          style="PADDING-BOTTOM: 2px"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Emerging Markets&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(d)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2,842
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,710
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="7%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right"&gt;
            66
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            8,727
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            4,789
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="7%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right"&gt;
            82
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="32%"
          style="BORDER-BOTTOM: black 4px double"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Total revenues
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            16,171
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            11,621
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="7%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            39
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            50,248
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            33,472
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="7%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            50
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td width="2%" style="WIDTH: 36pt"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt;
              (a)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td width="98%"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: left"&gt;
              Includes revenues from legacy Wyeth products for the
              three and nine months ended October 3, 2010. Revenues
              from legacy Wyeth products are not included in the
              three and nine months ended September 27, 2009.
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td width="2%" style="WIDTH: 36pt"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt;
              (b)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td width="98%"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: left"&gt;
              Developed Europe region includes the following
              markets: Western Europe and the Scandinavian
              countries.
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td width="2%" style="WIDTH: 36pt"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt;
              (c)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td width="98%"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: left"&gt;
              Developed Rest of World region includes the following
              markets: Australia, Canada, Japan, New Zealand, and
              South Korea.
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td width="2%" style="WIDTH: 36pt"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt;
              (d)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td width="98%"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: left"&gt;
              Emerging Markets region includes, but is not limited
              to, the following markets: Asia (excluding Japan and
              South Korea), Latin America, Middle East, Africa,
              Central and Eastern Europe, Russia and Turkey. Within
              the Biopharmaceutical segment, revenues from South
              Korea in 2009 have been reclassified from the
              Emerging Markets unit to the appropriate developed
              market units to conform to the current-year
              presentation.
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
  &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="Cur_9mos_20101003">&lt;div class="BWxbrlnote6"&gt;&lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;div&gt;&lt;div&gt;
    &lt;div
    style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
      &lt;a id="xbrlnote6" name="xbrlnote6"
      style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"&gt;Note
      6. Taxes on Income&lt;/a&gt;
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
      Our effective tax rate for continuing operations was 39.2%
      for the third quarter of 2010, compared to 27.5% for the
      third quarter of 2009, and 37.2% for the first nine months of
      2010, compared to 27.3% for the first nine months of 2009.
      The higher tax rates in the third quarter and first nine
      months of 2010 are primarily the result of:
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div&gt;
      &lt;table cellpadding="0" cellspacing="0" width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="right" style="WIDTH: 9pt"&gt;
            &lt;div style="DISPLAY: inline; FONT-SIZE: 10pt;"&gt;
              &lt;font
              style="DISPLAY: inline; FONT-FAMILY: Times New Roman"&gt;&amp;#9679;&lt;/font&gt;&amp;nbsp;&amp;nbsp;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: justify"&gt;
              higher expenses incurred as a result of our
              acquisition of Wyeth, and the mix of jurisdictions in
              which those expenses were incurred;
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div&gt;
      &lt;table cellpadding="0" cellspacing="0" width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="right" style="WIDTH: 9pt"&gt;
            &lt;div style="DISPLAY: inline; FONT-SIZE: 10pt;"&gt;
              &lt;font
              style="DISPLAY: inline; FONT-FAMILY: Times New Roman"&gt;&amp;#9679;&lt;/font&gt;&amp;nbsp;&amp;nbsp;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: justify"&gt;
              the expiration of the U.S. research and development
              tax credit; and
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div&gt;
      &lt;table cellpadding="0" cellspacing="0" width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="right" style="WIDTH: 9pt"&gt;
            &lt;div style="DISPLAY: inline; FONT-SIZE: 10pt;"&gt;
              &lt;font
              style="DISPLAY: inline; FONT-FAMILY: Times New Roman"&gt;&amp;#9679;&lt;/font&gt;&amp;nbsp;&amp;nbsp;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td style="TEXT-ALIGN: left"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
              the non-recurrence of a tax benefit of $174 million
              that was recorded in the third quarter of 2009
              related to the final resolution of a previously
              disclosed settlement which resulted in the receipt of
              information that raised our assessment of the
              likelihood of prevailing on the technical merits of
              our tax position;
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
      partially offset by:
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div&gt;
      &lt;table cellpadding="0" cellspacing="0" width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td align="right" style="WIDTH: 9pt"&gt;
            &lt;div style="DISPLAY: inline; FONT-SIZE: 10pt;"&gt;
              &lt;font
              style="DISPLAY: inline; FONT-FAMILY: Times New Roman"&gt;&amp;#9679;&lt;/font&gt;&amp;nbsp;&amp;nbsp;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: justify"&gt;
              the tax benefit associated with the charge incurred
              for asbestos litigation discussed in &lt;font
              style="DISPLAY: inline; FONT-STYLE: italic"&gt;Note
              5.&lt;/font&gt; &lt;font
              style="DISPLAY: inline; FONT-STYLE: italic"&gt;Other
              (Income)Deductions--Net&lt;/font&gt;.
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
      The effective tax rate for the first nine months of 2010 was
      additionally impacted by the write-off of the deferred tax
      asset of approximately $270 million related to the Medicare
      Part D subsidy for retiree prescription drug coverage,
      resulting from changes in the U.S. healthcare legislation
      enacted in March 2010 concerning the tax treatment of that
      subsidy, effective for tax years beginning after December 31,
      2012, offset by $460 million in tax benefits for the
      resolution of certain tax positions pertaining to prior years
      with various foreign tax authorities.
    &lt;/div&gt;
    &lt;div
    style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"&gt;
      &amp;nbsp;
    &lt;/div&gt;
  &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="Cur_9mos_20101003">&lt;div class="BWxbrlnote11"&gt;&lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;div&gt;&lt;div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;a id="xbrlnote11" name="xbrlnote11"
      style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"&gt;Note
      11. Pension and Postretirement Benefit Plans&lt;/a&gt;
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
      The components of net periodic benefit costs of the U.S. and
      international pension plans and the postretirement plans,
      which provide medical and life insurance benefits to retirees
      and their eligible dependents, follow:
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table cellpadding="0" cellspacing="0" width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr&gt;
          &lt;td valign="bottom"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="22" valign="bottom"
          style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: center"&gt;
              Pension Plans
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="6" valign="bottom"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="6" valign="bottom"
          style="BORDER-BOTTOM: black 2px solid"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: center"&gt;
              U.S. Qualified
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="6" valign="bottom"
          style="BORDER-BOTTOM: black 2px solid"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: center"&gt;
              U.S. Supplemental
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: center"&gt;
              (Non-Qualified)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="6" valign="bottom"
          style="BORDER-BOTTOM: black 2px solid"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: center"&gt;
              International
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="6" valign="bottom"
          style="BORDER-BOTTOM: black 2px solid"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: center"&gt;
              Postretirement
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: center"&gt;
              Plans
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom"
          style="BORDER-BOTTOM: black 2px solid"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-VARIANT: small-caps; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              (millions of dollars)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Oct. 3,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2010
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Sept. 27,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2009
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Oct. 3,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2010
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Sept. 27,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2009
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Oct. 3,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2010
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Sept. 27,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2009
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Oct. 3,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2010
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Sept. 27,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2009
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-DECORATION: underline; TEXT-INDENT: 0pt; text-align: left"&gt;
              For the Three Months Ended:
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="28%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Service cost
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            83
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            51
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            7
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            5
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            55
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            46
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            18
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            7
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="28%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Interest cost
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            183
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            116
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            19
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            12
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            103
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            85
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            52
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            30
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="28%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Expected return on plan assets
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (193
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (115
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            -
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            -
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (105
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (96
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (7
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (6
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="28%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Amortization of:
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="28%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Actuarial losses
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            38
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            51
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            7
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            7
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            17
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            6
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            7
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            4
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="28%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Prior service costs/(credits)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            -
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (1
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (1
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (1
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            -
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (15
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (1
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="28%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Curtailments and settlements&lt;font
              style="DISPLAY: inline; FONT-SIZE: 10pt"&gt;--&lt;/font&gt;net
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (3
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            47
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            8
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            -
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (4
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="28%"
          style="PADDING-BOTTOM: 2px"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Special termination benefits
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            7
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            5
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            3
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            -
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            3
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="28%"
          style="PADDING-BOTTOM: 4px"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Net periodic benefit costs
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            115
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            156
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            43
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            25
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            70
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            45
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            52
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            38
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="28%"&gt;
            &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
              &amp;nbsp;
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-DECORATION: underline; TEXT-INDENT: 0pt; text-align: left"&gt;
              For the Nine Months Ended:
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="28%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Service cost
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            266
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            162
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            22
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            15
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            172
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            133
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            61
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            22
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="28%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Interest cost
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            562
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            351
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            59
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            37
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            319
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            240
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            160
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            91
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="28%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Expected return on plan assets
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (595
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (349
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            -
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            -
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (324
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (268
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (23
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (19
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="28%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Amortization of:
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="28%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Actuarial losses
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            114
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            161
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            22
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            23
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            50
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            18
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            7
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            13
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="28%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Prior service costs/(credits)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (2
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (2
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (3
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (2
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (24
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (3
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="28%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Curtailments and settlements&lt;font
              style="DISPLAY: inline; FONT-SIZE: 10pt"&gt;--&lt;/font&gt;net
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (72
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            101
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (1
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            15
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (5
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (6
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            7
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="28%"
          style="PADDING-BOTTOM: 2px"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Special termination benefits
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            57
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            24
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            155
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            -
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            4
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            5
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            13
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            17
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="28%"
          style="BORDER-BOTTOM: black 4px double"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Net periodic benefit costs
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            333
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            452
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            255
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            88
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            213
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            128
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            188
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="6%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            128
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
      The decrease in net periodic benefit costs in the first nine
      months of 2010 compared to the first nine months of 2009 for
      our U.S. qualified pension plans was primarily driven by
      curtailment gains associated with Wyeth-related restructuring
      initiatives.&amp;nbsp;&amp;nbsp;The acquisition of Wyeth contributed
      to the increase in certain components of net periodic benefit
      costs, such as service cost and interest cost, offset by
      related expected return on plan assets.
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
      The increase in net periodic benefit costs in the first nine
      months of 2010 compared to the first nine months of 2009 for
      our U.S. supplemental (non-qualified) pension plans was
      primarily driven by special termination benefits recognized
      for certain executives as part of Wyeth-related restructuring
      initiatives.
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
      The increase in net periodic benefit costs in the first nine
      months of 2010 compared to the first nine months of 2009 for
      our international pension plans was primarily driven by the
      decrease in the discount rate and other differences in
      actuarial assumptions.
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
      For the first nine months of 2010, we contributed from our
      general assets $901 million to our U.S. qualified pension
      plans, $326 million to our U.S. supplemental (non-qualified)
      pension plans, $286 million to our international pension
      plans and $182 million to our postretirement plans.
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
      During 2010, we expect to contribute from our general assets
      a total of $901 million to our U.S. qualified pension plans,
      $456 million to our international pension plans, $420 million
      to our U.S. supplemental (non-qualified) pension plans, and
      $243 million to our postretirement plans. Contributions
      expected to be made during 2010 are inclusive of amounts
      contributed during the first nine months of 2010. The
      international pension plan, U.S. supplemental (non-qualified)
      pension plan and postretirement plan contributions from our
      general assets include direct employer benefit payments.
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &amp;nbsp;
    &lt;/div&gt;
  &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
  <us-gaap:EarningsPerShareTextBlock contextRef="Cur_9mos_20101003">&lt;div class="BWxbrlnote12"&gt;&lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;div&gt;&lt;div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;a id="xbrlnote12" name="xbrlnote12"
      style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"&gt;Note
      12. Earnings Per Share Attributable to Common
      Shareholders&lt;/a&gt;
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
      Basic and diluted earnings per share (EPS) were computed
      using the following data:
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table cellpadding="0" cellspacing="0" width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr&gt;
          &lt;td valign="bottom"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="6" valign="bottom"
          style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: center"&gt;
              Three Months Ended
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="6" valign="bottom"
          style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: center"&gt;
              Nine Months Ended
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom"
          style="BORDER-BOTTOM: black 2px solid"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-VARIANT: small-caps; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              (in millions)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Oct. 3,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2010
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Sept. 27,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2009
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Oct. 3,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2010
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Sept. 27,
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              2009
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              EPS Numerator--Basic:
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Income from continuing operations
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            876
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2,879
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            5,395
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            7,871
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"
          style="PADDING-BOTTOM: 2px"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;Less: Net income attributable
              to noncontrolling interests
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            5
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            3
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            24
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            9
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Income from continuing operations
              attributable to Pfizer Inc.
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            871
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2,876
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            5,371
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            7,862
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"
          style="PADDING-BOTTOM: 2px"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Less: Preferred stock
              dividends&lt;font
              style="DISPLAY: inline; FONT-SIZE: 10pt"&gt;--&lt;/font&gt;net
              of tax
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            -
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Income from continuing operations
              attributable to Pfizer Inc. common
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; &amp;nbsp;&amp;nbsp; shareholders
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            870
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2,876
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            5,369
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            7,860
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"
          style="PADDING-BOTTOM: 2px"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Discontinued operations&lt;font
              style="DISPLAY: inline; FONT-SIZE: 10pt"&gt;--&lt;/font&gt;net
              of tax
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (5
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (4
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            6
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"
          style="PADDING-BOTTOM: 4px"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Net income attributable to Pfizer
              Inc. common shareholders
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            865
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2,878
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            5,365
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            7,866
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign="bottom" width="52%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              EPS Numerator&lt;font
              style="DISPLAY: inline; FONT-SIZE: 10pt"&gt;--&lt;/font&gt;Diluted:
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Income from continuing operations
              attributable to Pfizer Inc. common
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; &amp;nbsp;&amp;nbsp; shareholders and
              assumed conversions
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            871
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2,876
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            5,371
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            7,862
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"
          style="PADDING-BOTTOM: 2px"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Discontinued operations&lt;font
              style="DISPLAY: inline; FONT-SIZE: 10pt"&gt;--&lt;/font&gt;net
              of tax
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (5
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (4
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            6
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"
          style="PADDING-BOTTOM: 4px"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Net income attributable to Pfizer
              Inc. common shareholders and assumed
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;conversions
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            866
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2,878
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            5,367
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            7,868
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign="bottom" width="52%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              EPS Denominator
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Weighted-average number of common
              shares outstanding&lt;font
              style="DISPLAY: inline; FONT-SIZE: 10pt"&gt;--&lt;/font&gt;Basic
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            8,027
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            6,730
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            8,045
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            6,727
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"
          style="PADDING-BOTTOM: 2px"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Common share equivalents: stock
              options, stock issuable under employee
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; &amp;nbsp;&amp;nbsp; compensation plans
              and convertible preferred stock
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            30
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            32
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            34
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            31
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"
          style="PADDING-BOTTOM: 4px"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Weighted-average number of common
              shares outstanding&lt;font
              style="DISPLAY: inline; FONT-SIZE: 10pt"&gt;--&lt;/font&gt;Diluted
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            8,057
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            6,762
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            8,079
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            6,758
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign="bottom" width="52%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="52%"
          style="BORDER-BOTTOM: black 4px double"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; Stock options that had exercise
              prices greater than the average market price
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: -9pt; text-align: left"&gt;
              &lt;font&gt;&amp;nbsp;&lt;/font&gt; &amp;nbsp;&amp;nbsp; of our common stock
              issuable under employee compensation plans&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            419
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            406
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            419
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            406
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td width="2%" style="WIDTH: 36pt"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt;
              (a)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td width="98%"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: left"&gt;
              These common stock equivalents were outstanding
              during the three and nine months ended October 3,
              2010 and September 27, 2009, but were not included in
              the computation of diluted EPS for those periods
              because their inclusion would have had an
              anti-dilutive effect.
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
  &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
  <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="Cur_9mos_20101003">&lt;div class="BWxbrlnote10"&gt;&lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;div&gt;&lt;div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;a id="xbrlnote10" name="xbrlnote10"
      style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"&gt;Note
      10. Goodwill and Other Intangible Assets&lt;/a&gt;
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"&gt;
      A. Goodwill
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
      The changes in the carrying amount of goodwill for the nine
      months ended October 3, 2010, follow:
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table cellpadding="0" cellspacing="0" width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="50%"
          style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-VARIANT: small-caps; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              (millions of dollars)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="12%"
          style="BORDER-TOP: black 2px solid; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Biopharmaceutical
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="10%"
          style="BORDER-TOP: black 2px solid; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Diversified
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="10%"
          style="BORDER-TOP: black 2px solid; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Other&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="10%"
          style="BORDER-TOP: black 2px solid; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Total
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign="bottom" width="50%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="12%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="10%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="10%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom" width="10%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="50%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Balance, December 31, 2009
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="11%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            22,165
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            173
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            20,038
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            42,376
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="50%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Additions
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="11%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            19
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2,127
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left; VERTICAL-ALIGN: text-top"&gt;
            (b)
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2,146
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="50%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Other&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(c)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="11%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (551
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (6
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (178
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (735
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="50%"
          style="PADDING-BOTTOM: 2px"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Allocation of Other goodwill&lt;font
              style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;(a)&lt;/font&gt;
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="11%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            19,091
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            2,896
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (21,987
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="50%"
          style="BORDER-BOTTOM: black 4px double"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Balance, October 3, 2010
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="11%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            40,705
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            3,082
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            --
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            43,787
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td width="2%" style="WIDTH: 36pt"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt;
              (a)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td width="98%"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: left"&gt;
              The &lt;font
              style="DISPLAY: inline; FONT-STYLE: italic"&gt;Other&lt;/font&gt;
              goodwill relates to our acquisition of Wyeth that was
              unallocated and subject to change until we completed
              the recording of the assets acquired and liabilities
              assumed from Wyeth (see &lt;font
              style="DISPLAY: inline; FONT-STYLE: italic"&gt;Note 3.
              Acquisition of Wyeth&lt;/font&gt;).
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td width="2%" style="WIDTH: 18pt"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt;
              (b)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td width="98%"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: left"&gt;
              Reflects the impact of measurement period adjustments
              (see &lt;font
              style="DISPLAY: inline; FONT-STYLE: italic"&gt;Note 3.
              Acquisition of Wyeth&lt;/font&gt;).
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table border="0" cellpadding="0" cellspacing="0"
      width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr valign="top"&gt;
          &lt;td width="2%" style="WIDTH: 18pt"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt;
              (c)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td width="98%"&gt;
            &lt;div
            style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: left"&gt;
              Primarily reflects the impact of foreign exchange.
            &lt;/div&gt;
          &lt;/td&gt;
        &lt;/tr&gt;
      &lt;/table&gt;
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-DECORATION: underline; TEXT-INDENT: 0pt; text-align: left"&gt;
      B. Other Intangible Assets
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div
    style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
      The components of identifiable intangible assets, primarily
      included in our Biopharmaceutical segment, follow:
    &lt;/div&gt;
    &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;
      &lt;br /&gt;
    &lt;/div&gt;
    &lt;div style="text-align: left"&gt;
      &lt;table cellpadding="0" cellspacing="0" width="100%"
      style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
        &lt;tr&gt;
          &lt;td valign="bottom"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="10" valign="bottom"
          style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: center"&gt;
              October 3, 2010
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="10" valign="bottom"
          style="BORDER-TOP: black 2px solid; BORDER-BOTTOM: black 2px solid"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: center"&gt;
              December 31, 2009
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom"
          style="BORDER-BOTTOM: black 2px solid"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-VARIANT: small-caps; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              (millions of dollars)
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Gross
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Carrying
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Amount
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Accumulated
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Amortization
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Identifiable
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Intangible
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Assets, less
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Accumulated
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Amortization
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Gross
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Carrying
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Amount
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Accumulated
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Amortization
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Identifiable
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Intangible
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Assets, less Accumulated
            &lt;/div&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right; TEXT-INDENT: 0pt"&gt;
              Amortization
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Finite-lived intangible assets:
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td colspan="2" valign="bottom"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="28%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Developed technology rights
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            68,436
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (24,782
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            43,654
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            68,870
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (21,223
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            $
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            47,647
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
          &lt;td align="left" valign="bottom" width="28%"&gt;
            &lt;div
            style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt; text-align: left"&gt;
              Brands
            &lt;/div&gt;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,622
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (587
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,035
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            1,637
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="9%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right"&gt;
            (535
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            )
          &lt;/td&gt;
          &lt;td align="left" valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valign="bottom" width="1%"
          style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left"&gt;
            &amp;nbsp;
          &lt;/td&gt;
          &lt;td valig